UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________________

FORM 10-Q

___________________________________________

(Mark One)


☒			Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, ~~2022~~2023


☐			Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from to

Commission File No. 0-22818

___________________________________________

THE HAIN CELESTIAL GROUP, INC.

(Exact name of registrant as specified in its charter)

___________________________________________


Delaware						22-3240619
(State or other jurisdiction of incorporation)						(I.R.S. Employer Identification No.)

~~1111 Marcus Avenue, Lake Success, NY 11042~~4600 Sleepytime Drive, Boulder, CO 80301

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (516) 587-5000

1111 Marcus Avenue, Lake Success, NY 11042

(Former name, former address and former fiscal year, if changed since last ~~report: N/A~~report)

___________________________________________

Table of Contents

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $.01 per share	HAIN	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

Non-accelerated filer

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ý

As ~~of April 29, 2022,~~of May 3, 2023, there were ~~89,797,463 shar~~es89,443,996 shares outstanding of the registrant’s Common Stock, par value $.01 per share.

Table of Contents

THE HAIN CELESTIAL GROUP, INC.

Index


	Part I - Financial Information	Page

Item 1.	Financial Statements
	Consolidated Balance Sheets - March 31, ~~2022~~202 3 and June 30, ~~2021~~2022	3
	Consolidated Statements of Operations - Three and nine months ended March 31, ~~2022~~2023 and ~~202~~12022	4
	Consolidated Statements of Comprehensive (Loss) Income ~~(Loss)~~ - Three and nine months ended March 31, ~~2022~~2023 and ~~202~~12022	5
	Consolidated Statement of Stockholders’ Equity - Three and nine months ended March 31, ~~202~~2 2023 and ~~202~~12022	6
	Consolidated Statements of Cash Flows - Nine months ended March 31, ~~202~~2 2023 and ~~202~~12022	8
	Notes to Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3635
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	51
Item 4.	Controls and Procedures	52

	Part II - Other Information

Items 3 and 4 are not ~~applicable~~applicable.
Item 1.	Legal Proceedings	53
Item 1A.	Risk Factors	53
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	53
Item 5.	Other Information	5355
Item 6.	Exhibits	5455
Signatures		5556

Table of Contents

Forward-Looking Statements

This Quarterly Report on Form 10-Q for the quarter ended March 31, ~~2022~~2023 (the “Form 10-Q”) contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties, and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of The Hain Celestial Group, Inc. (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”) may differ materially from those expressed or implied by such forward-looking statements. The words “believe,” “expect,” “anticipate,” “may,” “should,” “plan,” “intend,” “potential,” “will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; foreign exchange and inflation rates; our strategic initiatives, our business strategy, our supply chain, including the availability and pricing of raw materials, our brand portfolio, pricing actions and product performance; ~~the COVID-19 pandemic; the success of our pricing negotiations;~~ current or future macroeconomic trends; and future corporate acquisitions or dispositions.

Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and uncertainty resulting from the impact of competition; ~~challenges and uncertainty resulting from the COVID-19 pandemic;~~ our ability to manage our supply chain effectively; ~~supply chain disruptions, cybersecurity risks~~input cost inflation, including with respect to freight and other distribution costs; foreign currency exchange risk; risks arising from the ~~war in Ukraine;~~Russia-Ukraine war; disruption of operations at our manufacturing facilities; reliance on independent contract manufacturers; changes to consumer preferences; customer concentration; reliance on independent distributors; the availability of natural and organic ingredients; risks associated with ~~our international sales~~operating internationally; pending and ~~operations;~~future litigation, including litigation relating to Earth’s Best® baby food products; risks associated with outsourcing arrangements; our ability to execute our cost reduction initiatives and related strategic initiatives; our ability to identify and complete acquisitions or divestitures and our level of success in integrating acquisitions; our reliance on independent certification for a number of our products; the reputation of our Company and our brands; our ability to use and protect trademarks; general economic conditions; ~~input cost inflation;~~ the United Kingdom’s exit from the European Union; c~~ybersecurity~~cybersecurity incidents; disruptions to information technology systems; the impact of climate change; liabilities, claims or regulatory change with respect to environmental matters; potential liability if our products cause illness or physical harm; the highly regulated environment in which we operate; ~~pending and future litigation;~~ compliance with data privacy laws; compliance with our credit agreement; ~~the discontinuation of LIBOR;~~ our ability to issue preferred stock; the adequacy of our insurance coverage; impairments in the carrying value of goodwill or other intangible assets; and other risks and matters described in our most recent Annual Report on Form 10-K, this Form 10-Q and ~~our~~ other ~~filings from time to time with~~reports that we file in the ~~U.S. Securities and Exchange Commission.~~future.

We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

MARCH 31, ~~2022~~2023 AND JUNE 30, ~~2021~~2022

(In thousands, except par values)


		March 31,		June 30,			March 31,		June 30,
		2022		2021			2023		2022
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	57,808	$	75,871	Cash and cash equivalents	$	43,682	$	65,512
Accounts receivable, less allowance for doubtful accounts of $1,137 and $1,314, respectively		158,734		174,066
Accounts receivable, less allowance for doubtful accounts of $3,229 and $1,731, respectively						Accounts receivable, less allowance for doubtful accounts of $3,229 and $1,731, respectively	179,114		170,661
Inventories	Inventories	294,428		285,410		Inventories	316,345		308,034
Prepaid expenses and other current assets	Prepaid expenses and other current assets	45,308		39,834		Prepaid expenses and other current assets	58,719		54,079
Assets held for sale	Assets held for sale	3,313		1,874		Assets held for sale	1,250		1,840
Total current assets	Total current assets	559,591		577,055		Total current assets	599,110		600,126
Property, plant and equipment, net	Property, plant and equipment, net	312,819		312,777		Property, plant and equipment, net	296,433		297,405
Goodwill	Goodwill	950,820		871,067		Goodwill	931,729		933,796
Trademarks and other intangible assets, net	Trademarks and other intangible assets, net	492,939		314,895		Trademarks and other intangible assets, net	314,536		477,533
Investments and joint ventures	Investments and joint ventures	16,056		16,917		Investments and joint ventures	12,720		14,456
Operating lease right-of-use assets, net	Operating lease right-of-use assets, net	88,636		92,010		Operating lease right-of-use assets, net	98,306		114,691
Other assets	Other assets	20,619		21,187		Other assets	19,990		20,377

Total assets	Total assets	$	2,441,480	$	2,205,908	Total assets	$	2,272,824	$	2,458,384
LIABILITIES AND STOCKHOLDERS’ EQUITY	LIABILITIES AND STOCKHOLDERS’ EQUITY					LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	176,699	$	171,947	Accounts payable	$	146,340	$	174,765
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	98,181		117,957		Accrued expenses and other current liabilities	95,841		86,833
Current portion of long-term debt	Current portion of long-term debt	7,774		530		Current portion of long-term debt	7,575		7,705

Total current liabilities	Total current liabilities	282,654		290,434		Total current liabilities	249,756		269,303
Long-term debt, less current portion	Long-term debt, less current portion	827,771		230,492		Long-term debt, less current portion	848,982		880,938
Deferred income taxes	Deferred income taxes	86,120		42,639		Deferred income taxes	51,155		95,044
Operating lease liabilities, noncurrent portion	Operating lease liabilities, noncurrent portion	81,379		85,929		Operating lease liabilities, noncurrent portion	91,885		107,481
Other noncurrent liabilities	Other noncurrent liabilities	19,512		33,531		Other noncurrent liabilities	24,571		22,450

Total liabilities	Total liabilities	1,297,436		683,025		Total liabilities	1,266,349		1,375,216
Commitments and contingencies (Note 17)		0		0
Commitments and contingencies (Note 16)						Commitments and contingencies (Note 16)
Stockholders’ equity:	Stockholders’ equity:					Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	—		—		Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	—		—
Common stock - $.01 par value, authorized 150,000 shares; issued: 111,087 and 109,507 shares, respectively; outstanding: 89,800 and 99,069 shares, respectively		1,111		1,096
Common stock - $.01 par value, authorized 150,000 shares; issued: 111,263 and 111,090 shares, respectively; outstanding: 89,423 and 89,302 shares, respectively						Common stock - $.01 par value, authorized 150,000 shares; issued: 111,263 and 111,090 shares, respectively; outstanding: 89,423 and 89,302 shares, respectively	1,113		1,111
Additional paid-in capital	Additional paid-in capital	1,199,804		1,187,530		Additional paid-in capital	1,213,783		1,203,126
Retained earnings	Retained earnings	766,056		691,225		Retained earnings	671,260		769,098
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(110,350)		(73,011)		Accumulated other comprehensive loss	(152,945)		(164,482)
		1,856,621		1,806,840			1,733,211		1,808,853
Less: Treasury stock, at cost, 21,287 and 10,438 shares, respectively		(712,577)		(283,957)
Less: Treasury stock, at cost, 21,840 and 21,788 shares, respectively						Less: Treasury stock, at cost, 21,840 and 21,788 shares, respectively	(726,736)		(725,685)
Total stockholders’ equity	Total stockholders’ equity	1,144,044		1,522,883		Total stockholders’ equity	1,006,475		1,083,168
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	2,441,480	$	2,205,908	Total liabilities and stockholders’ equity	$	2,272,824	$	2,458,384

See notes to consolidated financial statements.

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, ~~2022~~2023 AND ~~2021~~2022

(In thousands, except per share amounts)
Three Months Ended March 31, Nine Months Ended March 31,
2022 2021 2022 2021
Net sales $ 502,939 $ 492,604 $ 1,434,783 $ 1,519,649
Cost of sales 387,236 362,698 1,096,367 1,140,614
Gross profit 115,703 129,906 338,416 379,035
Selling, general and administrative expenses 75,750 74,325 229,875 238,471
Amortization of acquired intangible assets 3,110 2,145 7,254 6,771
Productivity and transformation costs 1,679 4,451 8,448 10,895
Proceeds from insurance claim — (592) (196) (592)
Long-lived asset and intangibles impairment — — 303 57,676
Operating income 35,164 49,577 92,732 65,814
Interest and other financing expense, net 3,224 2,030 7,672 6,820
Other (income) expense, net (712) 1,566 (10,570) (852)
Income from continuing operations before income taxes and equity in net loss (income) of equity-method investees 32,652 45,981 95,630 59,846
Provision for income taxes 7,738 11,797 19,425 33,197
Equity in net loss (income) of equity-method investees 383 (70) 1,374 1,025
Net income from continuing operations $ 24,531 $ 34,254 $ 74,831 $ 25,624
Net income from discontinued operations, net of tax — — — 11,255
Net income $ 24,531 $ 34,254 $ 74,831 $ 36,879
Net income per common share:
Basic net income per common share from continuing operations $ 0.27 $ 0.34 $ 0.80 $ 0.25
Basic net income per common share from discontinued operations — — — 0.11
Basic net income per common share $ 0.27 $ 0.34 $ 0.80 $ 0.36
Diluted net income per common share from continuing operations $ 0.27 $ 0.34 $ 0.79 $ 0.25
Diluted net income per common share from discontinued operations — — — 0.11
Diluted net income per common share $ 0.27 $ 0.34 $ 0.79 $ 0.36
Shares used in the calculation of net income per common share:
Basic 91,139 99,831 94,099 100,502
Diluted 91,310 101,596 94,519 101,385


	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Net sales	$	455,243	$	502,939	$	1,348,802	$	1,434,783
Cost of sales	357,764		387,236		1,053,131		1,096,367
Gross profit	97,479		115,703		295,671		338,416
Selling, general and administrative expenses	75,047		75,750		222,355		229,679
Intangibles and long-lived asset impairment	156,583		—		156,923		303

Amortization of acquired intangible assets	2,842		3,110		8,415		7,254
Productivity and transformation costs	3,933		1,679		5,692		8,448





Operating (loss) income	(140,926)		35,164		(97,714)		92,732
Interest and other financing expense, net	13,421		3,224		31,910		7,672
Other expense (income), net	439		(712)		(2,413)		(10,570)
(Loss) income before income taxes and equity in net loss of equity-method investees	(154,786)		32,652		(127,211)		95,630
(Benefit) provision for income taxes	(39,587)		7,738		(30,599)		19,425
Equity in net loss of equity-method investees	528		383		1,226		1,374


Net (loss) income	$	(115,727)	$	24,531	$	(97,838)	$	74,831

Net (loss) income per common share:


Basic	$	(1.29)	$	0.27	$	(1.09)	$	0.80



Diluted	$	(1.29)	$	0.27	$	(1.09)	$	0.79

Shares used in the calculation of net (loss) income per common share:
Basic	89,421		91,139		89,369		94,099
Diluted	89,421		91,310		89,369		94,519

See notes to consolidated financial statements.

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (~~LOSS)~~(UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, ~~2022~~2023 AND ~~2021~~2022

(In thousands)
Three Months Ended
March 31, 2022 March 31, 2021

Pre-tax
amount
Tax (expense) benefit After-tax amount
Pre-tax
amount
Tax (expense) benefit After-tax amount
Net income $ 24,531 $ 34,254
Other comprehensive income (loss):
Foreign currency translation adjustments before reclassifications $ (18,701) $ — (18,701) $ 1,672 $ — 1,672
Reclassification of currency translation adjustment included in net loss from discontinued operations, net of tax — — — 14,725 — 14,725
Change in deferred gains (losses) on cash flow hedging instruments 1,841 (387) 1,454 322 (68) 254
Change in deferred gains (losses) on net investment hedging instruments 1,426 (299) 1,127 3,810 (800) 3,010
Total other comprehensive (loss) income $ (15,434) $ (686) $ (16,120) $ 20,529 $ (868) $ 19,661
Total comprehensive income $ 8,411 $ 53,915
Nine Months Ended
March 31, 2022 March 31, 2021
Pre-tax
amount Tax (expense) benefit After-tax amount Pre-tax
amount Tax (expense) benefit After-tax amount
Net income $ 74,831 $ 36,879
Other comprehensive income (loss):
Foreign currency translation adjustments before reclassifications $ (43,649) $ — (43,649) $ 80,491 $ — 80,491
Reclassification of currency translation adjustment included in net income — — — 15,906 — 15,906
Change in deferred gains (losses) on cash flow hedging instruments 2,567 (540) 2,027 474 (100) 374
Change in deferred gains (losses) on net investment hedging instruments 5,423 (1,140) 4,283 (3,875) 814 (3,061)
Total other comprehensive (loss) income $ (35,659) $ (1,680) $ (37,339) $ 92,996 $ 714 $ 93,710
Total comprehensive income $ 37,492 $ 130,589


	Three Months Ended
	March 31, 2023						March 31, 2022
	Pretax amount		Tax (expense) benefit		After-tax amount		Pretax amount		Tax (expense) benefit		After-tax amount
Net (loss) income					$	(115,727)					$	24,531

Other comprehensive income (loss):
Foreign currency translation adjustments before reclassifications	$	15,250	$	—	15,250		$	(18,701)	$	—	(18,701)

Change in deferred (losses) gains on cash flow hedging instruments	(6,031)		1,521		(4,510)		1,841		(387)		1,454
Change in deferred gains on fair value hedging instruments	172		(43)		129		—		—		—
Change in deferred (losses) gains on net investment hedging instruments	(628)		160		(468)		1,426		(299)		1,127

Total other comprehensive income (loss)	$	8,763	$	1,638	$	10,401	$	(15,434)	$	(686)	$	(16,120)

Total comprehensive (loss) income					$	(105,326)					$	8,411

	Nine Months Ended
	March 31, 2023						March 31, 2022
	Pretax amount		Tax (expense) benefit		After-tax amount		Pretax amount		Tax (expense) benefit		After-tax amount
Net (loss) income					$	(97,838)					$	74,831

Other comprehensive income (loss):
Foreign currency translation adjustments before reclassifications	$	7,774	$	—	7,774		$	(43,649)	$	—	(43,649)

Change in deferred gains on cash flow hedging instruments	5,724		(1,506)		4,218		2,567		(540)		2,027
Change in deferred gains on fair value hedging instruments	591		(145)		446		—		—		—
Change in deferred (losses) gains on net investment hedging instruments	(1,139)		238		(901)		5,423		(1,140)		4,283
Total other comprehensive income (loss)	$	12,950	$	(1,413)	$	11,537	$	(35,659)	$	(1,680)	$	(37,339)

Total comprehensive (loss) income					$	(86,301)					$	37,492

See notes to consolidated financial statements.

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, ~~2022~~2023

(In thousands, except par values)


		Common Stock			Additional							Accumulated Other					Common Stock			Additional							Accumulated Other
			Amount		Paid-in		Retained		Treasury Stock			Comprehensive						Amount		Paid-in		Retained		Treasury Stock			Comprehensive
		Shares	at $.01		Capital		Earnings		Shares	Amount		Loss		Total			Shares	at $.01		Capital		Earnings		Shares	Amount		Loss		Total
Balance at June 30, 2021		109,507	$	1,096	$	1,187,530	$	691,225	10,438	$	(283,957)	$	(73,011)	$	1,522,883
Balance at June 30, 2022																Balance at June 30, 2022	111,090	$	1,111	$	1,203,126	$	769,098	21,788	$	(725,685)	$	(164,482)	$	1,083,168
Net income	Net income						19,411							19,411		Net income						6,923							6,923

Other comprehensive loss	Other comprehensive loss											(20,963)		(20,963)		Other comprehensive loss											(52,462)		(52,462)
Issuance of common stock pursuant to stock-based compensation plans	Issuance of common stock pursuant to stock-based compensation plans	61	—		—									—		Issuance of common stock pursuant to stock-based compensation plans	24	1											1

Employee shares withheld for taxes	Employee shares withheld for taxes								29	(1,175)				(1,175)		Employee shares withheld for taxes								10	(229)				(229)
Repurchases of common stock									4,525	(175,687)				(175,687)

Stock-based compensation expense	Stock-based compensation expense				4,287									4,287		Stock-based compensation expense				3,994									3,994
Balance at September 30, 2021		109,568	$	1,096	$	1,191,817	$	710,636	14,992	$	(460,819)	$	(93,974)	$	1,348,756
Balance at September 30, 2022																Balance at September 30, 2022	111,114	$	1,112	$	1,207,120	$	776,021	21,798	$	(725,914)	$	(216,944)	$	1,041,395
Net income	Net income						30,889							30,889		Net income						10,966							10,966

Other comprehensive loss												(256)		(256)
Other comprehensive income																Other comprehensive income											53,598		53,598
Issuance of common stock pursuant to stock-based compensation plans	Issuance of common stock pursuant to stock-based compensation plans	1,436	14		(14)									—		Issuance of common stock pursuant to stock-based compensation plans	142	1											1

Employee shares withheld for taxes	Employee shares withheld for taxes								654	(29,858)				(29,858)		Employee shares withheld for taxes								39	(754)				(754)
Repurchases of common stock									2,027	(89,831)				(89,831)

Stock-based compensation expense	Stock-based compensation expense				4,156									4,156		Stock-based compensation expense				3,435									3,435
Balance at December 31, 2021		111,004	$	1,110	$	1,195,959	$	741,525	17,673	$	(580,508)	$	(94,230)	$	1,263,856
Net income							24,531							24,531
Other comprehensive loss												$	(16,120)	(16,120)
Balance at December 31, 2022																Balance at December 31, 2022	111,256	$	1,113	$	1,210,555	$	786,987	21,837	$	(726,668)	$	(163,346)	$	1,108,641
Net loss																Net loss						(115,727)							(115,727)

Other comprehensive income																Other comprehensive income											10,401		10,401
Issuance of common stock pursuant to stock-based compensation plans	Issuance of common stock pursuant to stock-based compensation plans	83	1		(1)									—		Issuance of common stock pursuant to stock-based compensation plans	7												—

Employee shares withheld for taxes	Employee shares withheld for taxes								40	(1,597)				(1,597)		Employee shares withheld for taxes								3	(68)				(68)
Repurchases of common stock									3,574	(130,472)				(130,472)

Stock-based compensation expense	Stock-based compensation expense				3,846									3,846		Stock-based compensation expense				3,228									3,228
Balance at March 31, 2022		111,087	$	1,111	$	1,199,804	$	766,056	21,287	$	(712,577)	$	(110,350)	$	1,144,044
Balance at March 31, 2023																Balance at March 31, 2023	111,263	$	1,113	$	1,213,783	$	671,260	21,840	$	(726,736)	$	(152,945)	$	1,006,475

See notes to consolidated financial statements.

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, ~~2021~~2022

(In thousands, except par values)


		Common Stock			Additional							Accumulated Other					Common Stock			Additional							Accumulated Other
			Amount		Paid-in		Retained		Treasury Stock			Comprehensive						Amount		Paid-in		Retained		Treasury Stock			Comprehensive
		Shares	at $.01		Capital		Earnings		Shares	Amount		Income (Loss)		Total			Shares	at $.01		Capital		Earnings		Shares	Amount		Loss		Total
Balance at June 30, 2020		109,123	$	1,092	$	1,171,875	$	614,171	7,238	$	(172,192)	$	(171,392)	$	1,443,554
Balance at June 30, 2021																Balance at June 30, 2021	109,507	$	1,096	$	1,187,530	$	691,225	10,438	$	(283,957)	$	(73,011)	$	1,522,883
Net income	Net income						485							485		Net income						19,411							19,411
Cumulative effect of adoption of ASU 2016-02							(310)							(310)

Other comprehensive income												31,005		31,005

Other comprehensive loss																Other comprehensive loss											(20,963)		(20,963)
Issuance of common stock pursuant to stock-based compensation plans	Issuance of common stock pursuant to stock-based compensation plans	54	1		(1)									—		Issuance of common stock pursuant to stock-based compensation plans	61	—		—									—

Employee shares withheld for taxes	Employee shares withheld for taxes								20	(468)				(468)		Employee shares withheld for taxes								29	(1,175)				(1,175)
Repurchase of common stock	Repurchase of common stock								1,281	(42,052)				(42,052)		Repurchase of common stock								4,525	(175,687)				(175,687)
Stock-based compensation expense	Stock-based compensation expense				4,367									4,367		Stock-based compensation expense				4,287									4,287
Balance at September 30, 2020		109,177	$	1,093	$	1,176,241	$	614,346	8,539	$	(214,712)	$	(140,387)	$	1,436,581
Balance at September 30, 2021																Balance at September 30, 2021	109,568	$	1,096	$	1,191,817	$	710,636	14,992	$	(460,819)	$	(93,974)	$	1,348,756
Net income	Net income						2,140							2,140		Net income						30,889							30,889

Other comprehensive income												43,044		43,044
Other comprehensive loss																Other comprehensive loss											(256)		(256)
Issuance of common stock pursuant to stock-based compensation plans	Issuance of common stock pursuant to stock-based compensation plans	162	2		(2)									—		Issuance of common stock pursuant to stock-based compensation plans	1,436	14		(14)									—

Employee shares withheld for taxes	Employee shares withheld for taxes								38	(1,255)				(1,255)		Employee shares withheld for taxes								654	(29,858)				(29,858)
Repurchase of common stock	Repurchase of common stock								923	(29,684)				(29,684)		Repurchase of common stock								2,027	(89,831)				(89,831)
Stock-based compensation expense	Stock-based compensation expense				3,823									3,823		Stock-based compensation expense				4,156									4,156
Balance at December 31, 2020		109,339	$	1,095	$	1,180,062	$	616,486	9,500	$	(245,651)	$	(97,343)	$	1,454,649
Balance at December 31, 2021																Balance at December 31, 2021	111,004	$	1,110	$	1,195,959	$	741,525	17,673	$	(580,508)	$	(94,230)	$	1,263,856
Net income	Net income						34,254							34,254		Net income						24,531							24,531
Other comprehensive income												19,661		19,661
Other comprehensive loss																Other comprehensive loss											(16,120)		(16,120)
Issuance of common stock pursuant to stock-based compensation plans	Issuance of common stock pursuant to stock-based compensation plans	127	1		(1)									—		Issuance of common stock pursuant to stock-based compensation plans	83	1		(1)									—
Employee shares withheld for taxes	Employee shares withheld for taxes								49	(2,018)				(2,018)		Employee shares withheld for taxes								40	(1,597)				(1,597)
Repurchase of common stock	Repurchase of common stock								204	(8,562)				(8,562)		Repurchase of common stock								3,574	(130,472)				(130,472)
Stock-based compensation expense	Stock-based compensation expense				3,698									3,698		Stock-based compensation expense				3,846									3,846
Balance at March 31, 2021		109,466	$	1,096	$	1,183,759	$	650,740	9,753	$	(256,231)	$	(77,682)	$	1,501,682
Balance at March 31, 2022																Balance at March 31, 2022	111,087	$	1,111	$	1,199,804	$	766,056	21,287	$	(712,577)	$	(110,350)	$	1,144,044

See notes to consolidated financial statements.

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

FOR THE NINE MONTHS ENDED MARCH 31, ~~2022~~2023 AND ~~2021~~2022

(In thousands)


		Nine Months Ended March 31,					Nine Months Ended March 31,
		2022		2021			2023		2022
CASH FLOWS FROM OPERATING ACTIVITIES	CASH FLOWS FROM OPERATING ACTIVITIES					CASH FLOWS FROM OPERATING ACTIVITIES
Net income		$	74,831	$	36,879
Net income from discontinued operations		—		11,255
Net income from continuing operations		74,831		25,624
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities from continuing operations:
Net (loss) income						Net (loss) income	$	(97,838)	$	74,831

Adjustments to reconcile net (loss) income to net cash provided by operating activities:						Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	Depreciation and amortization	34,396		37,768		Depreciation and amortization	37,909		34,396
Deferred income taxes	Deferred income taxes	7,374		3,216		Deferred income taxes	(44,809)		7,374

Equity in net loss of equity-method investees	Equity in net loss of equity-method investees	1,374		1,025		Equity in net loss of equity-method investees	1,226		1,374
Stock-based compensation, net	Stock-based compensation, net	12,289		11,888		Stock-based compensation, net	10,657		12,289

Long-lived asset and intangibles impairment		303		57,676
Intangibles and long-lived asset impairment						Intangibles and long-lived asset impairment	156,923		303
Gain on sale of assets	Gain on sale of assets	(8,869)		—		Gain on sale of assets	(3,529)		(8,869)
Loss on sale of businesses		—		1,217
Other non-cash items, net	Other non-cash items, net	(2,155)		(723)		Other non-cash items, net	(1,526)		(2,155)
Increase (decrease) in cash attributable to changes in operating assets and liabilities:
(Decrease) increase in cash attributable to changes in operating assets and liabilities:						(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable	Accounts receivable	14,150		(20,721)		Accounts receivable	(7,926)		14,150
Inventories	Inventories	(4,371)		(60,304)		Inventories	(8,534)		(4,371)
Other current assets	Other current assets	(10,996)		56,487		Other current assets	455		(10,996)
Other assets and liabilities	Other assets and liabilities	(2,705)		(952)		Other assets and liabilities	3,496		(2,705)
Accounts payable and accrued expenses	Accounts payable and accrued expenses	(16,435)		34,316		Accounts payable and accrued expenses	(20,195)		(16,435)
Net cash provided by operating activities from continuing operations		99,186		146,517
Net cash provided by operating activities						Net cash provided by operating activities	26,309		99,186
CASH FLOWS FROM INVESTING ACTIVITIES	CASH FLOWS FROM INVESTING ACTIVITIES					CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	Purchases of property, plant and equipment	(33,939)		(53,062)		Purchases of property, plant and equipment	(21,434)		(33,939)
Acquisitions of businesses, net of cash acquired	Acquisitions of businesses, net of cash acquired	(260,474)		—		Acquisitions of businesses, net of cash acquired	—		(260,474)
Investment in joint venture		(614)		(694)
Investments and joint ventures, net						Investments and joint ventures, net	433		(614)
Proceeds from sale of assets	Proceeds from sale of assets	10,756		—		Proceeds from sale of assets	7,758		10,756
Proceeds from sale of businesses, net and other		—		27,788
Net cash used in investing activities from continuing operations		(284,271)		(25,968)

Net cash used in investing activities						Net cash used in investing activities	(13,243)		(284,271)
CASH FLOWS FROM FINANCING ACTIVITIES	CASH FLOWS FROM FINANCING ACTIVITIES					CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility	Borrowings under bank revolving credit facility	678,000		206,000		Borrowings under bank revolving credit facility	275,000		678,000
Repayments under bank revolving credit facility	Repayments under bank revolving credit facility	(370,000)		(231,000)		Repayments under bank revolving credit facility	(301,000)		(370,000)
Borrowings under term loan	Borrowings under term loan	300,000		—		Borrowings under term loan	—		300,000
Repayments under term loan	Repayments under term loan	(1,875)		—		Repayments under term loan	(5,625)		(1,875)

Payments of other debt, net	Payments of other debt, net	(3,232)		(1,917)		Payments of other debt, net	(2,116)		(3,232)
Share repurchases	Share repurchases	(397,405)		(80,298)		Share repurchases	—		(397,405)
Employee shares withheld for taxes	Employee shares withheld for taxes	(32,630)		(3,741)		Employee shares withheld for taxes	(1,051)		(32,630)
Net cash provided by (used in) financing activities from continuing operations		172,858		(110,956)
Effect of exchange rate changes on cash from continuing operations		(5,836)		5,650
Net cash (used in) provided by financing activities						Net cash (used in) provided by financing activities	(34,792)		172,858
Effect of exchange rate changes on cash						Effect of exchange rate changes on cash	(104)		(5,836)

Net (decrease) increase in cash and cash equivalents		(18,063)		15,243
Net decrease in cash and cash equivalents						Net decrease in cash and cash equivalents	(21,830)		(18,063)
Cash and cash equivalents at beginning of period	Cash and cash equivalents at beginning of period	75,871		37,771		Cash and cash equivalents at beginning of period	65,512		75,871
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	57,808	$	53,014	Cash and cash equivalents at end of period	$	43,682	$	57,808

See notes to consolidated financial statements.

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(Amounts in thousands, except par values and per share data)

1. BUSINESS

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”), was founded in 1993 and is headquartered in ~~Lake Success, New York.~~Boulder, Colorado. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet. The Company continues to be a leading marketer, manufacturer, and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug, and convenience stores ~~in over 80 countries~~ worldwide. The Company operates under 2two reportable segments: North America and International.

~~Acquisition~~

~~Discontinued Operations~~

~~The financial statements separately report discontinued operations and the results of continuing operations (see Note 4,~~ ~~Acquisitions and Dispositions). All footnotes exclude discontinued operations unless otherwise noted.~~

2. BASIS OF PRESENTATION

The Company’s unaudited consolidated financial statements include the accounts of the Company and its ~~wholly-owned~~wholly owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net (loss) income includes the Company's equity in the current earnings or losses of such companies.

The Company's unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021~~2022 (the “Form 10-K”). The amounts as of and for the periods ended June 30, ~~2021~~2022 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for ~~the nine months ended March 31, 2022~~interim periods are not necessarily indicative of the results ~~that may be expected~~ for the ~~fiscal year ending June 30, 2022.~~full year. Please refer to the Notes to the Consolidated Financial Statements as of June 30, ~~2021~~2022 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes.

All amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated.

Reclassifications

Certain prior year amounts have been reclassified to conform with current year presentation.

Significant Accounting Policies

The Company's significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies.

Transfer of Financial Assets

The Company ~~has~~accounts for transfers of financial assets, such as non-recourse accounts receivable financing arrangements, when the Company has surrendered control over the related assets. Determining whether control has transferred requires an evaluation of relevant legal considerations, an assessment of the nature and extent of the Company’s continuing involvement with the assets transferred and any other relevant considerations. The Company has non-recourse financing arrangements in which eligible receivables are sold to third-party buyers in exchange for cash. The Company transferred accounts receivable in their entirety to the buyers and satisfied all of the conditions to report the transfer of financial assets in their entirety as a sale. The principal amount of receivables sold under these arrangements ~~was~~was $290,856 and $112,607 ~~and $59,871~~ during the nine months ended March 31, 2023 and 2022, ~~and 2021,~~ respectively. The incremental cost

~~Table~~ of ~~Contents~~

~~of accounts receivable~~ financing ~~arrangeme~~receivables~~nts~~ under these arrangements is included in ~~Other (income) expense, net in~~selling, general and administrative expenses on the Company’s Consolidated Statements of Operations. The proceeds from the sale of receivables are included in cash ~~provided by~~used in operating activities inon the ~~accompanying~~ Consolidated Statements of Cash Flows.

~~0Recently~~

Table of Contents

Recently Issued and Adopted Accounting Pronouncements

In ~~October 2021,~~March 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (“ASU”) ~~2021-08, Business Combinations~~2023-02, Investments — Equity Method and Joint Ventures (Topic ~~805)~~323): Accounting for ~~Contract Assets~~Investments in Tax Credit Structures Using the Proportional Amortization Method which would allow reporting entities to consistently account for equity investments made primarily for the purpose of receiving income tax credits and Contract Liabilities from Contracts with Customers, which requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination on the acquisition date in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers, as if it had originated the contracts.other income tax benefits This ~~approach differs from the current requirement to measure contract assets and contract liabilities acquired in a business combination at fair value. The Company adopted~~ ASU ~~2021-08 during the second quarter of~~is effective for fiscal ~~year 2022, and the adoption did~~years beginning after December 15, 2023. This standard will not have anany impact on the Company's consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, ~~Reference~~"Reference Rate Reform (Topic 848):, Facilitation of the Effects of Reference Rate Reform on Financial ~~Reporting, which provides temporary optional expedients~~Reporting". The guidance allows for companies to: (1) account for certain contract modifications as a continuation of the existing contract without additional analysis; (2) continue hedge accounting when certain critical terms of a hedging relationship change and ~~exceptions for applying U.S. GAAP~~assess effectiveness in ways that disregard certain potential sources of ineffectiveness; and (3) make a one-time sale and/or transfer of certain debt securities from held-to-maturity to ~~contracts,~~available-for-sale or trading. This ASU was adopted by the Company and applies prospectively to contract modifications and hedging ~~relationships and other transactions affected by reference rate reform.~~relationships. ASU 2020-04 is currently effective and ~~upon adoption~~ may be applied prospectively to contract modifications made on or before December 31, 2022. In ~~January 2021,~~December 2022, the FASB issued ASU ~~2021-01,~~2022-06, Reference Rate Reform (Topic 848): ~~Scope,~~Deferral of the Sunset Date of Topic 848, which ~~clarifies~~extends certain provisions inof Topic 848 ~~if elected by an entity,~~ to ~~apply~~December 31, 2024.

ASU 2020-04 allows for different elections to ~~derivative instruments that use an interest rate for margining, discounting,~~be made at different points in time and the timing of those elections will be documented as applicable. For the avoidance of doubt, the Company intends to reassess its elections of optional expedients and exceptions included within ASU 2020-04 related to its hedging activities and will document the election of these items on a quarterly basis or ~~contract price alignment that is modified as a result of reference rate reform.~~ when changes/additions are necessary.

During ~~the first quarter of~~ fiscal year ~~2022,~~2023, the Company adopted ~~the~~ hedge accounting expedients related to probability ~~and~~of forecasted transactions to assert probability of the ~~assessments~~hedged interest (payments/receipts) regardless of ~~effectiveness for future LIBOR-indexed cash flows~~any expected modification in terms related to ~~assume that~~reference rate reform. The Company has also adopted the ~~index upon which future hedged transactions will be based matches~~Secured Overnight Financing Rate (“SOFR”) as the ~~index on~~alternative reference rate to replace LIBOR with respect to the ~~corresponding derivatives.~~Company’s long-term debt. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company ~~continues~~is continuing to ~~evaluate~~assess the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.

~~Table of Contents~~

3. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted net (loss) income per ~~share:~~share utilized to calculate (loss) earnings per share on the Consolidated Statements of Operations:

Three Months Ended March 31, Nine Months Ended March 31,
2022 2021 2022 2021
Numerator:
Net income from continuing operations $ 24,531 $ 34,254 $ 74,831 $ 25,624
Net income from discontinued operations — — — 11,255
Net income $ 24,531 $ 34,254 $ 74,831 $ 36,879
Denominator:
Basic weighted average shares outstanding 91,139 99,831 94,099 100,502
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units 171 1,765 420 883
Diluted weighted average shares outstanding 91,310 101,596 94,519 101,385
Basic net income per common share:
Continuing operations $ 0.27 $ 0.34 $ 0.80 $ 0.25
Discontinued operations — — — 0.11
Basic net income per common share $ 0.27 $ 0.34 $ 0.80 $ 0.36
Diluted net income per common share:
Continuing operations $ 0.27 $ 0.34 $ 0.79 $ 0.25
Discontinued operations — �� — 0.11
Diluted net income per common share $ 0.27 $ 0.34 $ 0.79 $ 0.36


	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Numerator:


Net (loss) income	$	(115,727)	$	24,531	$	(97,838)	$	74,831

Denominator:
Basic weighted average shares outstanding	89,421		91,139		89,369		94,099
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units(1)	—		171		—		420
Diluted weighted average shares outstanding	89,421		91,310		89,369		94,519

(1)Due to a loss from operations, common stock equivalents are excluded from the calculation of diluted weighted average shares outstanding for the three and nine months ended March 31, 2023, respectively, as the impact would be anti-dilutive.

There were ~~508~~329 and 4508 restricted stock awards excluded from our calculation of diluted net (loss) income per ~~sha~~reshare for the three months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, as such awards were anti-dilutive. There were ~~275~~524 and ~~182~~275 stock-based awards comprised of restricted stock awards and stock options excluded from the calculation of diluted net (loss) income per share for the nine months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, as such awards were anti-dilutive.

Additionally, ~~231~~399 and 23231 stock-based awards outstanding at March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, were excluded from the calculation of diluted net (loss) income per share for the three months ended March 31, 2023 and 2022, respectively, as such awards

Table of Contents

were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Furthermore, 366 and 541 stock-based awards outstanding at March 31, 2023 and 2022, respectively, were excluded from the calculation of diluted net (loss) income per share for the nine months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. ~~There were 541 and 957 stock-based awards outstanding at~~ ~~March 31, 2022 and~~ ~~2021, respectively, that were excluded from the calculation of diluted net income per share for the nine months ended~~ ~~March 31, 2022 and~~ ~~2021, respectively, as such awards were contingently issuable based on market or performance conditions.~~

Share Repurchase Program

In ~~June 2017, August 2021 and~~ January 2022, the Company's Board of Directors (the "Board") authorized the repurchase of up to ~~$250,000, $300,000 and~~ $200,000 of the Company’s issued and outstanding common ~~stock, respectively. Share repurchases under the 2021 and 2022 authorizations commenced after the previous authorizations were fully utilized.~~stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The current ~~2022~~ authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. ~~In November 2021,~~During the nine months ended March 31, 2023, the Company ~~entered into a~~did not repurchase any shares under the repurchase program. As of March 31, 2023, the Company had $173,514 of remaining authorization under the share repurchase agreement with affiliates of Engaged Capital, LLC (collectively, the “Selling Stockholders”), pursuant to which the Company repurchased 1,700 shares directly from the Selling Stockholders at a price of $45.00 per share (see Note 19,program. In addition, ~~Related Party Transactions). During~~during the nine months ended March 31, 2022, the Company repurchased ~~10,126~~ ~~shares under the repurchase program, inclusive of the shares repurchased from the Selling Stockholders, for a total of~~ ~~$395,821,~~ ~~excluding commissions, at an average price of~~ ~~$39.09~~ ~~per share. As of March 31, 2022, the Company had~~ ~~$186,579~~ ~~of remaining authorization under the share repurchase program. During the nine months ended March 31, 2021, the Company repurchased 2,408~~6,552 shares under the repurchase program for a total of ~~$80,255,~~$265,420 excluding commissions, at an average price of ~~$33.33~~$40.50 per share. Repurchases made during the nine months ended March 31, 2022, were made under a previous Board authorization.

~~Table of Contents~~

4. ~~ACQUISITIONS~~ACQUISITION AND ~~DISPOSITIONS~~DISPOSITION

Acquisition

That's How We Roll

On December 28, 2021, the Company acquired all outstanding stock of THWR, the producer and marketer of ParmCrisps® and Thinsters®, deepening the Company's position in the snacking category. Consideration for the transaction consisted of cash, net of cash acquired, totaling ~~$260,871, subject to an adjustment for working capital. Of the total consideration, $260,474 was paid with the remaining $397 payable as of March 31, 2022.~~$260,185. The ac~~quisition~~acquisition was funded with borrowings under the Credit Agreement (as defined in Note 9, Debt and Borrowings). The Company incurred $5,103 of transaction costs in connection with the acquisition which were expensed as incurred, and are included as a component of Selling, general and administrative expenses in the Company's Consolidated Statements of Operations for the nine months ended March 31, 2022.

~~The following table summarizes~~During the ~~Company's preliminary allocation of~~three months ended December 31, 2022 the Company finalized the purchase price allocation and recognized a measurement period adjustment of $794 to ~~the~~acquired deferred tax assets, ~~acquired and liabilities assumed based on their respective estimated fair values on the acquisition date. The Company expects to finalize the allocation during fiscal 2022.~~


	~~March 31, 2022~~
~~Accounts receivable, net~~	$	~~5,107~~
~~Inventory~~	~~9,871~~
~~Prepaid expenses and other current assets~~	~~542~~
~~Property, plant & equipment~~	~~9,198~~
~~Identifiable intangible assets~~	~~193,800~~
~~Operating lease right-of-use assets~~	~~3,676~~
~~Other assets~~	~~164~~
~~Deferred income taxes~~	~~(42,252)~~
~~Goodwill~~	~~94,071~~
~~Accounts payable & accrued expenses~~	~~(9,082)~~
~~Operating lease liabilities~~	~~(4,225)~~
	$	~~260,870~~

The fair values assigned to identifiable intangible assets acquired were based on assumptions and estimates made by management. Of the $193,800 of identifiable intangible assets acquired, $70,800 was preliminarily assigned to customer relationships with a ~~weighted average estimated useful life of 17 years, and $123,000 was preliminarily assigned~~related impact to ~~tradenames with indefinite lives. The goodwill recorded as a result of this acquisition is not expected to be deductible for tax purposes.~~

goodwill. Results of THWR are included in the United States operating segment, a component of the North America reportable segment. THWR's net sales included in our consolidated results were ~~5.0%~~2.2% and ~~1.8%~~3.08% of consolidated net sales for the three and nine months ended March 31, ~~2022.~~2023 respectively.

The following table provides unaudited pro forma results of ~~continuing~~ operations had the acquisition been completed at the beginning of fiscal ~~2021.~~2022. The ~~proforma~~pro forma information reflects certain adjustments related to the acquisition but does not reflect any potential operating efficiencies or cost savings that may result from the acquisition. Accordingly, this information has been provided for illustrative purposes only and does not purport to be indicative of the actual results that would have been achieved by the Company for the periods presented or that will be achieved by the combined company in the future. The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results.



	Unaudited supplemental pro forma information
	Three Months Ended		Nine Months Ended
	March 31, 2022		March 31, 2022
Net sales	$	502,939	$	1,488,483
Net income from operations(1)	$	26,970	$	81,415
Diluted net (loss) income per common share from operations	$	0.30	$	0.86

~~Table of Contents~~

Unaudited supplemental pro forma information
Three Months Ended March 31, Nine Months Ended March 31,
2022 2021 2022 2021
Net sales $ 502,939 $ 514,867 $ 1,488,483 $ 1,584,194
Net income from continuing operations(1)
$ 26,970 $ 30,927 $ 81,415 $ 26,929
Diluted net income per common share from continuing operations $ 0.30 $ 0.30 $ 0.86 $ 0.27

(1)The pro forma adjustments include the elimination of transaction costs totaling $5,103 from the nine months ended March 31, ~~2022 and recognition of those costs in the nine months ended March 31, 2021.~~2022. Additionally, the pro forma adjustments include the elimination of integration costs and a fair value inventory adjustment totaling $1,500 and $1,800, respectively, for the three and nine months ended March 31, ~~2022 and recognition of those costs in the three and nine months ended March 31, 2021.~~

~~Dispositions~~

~~GG UniqueFiber~~®

~~On June 28, 2021, the Company completed the divestiture of its crispbread crackers business, GG UniqueFiber~~® (“GG”) for total cash consideration of $336. The sale of GG is consistent with the Company’s transformation and portfolio simplification process. GG operated in Norway and was part of the Company’s International reportable segment. The Company deconsolidated the net assets of GG during the twelve months ended June 30, 2021, recognizing a pre-tax loss on sale of $3,753 in the fourth quarter of fiscal 2021.

~~Dream~~® ~~and WestSoy~~®

~~On April 15, 2021, the Company completed the divestiture of its North America non-dairy beverages business, consisting of the Dream~~® ~~and WestSoy~~® brands, for total cash consideration of $33,000, subject to customary post-closing adjustments. The final purchase price was $31,320. The non-dairy beverage business was considered to be non-core within our broader North American business, and the sale aligns with the Company’s portfolio simplification process. The business operated out of the United States and Canada and was part of the Company’s North America reportable segment. ~~The Company deconsolidated the net assets of the North American non-dairy beverage business during the twelve months ended June 30, 2021, recognizing a pre-tax gain on sale of $7,519 in the fourth quarter of fiscal 2021~~.

~~Fruit~~

In August 2020, the Company's Board of Directors approved a plan to sell its prepared fresh fruit, fresh fruit drinks and fresh fruit desserts division ("Fruit"), primarily consisting of the Orchard House® Foods Limited business and associated brands. This decision supported the Company's overall strategy as the Fruit business did not align, and had limited synergies, with the rest of the Company's businesses. The Fruit business operated in the U.K. and was part of the Company’s International reportable segment. ~~The Compan~~y determined that the held for sale criteria was met and classified the assets and liabilities of the Fruit business as held for sale as of September 30, 2020 and December 31, 2020, recognizing a pre-tax non-cash loss to reduce the carrying value to its estimated fair value less costs to sell of $56,093 during the nine months ended March 31, 2021. The sale was completed on January 13, 2021 for a total cash consideration of $38,547, recognizing a pre-tax loss on sale of $1,904 during the third quarter of fiscal 2021.

~~Danival~~

The Company entered into a definitive stock purchase agreement on June 30, 2020 for the sale of its Danival business, a component of the International reportable segment, and the transaction closed on July 21, 2~~020. The Company deconsolidated the net assets of the Danival business upon closing of the sale during the quarter ended September 30, 2020, recognizing a pre-tax gain on sale of $611 during the first quarter of fiscal 2021.~~2022.

1311

Table of Contents

~~Discontinued Operations~~

~~Sale of Tilda Business~~

On August 27, 2019, the Company sold the entities comprising the Tilda Group Entities and certain other assets of the Tilda business for an aggregate price of $342,000 in cash, subject to customary post-closing adjustments based on the balance sheets of the Tilda business. The disposition of the Tilda operating segment represented a strategic shift that had a major impact on the Company’s operations and financial results and has been accounted for as discontinued operations. Net income from discontinued operations, net of tax in our Consolidated Statements of Operations was nil for the three months ended March 31, 2022 and 2021 as well as for the nine months ended March 31, 2022. The following table presents the major classes of Tilda’s results within Net income from discontinued operations, net of tax in our Consolidated Statements of Operations for the nine months ended March 31, 2021:

~~Nine Months Ended March 31,~~

~~2021~~

~~Net sales~~

—

~~Cost of sales~~

—

~~Gross profit~~

—

~~Other expense~~

~~Net loss from discontinued operations before income taxes~~

~~(75)~~

~~Benefit for income taxes(1)~~

~~(11,320)~~

~~Net income from discontinued operations, net of tax~~

~~11,245~~

~~(1) Includes $11,320 of tax benefit related to the legal entity reorganization for the nine months ended March 31, 2021.~~

~~There were no assets or liabilities from discontinued operations associated with Tilda as of March 31, 2022 or June 30, 2021.~~

The Company's ~~dispositions are~~acquisition is described in more detail in Note 5,4, Acquisitions and Dispositions, in the Notes to the Consolidated Financial Statements in the Form 10-K.

Disposition

Westbrae Natural®

On December 15, 2022, the Company completed the divestiture of its Westbrae Natural® brand (Westbrae) for total cash consideration of $7,498. The sale of Westbrae is consistent with the Company’s portfolio simplification process. Westbrae operated out of the United States and was part of the Company’s North America reportable segment. During the nine months ended March 31, 2023, the Company deconsolidated the net assets of Westbrae, primarily consisting of $3,054 of goodwill, and recognized a pretax gain on sale of $3,488.

5. INVENTORIES

Inventories consisted of the following:


		March 31, 2022		June 30, 2021			March 31, 2023		June 30, 2022
Finished goods	Finished goods	$	189,288	$	187,884	Finished goods	$	194,858	$	202,544
Raw materials, work-in-progress and packaging	Raw materials, work-in-progress and packaging	105,140		97,526		Raw materials, work-in-progress and packaging	121,487		105,490
		$	294,428	$	285,410		$	316,345	$	308,034

~~At each period end, inventory is reviewed to ensure that it is recorded at the lower of cost or net realizable value.~~

1412

Table of Contents

6. PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:


		March 31, 2022		June 30, 2021			March 31, 2023		June 30, 2022
Land	Land	$	11,675	$	13,666	Land	$	11,293	$	11,216
Buildings and improvements	Buildings and improvements	54,317		58,143		Buildings and improvements	50,818		51,849
Machinery and equipment	Machinery and equipment	313,795		306,811		Machinery and equipment	317,883		296,398
Computer hardware and software	Computer hardware and software	66,279		65,132		Computer hardware and software	65,065		65,680
Furniture and fixtures	Furniture and fixtures	24,597		23,546		Furniture and fixtures	19,762		23,522
Leasehold improvements	Leasehold improvements	58,929		54,360		Leasehold improvements	48,757		54,999
Construction in progress	Construction in progress	26,745		21,633		Construction in progress	32,070		27,200
		556,337		543,291			545,648		530,864
Less: Accumulated depreciation and amortization		243,518		230,514
Less: Accumulated depreciation and impairment						Less: Accumulated depreciation and impairment	249,215		233,459
		$	312,819	$	312,777		$	296,433	$	297,405

Depreciation ~~and amortization~~ expense for the three months ended March 31, 2023 and 2022 was $9,649 and ~~2021 was~~ ~~$8,292~~ ~~and $9,118,~~$8,292, respectively. Depreciation ~~and amortization~~ expense for the nine months ended March 31, 2023 and 2022 was $25,911 and ~~2021 was~~ ~~$22,944~~ ~~and~~ ~~$26,302~~,$22,944, respectively.

~~During~~The Company recognized impairment charges of $244 and $584 during the three and nine months ended March 31, 2022, the Company completed the sale of undeveloped land plots in Boulder, Colorado in the United States for total cash proceeds of $10,005, net of brokerage and other fees, resulting in a gain in the amount of $8,656, which is included as a component of Other (income) expense, net in our Consolidated Statement of Operations.

~~The Company recognized an impairment charge of $303 during the nine months ended March 31, 2022~~2023 respectively, relating to a facility in the United ~~Kingdom.~~States that is held for sale. The facility ~~was held for sale~~had a net carrying value of $1,250 and $1,840 as of March 31, ~~2022~~2023 and June 30, ~~2021 with a net carrying amount of $1,545 and $1,874,~~ 2022,respectively. ~~Further, a facility in the United States was held for sale as of March 31, 2022 with a net carrying amount of $1,768.~~

During the nine months ended March 31, ~~2021,~~2022, the Company ~~recorded~~recognized a non-cash impairment charge of ~~$1,333 related~~$303 relating to ~~the write-down of building improvements.~~

~~7. LEASES~~

The Company leases office space, warehouse and distribution facilities, manufacturing equipment and vehicles primarily in North America and Europe. The Company determines if an arrangement is or contains a lease at inception. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company’s lease agreements generally do not contain residual value guarantees or material restrictive covenants.

Some of the Company’s leases contain variable lease payments, which are expensed as incurred unless those payments are based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease commencement and includedfacility in the measurement of the lease liability; thereafter, changes to lease payments due to rate or index changes are recorded as variable lease expense in the period incurred. The Company does not have any related party leases, and sublease transactions are de minimis.United Kingdom.

1513

Table of Contents

7. LEASES

The components of lease expenses for the three and nine months ended March 31, ~~2022 and 2021~~2023 were as follows:


		Three Months Ended				Nine Months Ended					Three Months Ended				Nine Months Ended
		March 31, 2022		March 31, 2021		March 31, 2022		March 31, 2021			March 31, 2023		March 31, 2022		March 31, 2023		March 31, 2022
Operating lease expenses	Operating lease expenses	$	4,155	$	4,129	$	11,572	$	12,290	Operating lease expenses	$	6,657	$	4,155	$	13,869	$	11,572

Finance lease expenses	Finance lease expenses	50		72		187		319		Finance lease expenses	48		50		188		187
Variable lease expenses	Variable lease expenses	129		247		838		1,204		Variable lease expenses	207		129		556		838
Short-term lease expenses	Short-term lease expenses	813		458		2,855		1,701		Short-term lease expenses	726		813		1,612		2,855
Total lease expenses	Total lease expenses	$	5,147	$	4,906	$	15,452	$	15,514	Total lease expenses	$	7,638	$	5,147	$	16,225	$	15,452

Supplemental balance sheet information related to leases was as follows:


Leases	Leases	Classification	March 31, 2022		June 30, 2021		Leases	Classification	March 31, 2023		June 30, 2022
Assets	Assets						Assets
Operating lease ROU assets, net	Operating lease ROU assets, net	Operating lease right-of-use assets, net	$	88,636	$	92,010	Operating lease ROU assets, net	Operating lease right-of-use assets, net	$	98,306	$	114,691

Finance lease ROU assets, net	Finance lease ROU assets, net	Property, plant and equipment, net	466		547		Finance lease ROU assets, net	Property, plant and equipment, net	312		413

Total leased assets	Total leased assets		$	89,102	$	92,557	Total leased assets		$	98,618	$	115,104

Liabilities	Liabilities						Liabilities
Current	Current						Current
Operating	Operating	Accrued expenses and other current liabilities	$	13,097	$	10,870	Operating	Accrued expenses and other current liabilities	$	10,827	$	13,154

Finance	Finance	Current portion of long-term debt	182		229		Finance	Current portion of long-term debt	84		149

Non-current	Non-current						Non-current
Operating	Operating	Operating lease liabilities, noncurrent portion	81,379		85,929		Operating	Operating lease liabilities, noncurrent portion	91,885		107,481
Finance	Finance	Long-term debt, less current portion	296		326		Finance	Long-term debt, less current portion	243		278
Total lease liabilities	Total lease liabilities		$	94,954	$	97,354	Total lease liabilities		$	103,039	$	121,062

Additional information related to leases is as follows:


	Nine Months Ended
	March 31, 2023			March 31, 2022
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	12,299		$	11,632
Operating cash flows from finance leases	$	12		$	16
Financing cash flows from finance leases	$	137		$	182
ROU assets obtained in exchange for lease obligations:
Operating leases(1)	$	(2,740)		$	8,198
Finance leases	$	60		$	251


Weighted average remaining lease term:
Operating leases	10.5 years			9.0 years
Finance leases	4.1 years			4.2 years
Weighted average discount rate:
Operating leases	4.7		%	3.3		%
Finance leases	4.5		%	4.0		%

1614

Table of Contents

~~Additional information~~(1) Includes adjustment for modification of an operating lease during the nine months ended March 31, 2023 which resulted in a reduction of ROU assets and lease liabilities of $13,876 and $17,244 respectively, and recognition of a gain of $3,368 related to ~~leases is as follows:~~the modification.
Nine Months Ended
March 31, 2022 March 31, 2021
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases $ 11,632 $ 12,954
Operating cash flows from finance leases $ 16 $ 13
Financing cash flows from finance leases $ 182 $ 285
ROU assets obtained in exchange for lease obligations:
Operating leases $ 4,100 $ 18,349
Finance leases $ 251 $ 671
ROU assets obtained in connection with an acquisition (See Note 4):
Operating leases $ 4,098 $ —
Weighted average remaining lease term:
Operating leases 9.0 years 10.0 years
Finance leases 4.2 years 4.1 years
Weighted average discount rate:
Operating leases 3.3 % 3.2 %
Finance leases 4.0 % 3.9 %

Maturities of lease liabilities as of March 31, ~~2022~~2023 were as follows:


Fiscal Year	Fiscal Year	Operating leases		Finance leases		Total		Fiscal Year	Operating leases		Finance leases		Total
2022 (remainder of year)		$	3,427	$	56	$	3,483
2023		16,144		162		16,306
2023 (remainder of year)								2023 (remainder of year)	$	3,818	$	25	$	3,843
2024	2024	14,498		80		14,578		2024	15,038		95		15,133
2025	2025	12,270		80		12,350		2025	12,755		93		12,848
2026	2026	11,581		67		11,648		2026	12,072		68		12,140
2027								2027	11,772		53		11,825
Thereafter	Thereafter	53,640		78		53,718		Thereafter	77,724		25		77,749
Total lease payments	Total lease payments	111,560		523		112,083		Total lease payments	133,179		359		133,538
Less: Imputed interest	Less: Imputed interest	17,084		45		17,129		Less: Imputed interest	30,467		32		30,499
Total lease liabilities	Total lease liabilities	$	94,476	$	478	$	94,954	Total lease liabilities	$	102,712	$	327	$	103,039

On December 17, 2021, the Company entered into an operating lease in the United States that has not yet commenced. Obligations under this lease are approximately $41,638, and the lease is expected to commence during the fourth quarter of fiscal year ending June 30, 2022 with a lease term of 10.5 years, excluding 1 renewal option.

1715

Table of Contents

8. GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table provides ~~the~~ changes in the carrying value of goodwill by reportable segment:

North America International Total
Balance as of June 30, 2021 $ 600,812 $ 270,255 $ 871,067
Acquisition activity (See Note 4) 94,071 — 94,071
Translation and other adjustments, net (9) (14,308) (14,318)
Balance as of March 31, 2022 $ 694,874 $ 255,947 $ 950,820


	North America		International		Total
Balance as of June 30, 2022	$	695,715	$	238,081	$	933,796
Acquisition(1)	(794)		—		(794)
Divestiture(2)	(3,054)		—		(3,054)


Translation and other adjustments, net	4,364		(2,583)		1,781
Balance as of March 31, 2023	$	696,231	$	235,498	$	931,729

(1) During the nine months ended March 31, 2023, the Company finalized purchase accounting related to THWR resulting in a $794 reduction to goodwill. See Note 4, Acquisition and Disposition.

(2) During the nine months ended March 31, 2023, the Company completed the divestiture of Westbrae, a component of the United States reporting unit. Goodwill of $3,054 was assigned to the divested businesses on a relative fair value basis.

As a result of the same factors triggering the interim impairment tests for the ParmCrisps® and Thinsters® trademarks and other intangible assets discussed below, the Company completed an interim impairment test of goodwill in the U.S. reporting unit during the three months ended March 31, 2023 and concluded that the reporting unit’s estimated fair value exceeded its carrying amount. The fair value of the reporting unit was estimated using an income approach that utilized a discounted cash flow model.

Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:


		March 31, 2022		June 30, 2021			March 31, 2023		June 30, 2022
Non-amortized intangible assets:	Non-amortized intangible assets:					Non-amortized intangible assets:
Trademarks and tradenames(1)	Trademarks and tradenames(1)	$	390,002	$	273,471	Trademarks and tradenames(1)	$	266,445	$	379,466
Amortized intangible assets:	Amortized intangible assets:					Amortized intangible assets:
Other intangibles(2)	Other intangibles(2)	211,747		146,856		Other intangibles(2)	159,027		199,448
Less: Accumulated amortization	Less: Accumulated amortization	(108,810)		(105,432)		Less: Accumulated amortization	(110,936)		(101,381)
Net amortized intangible assets	Net amortized intangible assets	102,937		41,424		Net amortized intangible assets	48,091		98,067
Net other intangible assets	Net other intangible assets	$	492,939	$	314,895	Net other intangible assets	$	314,536	$	477,533

~~There were no events or circumstances~~(1) The gross carrying value of trademarks and trade names is reflected net of $205,373 and $94,873 of accumulated impairment charges as of March 31, 2023 and June 30, 2022, respectively.

(2) The reduction in carrying value of other intangible assets as of March 31, 2023 reflected a non-cash impairment charge of $45,798 recognized in the third quarter of 2023.

During the three months ended March 31, 2023, as a result of a decline in actual and projected performance and cash flows of the ParmCrisps® and Thinsters® brands, the Company determined that ~~warranted an~~ interim impairment ~~test~~tests of these indefinite-lived trademarks were required to be performed. During the three months ended March 31, 2023, the Company recorded non-cash impairment charges of $102,000 and $8,500 for ~~indefinite-lived~~the ParmCrisps® and Thinsters® trademarks, respectively, to reduce the carrying value of such intangible assets ~~during~~to their estimated fair value. The fair value was determined using the relief from royalty method, and impairment charges were recorded within intangibles and long-lived asset impairment on the Consolidated Statements of Operations. The assets are part of the North America reportable segment and have a remaining aggregate carrying value of $12,500 as of March 31, 2023.

As a result of the same factors triggering the interim impairment tests for the ParmCrisps® and Thinsters® trademarks discussed above, the Company completed interim impairment tests of the ParmCrisps® and Thinsters® asset groups, which were primarily comprised of amortizable customer relationships. The Company determined that the ParmCrisps® asset group’s carrying amount exceeded the estimated fair value. During the three ~~and nine~~ months ended March 31, ~~2022 or 2021. See Note 4,~~ 2023, the Company recorded non-cash impairment charges of $45,798 to reduce the carrying value of the ParmCrisps~~Acquisitions~~® customer relationships, the primary asset in the asset group, to their estimated fair

Table of Contents

value. Impairment charges were recorded within intangibles and ~~Dispositions~~long-lived asset impairment on the Consolidated Statements of Operations. The fair value of the Thinsters~~, for details surrounding~~® asset group exceeded its carrying amount. The assets are part of the ~~acquisition~~North America reportable segment and have a remaining aggregate carrying value of ~~THWR, including~~ ~~$193,800~~$19,767 as of ~~identifiable intangible assets acquired~~ ~~on December 28, 2021.~~March 31, 2023.

Amortized intangible assets, which are deemed to have a finite life, primarily consist of customer relationships, ~~and~~ trademarks and tradenames and are amortized over their estimated useful lives of 57 to 25 years. Amortization expense included in ~~continuing operations~~the Consolidated Statements of Operations was as follows:

Three Months Ended March 31, Nine Months Ended March 31,
2022 2021 2022 2021
Amortization of acquired intangibles $ 3,110 $ 2,145 $ 7,255 $ 6,771


	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Amortization of acquired intangibles	$	2,842	$	3,110	$	8,415	$	7,255

Expected amortization expense over the next five fiscal years is as follows:

Fiscal Year Ending June 30,
2022 (remainder of year) 2023 2024 2025 2026
Estimated amortization expense $ 2,973 $ 11,611 $ 9,008 $ 8,005 $ 7,565


	Fiscal Year Ending June 30,
	2023 (remainder of year)		2024		2025		2026		2027
Estimated amortization expense	$	2,036	$	6,298	$	5,245	$	4,762	$	4,073

The weighted average remaining amortization period of amortized intangible assets is ~~13.7~~8.4 years.

~~Table of Contents~~

9. DEBT AND BORROWINGS

Debt and borrowings consisted of the following:


		March 31, 2022		June 30, 2021			March 31, 2023		June 30, 2022
Revolving credit facility	Revolving credit facility	$	538,000	$	230,000	Revolving credit facility	$	567,000	$	593,000
Term loans	Term loans	298,125		—		Term loans	290,625		296,250
Less: Unamortized issuance costs	Less: Unamortized issuance costs	(1,167)		—		Less: Unamortized issuance costs	(1,401)		(1,105)
Other borrowings(1)	Other borrowings(1)	587		1,022		Other borrowings(1)	333		498
		835,545		231,022			856,557		888,643
Short-term borrowings and current portion of long-term debt(2)	Short-term borrowings and current portion of long-term debt(2)	7,774		530		Short-term borrowings and current portion of long-term debt(2)	7,575		7,705
Long-term debt, less current portion	Long-term debt, less current portion	$	827,771	$	230,492	Long-term debt, less current portion	$	848,982	$	880,938

(1) Includes $327 (June 30, 2022: $427) of finance lease obligations as discussed in Note 7, Leases.

(2) Includes $84 (June 30, 2022: $149) of short-term finance lease obligations as discussed in Note 7, Leases.

Amended and Restated Credit Agreement

On December 22, 2021, the Company refinanced its revolving credit facility by entering into a Fourth Amended and Restated Credit Agreement ~~(the~~(as amended by a First Amendment dated December 16, 2022, the “Credit Agreement”). The Credit Agreement provides for senior secured financing of $1,100,000 in the aggregate, consisting of (1) $300,000 in aggregate principal amount of term loans (the ~~"Term Loans"~~“Term Loans”) and (2) an $800,000 senior secured revolving credit facility (which includes borrowing capacity available for letters of credit and is comprised of a $440,000 U.S. revolving credit facility and $360,000 global revolving credit facility) (the ~~"Revolver"~~“Revolver”). Both the Revolver and the Term Loans mature on December 22, 2026. ~~As of March~~

The Credit Agreement includes financial covenants that require compliance with a consolidated interest coverage ratio, a consolidated leverage ratio and a consolidated secured leverage ratio. The minimum consolidated interest coverage ratio is 2.75:1.00. The maximum consolidated leverage ratio is 6.00:1.00. Through December 31, ~~2022~~2023 or such earlier date as elected by the Company (the “Amendment Period”), ~~there were $538,000 of~~the maximum consolidated secured leverage ratio is 5.00:1.00. Following the Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions.

During the Amendment Period, loans under the ~~Revolver, $298,125~~Credit Agreement will bear interest at (a) Term SOFR, plus a credit spread adjustment of ~~Term Loans, and $8,919 letters of credit outstanding under~~0.10% (as adjusted, “Term SOFR”) plus 2.0% per annum or (b) the Base Rate (as defined in the Credit ~~Agreement.~~

~~The Credit Agreement provides that~~Agreement) plus 1.0% per annum. Following the Amendment Period, loans will bear interest at rates based on (a) ~~the Eurodollar Rate~~Term SOFR plus a rate ranging from 0.875%

Table of Contents

to ~~1.75%~~1.750% per annum or (b) the Base Rate plus a rate ranging from 0.00% to ~~0.75%~~0.750% per annum, the relevant rate in each case being the Applicable Rate. The Applicable Rate following the Amendment Period will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Swing Line Loans and Global Swing Line Loans denominated in U.S. Dollars will bear interest at the Base Rate plus the Applicable Rate, and Global Swing Line Loans denominated in foreign currencies shall bear interest based on (a) the Euro Short Term Rate, or €STR, in the case of such loans denominated in Euros plus the Applicable Rate, (b) the Sterling Overnight Index Average Reference Rate, or SONIA, in the case of such loans denominated in Sterling plus the Applicable Rate or (c) the Canadian Prime Rate plus the Applicable ~~Rate.~~ The weighted average interest rate on outstanding borrowings under the Credit Agreement at March 31, ~~2022~~2023 was ~~1.67%~~5.90%. ~~Additionally,~~Additionally, the Credit Agreement contains a Commitment Fee (as defined in the Credit Agreement) on the amount unused under the Credit Agreement ranging from 0.15% to 0.25% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

~~The Credit Agreement includes maintenance covenants that will require compliance with a consolidated interest coverage ratio, a consolidated secured leverage ratio and a consolidated leverage ratio.~~ As of March 31, ~~2022, $253,081~~2023, there were $567,000 of loans under the Revolver, $290,625 of Term Loans, and $4,054 of letters of credit outstanding under the Credit Agreement. As of March 31, 2023, $228,946 was available under the Credit Agreement, ~~and~~subject to compliance with the financial covenants. As of March 31, 2023, the Company was in compliance with all associated covenants.

In connection with the Credit Agreement, the Company and its material domestic subsidiaries entered into an Amended and Restated Security and Pledge Agreement (the “Security Agreement”), pursuant to which all of the obligations under the Credit Agreement will be secured by liens on assets of the Company and its material domestic subsidiaries, including the equity interests in each of their direct subsidiaries and intellectual property, subject to agreed-upon exceptions.

Credit Agreement Issuance Costs

~~Based on the Company's evaluation of the borrowing capacity associated~~In connection with the ~~creditors participating in the previous facility compared~~First Amendment to ~~those in the~~its Credit Agreement ~~$1,762~~during the second quarter of the $2,036 of unamortized deferred financing costs at December 22, 2021 were deferred and the remaining $274 were expensed as a component of Interest and other financing expense, net on our Consolidated Statement of Operations. Additionally,fiscal year 2023, the Company incurred debt issuance costs of approximately ~~$2,764 in connection with the Credit Agreement.~~$1,987, of which $1,916 was deferred. Of the total ~~$4,526 of~~ deferred ~~debt issuance~~ costs, ~~$3,292~~$1,396 were associated with the Revolver and are being amortized on a straight-line basis within Other assets on our Consolidated Balance ~~Sheet,~~Sheets, and ~~$1,234~~$520 are being amortized on a straight-line basis, which approximates the effective interest method, as an adjustment to the carrying amount of the Term Loans as a component of Interest and other financing expense, net ~~on our Consolidated Statement of Operations~~ over the term of the Credit Agreement.

~~Table of Contents~~

10. INCOME TAXES

In general, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability on the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

The effective income tax rate ~~from continuing operations~~ was a benefit of 25.6% and an expense of 23.7% ~~and 25.7%~~ for the three months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively. The effective income tax rate ~~from continuing operations~~ was a benefit of 24.1% and an expense of 20.3% ~~and 55.5%~~ for the nine months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively. The effective income tax rate for the nine months ended March 31, 2023 was impacted by ParmCrisps® and Thinsters® trademarks and ParmCrisps® asset group impairment charges (See Note 8, Goodwill and Other Intangible Assets), gain on the sale of Westbrae, an operating lease modification during the second quarter, severance with respect to our former CEO (as part of the limitation on the deductibility of executive compensation), stock-based compensation and changes in uncertain tax positions. The effective income tax rate ~~from continuing operations~~ for the nine months ended March 31, 2022 was impacted by the reversal of uncertain tax position accruals based on filing and approval of certain elections by taxing authorities, deductions related to stock-based compensation, non-deductible transaction costs related to the acquisition of THWR ~~(see~~(see Note 4, Acquisition and Disposition)~~Acquisitions and Dispositions~~), the reversal of a valuation allowance due to the utilization of a capital loss carryover and the finalization of fiscal year 2021 U.S. income tax returns. The effective income tax rate from continuing operations for the nine months ended March 31, 2021 was negatively impacted by various discrete items including the tax impact of the United Kingdom Fruit business reserve, the legal entity reorganization, and the U.K. rate change. The effective income tax rates in each period were also impacted by the geographical mix of earnings and state ~~valuation allowance.~~income taxes.

T~~he income tax benefit from discontinued operations was nil for the~~ ~~three and nine months ended~~ ~~March 31, 2022~~, while the income tax from discontinued operations was nil and a benefit of $11,320 for the three and nine months ended March 31, 2021, respectively. The benefit for income tax for the nine months ended March 31, 2021 was impacted by a legal entity reorganization.

2018

Table of Contents

11. ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table presents the changes in accumulated other comprehensive loss (AOCL):

Three Months Ended March 31, Nine Months Ended March 31,
2022 2021 2022 2021
Foreign currency translation adjustments:
Other comprehensive (loss) income before reclassifications $ (18,701) $ 1,672 $ (43,649) $ 80,491
Amounts reclassified into income (1)
— 14,725 — 15,906
Deferred gains (losses) on cash flow hedging instruments:
Amount of gain (loss) recognized in AOCL on derivatives (2)
2,007 1,168 3,544 (621)
Amount of (loss) gain reclassified from AOCL into (expense) income (2)
(553) (914) (1,517) 995
Deferred gains (losses) on net investment hedging instruments:
Amount of gain (loss) recognized in AOCL on derivatives (2)
1,240 3,107 4,610 (2,763)
Amount of loss reclassified from AOCL into expense (2)
(113) (97) (327) (298)
Net change in AOCL $ (16,120) $ 19,661 $ (37,339) $ 93,710


	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Foreign currency translation adjustments:
Other comprehensive income (loss) income before reclassifications	$	15,250	$	(18,701)	$	7,774	$	(43,649)

Deferred (losses) gains on cash flow hedging instruments:

Amount of (loss) gain recognized in AOCL on derivatives (1)	(3,190)		2,007		7,718		3,544
Amount of gain reclassified from AOCL into income (1)	(1,320)		(553)		(3,500)		(1,517)
Deferred (losses) gains on fair value hedging instruments:
Amount of (loss) gain recognized in AOCL on derivatives (1)	(28)		—		50		—
Amount of loss reclassified from AOCL into expense (1)	157		—		396		—
Deferred (losses) gains on net investment hedging instruments:

Amount of (loss) gain recognized in AOCL on derivatives (1)	(108)		1,240		201		4,610
Amount of gain reclassified from AOCL into income (1)	(360)		(113)		(1,102)		(327)
Net change in AOCL	$	10,401	$	(16,120)	$	11,537	$	(37,339)

(1)Foreign currency translation gains or losses of foreign subsidiaries related to divested businesses are reclassified into income once the liquidation of the respective foreign subsidiaries is substantially cSee~~omplete. During the three and nine months ended March 31, 2021, the Company reclassified $14,725 and $15,906 of translation losses, respectively, from AOCL to Other income, net on the Consolidated Statements of Operations.~~

~~(2)See~~ Note 15, Derivatives and Hedging Activities, for the amounts reclassified into income for deferred gains (losses) on cash flow ~~and net investment~~ hedging instruments recorded in the Consolidated Statements of Operations in the three and nine months ended March 31, ~~2022~~2023 and ~~2021.~~2022.

Table of Contents

12. STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

~~The Company has a stockholder-approved plan,~~Under the Company's Amended and Restated 2002 Long-Term Incentive and Stock Award Plan (the "2002 Plan"), ~~under which~~ the ~~Company’s~~Company historically granted equity-based awards to its officers, senior management, other key employees, consultants, and directors. The Company currently utilizes a stockholder-approved plan, The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (the “2022 Plan”) which was approved at the Company’s 2022 Annual Meeting of Stockholders held on November 17, 2022. The 2022 Plan permits the Company to continue making equity-based and other incentive awards in a manner intended to properly incentivize its employees, directors, ~~may be granted equity-based awards.~~consultants and other service providers by aligning their interests with the interests of the Company’s stockholders. The Company also ~~grants~~historically granted shares under its 2019 Equity Inducement Award Program (the "2019 Inducement Program") to induce selected individuals to become employees of the Company. The 2002 Plan, the 2022 Plan and the 2019 Inducement Program are collectively referred to as the "Stock Award Plans." In conjunction with the Stock Award Plans, the Company maintains a long-term incentive program (the “LTI Program” or "LTIP") that provides for equity awards, including performance and market-based equity awards that can be earned over defined performance periods. The Company's LTIP plans, with the exception of the 2023 - 2025 LTIP described below, are described in Note ~~14,~~13, Stock-Based Compensation and Incentive Performance Plans, in the Notes to the Consolidated Financial Statements in the Form 10-K.

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Operations for stock-based compensation plans were as follows:


		Three Months Ended March 31,				Nine Months Ended March 31,					Three Months Ended March 31,				Nine Months Ended March 31,
		2022		2021		2022		2021			2023		2022		2023		2022
Selling, general and administrative expense	Selling, general and administrative expense	$	3,846	$	3,698	$	12,289	$	11,888	Selling, general and administrative expense	$	3,228	$	3,846	$	10,657	$	12,289

Related income tax benefit	Related income tax benefit	$	438	$	441	$	1,145	$	1,447	Related income tax benefit	$	464	$	438	$	1,417	$	1,145

~~Table of Contents~~

Restricted Stock

Awards of restricted stock are either restricted stock awards ("RSAs") or restricted stock units ("RSUs") that are issued at no cost to the recipient. Performance-based or market-based RSUs are issued in the form of performance share units ("PSUs"). A summary of the restricted stock activity (including all RSAs, RSUs and PSUs) for the nine months ended March 31, ~~2022~~2023 is as follows:


		Number of Shares and Units	Weighted Average Grant Date Fair Value (per share)			Number of Shares and Units	Weighted Average Grant Date Fair Value (per share)
Non-vested RSAs, RSUs and PSUs outstanding at June 30, 2021		1,780	$	16.55
Non-vested RSAs, RSUs and PSUs outstanding at June 30, 2022					Non-vested RSAs, RSUs and PSUs outstanding at June 30, 2022	790	$	42.44
Granted	Granted	828	$	44.70	Granted	1,189	$	20.64
Vested	Vested	(1,579)	$	15.58	Vested	(173)	$	38.70
Forfeited	Forfeited	(158)	$	25.26	Forfeited	(465)	$	33.53
Non-vested RSAs, RSUs and PSUs outstanding at March 31, 2022		871	$	43.54
Non-vested RSAs, RSUs and PSUs outstanding at March 31, 2023					Non-vested RSAs, RSUs and PSUs outstanding at March 31, 2023	1,341	$	26.68

The table above includes a total of ~~190~~420 shares granted during the nine months ended March 31, ~~2022~~2023 that represent the target number of shares that may be earned based on pre-defined market conditions that are eligible to vest ranging from zero to 200% of target. All such shares relate to the ~~2022-2024~~2023 – 2025 LTIP as further described below. ~~Granted shares also include 56 shares that may be earned based on certain performance-based metrics being met.~~ Vested shares during the nine months ended March 31, ~~2022~~2023 include a total ~~of 1,299~~of 5 shares ~~under the 2019-2021 LTIP that vested at 100% of target based on achievement of target absolute total shareholder return ("TSR") levels,~~related to certain performance-based metrics being met and a total of 13168 shares ~~granted in a previous period that vested based on certain performance-based metrics being met.~~related to service-based RSUs. There are market-based PSU awards outstanding under both the 2023 – 2025 LTIP and the 2022 – 2024 LTIP. At March 31, 2023, 321 of such shares were outstanding under the 2023 – 2025 LTIP while 68 shares were outstanding under the 2022 – 2024 LTIP.

The fair value of RSAs, RSUs and PSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting was as follows:

Nine Months Ended March 31,
2022 2021
Fair value of RSAs, RSUs and PSUs granted $ 37,005 $ 7,298
Fair value of shares vested $ 71,285 $ 12,266
Tax benefit recognized from restricted shares vesting $ 3,643 $ 1,786

Table of Contents


	Nine Months Ended March 31,
	2023		2022
Fair value of RSAs, RSUs and PSUs granted	$	24,560	$	37,005
Fair value of shares vested	$	3,467	$	71,285
Tax benefit recognized from restricted shares vesting	$	520	$	3,643

At March 31, ~~2022,~~2023, there was ~~$29,787~~$22,478 of unrecognized stock-based compensation expense related to non-vested restricted stock awards which is expected to be recognized over a weighted average period of ~~2.2~~1.8 years.

~~2022-2024~~2023-2025 LTIP

During the nine months ended March 31, ~~2022,~~2023, the Company granted market-based PSU awards under the LTI Program with a total target payout of ~~190~~420 shares of common stock. ~~At March 31, 2022, 175 of such shares were outstanding. Vesting is~~Such PSU awards (the "Absolute TSR PSUs") will vest, if at all, pursuant to a defined calculation of either relative TSR or absolute TSR (as defined) over the period from ~~November 18, 2021~~September 6, 2022 through the earlier of (i) ~~November 17, 2024;~~September 6, 2025; (ii) the date the participant’s employment is terminated due to death or Disability (as defined); or (iii) the effective date of a Change in Control (as defined) (the “TSR Performance Period”). Vesting of ~~117~~281 target shares of the outstanding PSU awards is pursuant to a defined calculation of relative TSR over the TSR Performance Period (the “Relative TSR PSUs”). Vesting of 58139 target shares of the outstanding PSU awards is pursuant to the achievement of pre-established three-year compound annual TSR targets over the TSR Performance Period (the “Absolute TSR PSUs”). Total shares eligible to vest for both the Relative TSR PSUs and Absolute TSR PSUs range from zero to 200% of the target amount. Grant date fair values are calculated using a Monte-Carlo simulation model with grant date fair values per target share and related valuation assumptions as ~~follows:~~follows, except for shares granted after December 31, 2022:


	Absolute TSR PSUs		Relative TSR PSUs
Grant date fair value (per target share)	$20.18		$27.47
Risk-free interest rate	3.54	%	3.54	%
Expected dividend yield	—		—
Expected volatility	40.30	%	26.60	%
Expected term	3.00 years		3.00 years

CEO Succession

On November 22, 2022, the Board approved a succession plan pursuant to which the Board appointed Wendy P. Davidson to the role of President and Chief Executive Officer and as a director on the Board, in each case effective as of January 1, 2023 (the “Start Date”).

On the Start Date, Ms. Davidson received the following awards under the 2023-2025 LTIP: 36 Relative TSR PSUs (at target), 18 Absolute TSR PSUs (at target) and 36 RSUs. The Relative TSR PSUs and Absolute TSR PSUs have the same TSR Performance Period, performance goals and beginning stock price as those applicable to awards granted to other employees under the 2023-2025 LTIP. The RSUs will vest in one-third (1/3) installments on each of September 6, 2023, 2024 and 2025. Additionally, in recognition of the compensation Ms. Davidson forfeited by leaving her former employer, on the Start Date Ms. Davidson also received a one-time make-whole RSU award of 95 RSUs that will vest in one-third (1/3) installments on each of the first, second and third anniversaries of the Start Date. Grant date fair values were calculated using a Monte-Carlo simulation model with grant date fair values per target share and related valuation assumptions as follows:


	Absolute TSR PSUs			Relative TSR PSUs
Grant date fair value (per target share)	$	13.84		$	19.54
Risk-free interest rate	4.28		%	4.28		%
Expected dividend yield	—			—
Expected volatility	40.70		%	28.20		%
Expected term	3.00 years			3.00 years

Table of Contents

Absolute TSR PSUs Relative TSR PSUs
Grant date fair value (per target share) $39.51 $60.99
Risk-free interest rate 0.84 % 0.84 %
Expected dividend yield — —
Expected volatility 36.90 % 24.20 %
Expected term 3.00 years 3.00 years

As part of the succession plan, Mark L. Schiller transitioned from his position as President and Chief Executive Officer of the Company effective as of December 31, 2022 (the “Transition Date”). Mr. Schiller remains a director on the Board following the Transition Date. As of the Transition Date, certain of Mr. Schiller's stock-based compensation awards were modified and others were forfeited. Additionally, Mr. Schiller will receive severance totaling $4,725, paid in installments over a two-year period following the Transition Date. Severance, including payroll taxes and other costs, was recognized during the nine months ended March 31, 2023, and unpaid amounts are accrued at March 31, 2023.

13. INVESTMENTS

On October 27, 2015, the Company acquired a minority equity interest in Chop’t Creative Salad Company LLC, predecessor to Founders Table Restaurant Group, LLC (“Founders Table”). Founders Table owns and operates the fast-casual restaurant chains Chop't Creative Salad Co. and Dos Toros Taqueria. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors of Founders Table. At March 31, ~~2022~~2023 and June 30, ~~2021,~~2022, the carrying value of the Company’s investment in Founders Table was ~~$9,808 and $10,699,~~$7,788 and $9,491, respectively, and is included in the Consolidated Balance Sheets as a component of Investments and joint ventures.

The Company also holds ~~the following investments: (a)~~an investment in Hutchison Hain Organic Holdings Limited, a joint venture with HUTCHMED (China) Limited, accounted for under the equity method of ~~accounting, (b) Hain Future Natural Products Private Ltd., a joint venture with Future Consumer Ltd, accounted for under the equity method of accounting, and (c) Yeo Hiap Seng Limited, in which the Company holds a less than 1% equity ownership interest.~~accounting. The carrying value of ~~these combined~~the remaining investments ~~was $6,248~~were $4,932 and ~~$6,218~~$4,965 as of March 31, ~~2022~~2023 and June 30, ~~2021,~~2022, respectively, and is included in the Consolidated Balance Sheets asas a component of Investments and joint ventures.

14. ~~FINANCIAL INSTRUMENTS MEASURED AT~~ FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

•Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

•Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents assets and liabilities measured at fair value on a recurring basis as of March 31, ~~2022:~~2023:

Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Derivative financial instruments $ 2,698 $ — $ 2,698 $ —
Equity investment 603 603 — —
Total $ 3,301 $ 603 $ 2,698 $ —
Liabilities:
Derivative financial instruments $ 3,841 — $ 3,841 —
Total $ 3,841 $ — $ 3,841 $ —


	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:

Derivative financial instruments	$	8,858	$	—	$	8,858	$	—




Liabilities:
Derivative financial instruments	$	540	$	—	$	540	$	—

2322

Table of Contents

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, ~~2021:~~2022:

Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Derivative financial instruments $ 699 $ — $ 699 $ —
Equity investment 646 646 — —
Total $ 1,345 $ 646 $ 699 $ —
Liabilities:
Derivative financial instruments 11,968 — 11,968 —
Total $ 11,968 $ — $ 11,968 $ —

The equity investment consists of the Company’s less than 1% investment in Yeo Hiap Seng Limited, a food and beverage manufacturer and distributor based in Singapore. Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.


	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:

Derivative financial instruments	$	7,476	$	—	$	7,476	$	—
Equity investment	560		560		—		—
Total	$	8,036	$	560	$	7,476	$	—
Liabilities:
Derivative financial instruments	3,184		—		3,184		—

Total	$	3,184	$	—	$	3,184	$	—

There were no transfers of financial instruments between the three levels of fair value hierarchy during the nine months ended March 31, ~~2022~~2023 or ~~2021.~~

The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (see Note 9, ~~Debt and Borrowings~~).

In addition to the instruments named above, the Company makes fair value measurements in connection with its interim and annual goodwill and tradename impairment testing and accounting for acquisitions. These measurements fall into Level 3 of the fair value hierarchy (See Note 8, ~~Goodwill and Other Intangible Assets~~).2022.

Derivative Instruments

The Company uses interest rate swaps to manage its interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage its exposure to fluctuations in foreign currency exchange rates. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.

~~In accordance with the provisions of ASC 820,~~ ~~Fair Value Measurements, the~~The Company incorporates credit valuation adjustments to appropriately reflect both the Company’s nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of the Company’s derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. The Company has determined that the significance of the impact of the credit valuation adjustments made to its derivative contracts, which determination was based on the fair value of each individual contract, was not significant to the overall valuation. As a result, all of the derivatives held as of March 31, ~~2022~~2023 and June 30, ~~2021~~2022 were classified as Level 2 ofwithin the fair value hierarchy.

Nonrecurring Fair Value Measurements

The Company measures certain non-financial assets at fair value on a nonrecurring basis including goodwill, intangible assets, property and equipment and right-of-use lease assets. These assets were initially measured and recognized at amounts equal to the fair value determined as of the date of acquisition or purchase subject to changes in value only for foreign currency translation. Periodically, these assets are tested for impairment by comparing their respective carrying values to the estimated fair value of the reporting unit or asset group in which they reside. In the event any of these assets were to become impaired, the Company would recognize an impairment expense equal to the amount by which the carrying value of the reporting unit, impaired asset or asset group exceeds its estimated fair value. For indefinite-lived intangible assets, the relief from royalty approach is dependent on a number of factors, including estimates of future growth and trends, royalty rates in the category of intellectual property, discount rates and other variables. Fair value measurements of reporting units are estimated using an income approach involving discounted cash flow models that contain certain Level 3 inputs requiring significant management judgment, including projections of economic conditions, customer demand and changes in competition, revenue growth rates, gross profit margins, operating margins, capital expenditures, working capital requirements, terminal growth rates and discount rates. Fair value measurements of the reporting units associated with our goodwill balances and our indefinite-lived intangible assets are estimated at least annually in the fourth quarter of each fiscal year for purposes of impairment testing if a quantitative

Table of Contents

analysis is performed. The Company bases its fair value estimates ~~presented in~~on assumptions its management believes to be reasonable, but which are unpredictable and inherently uncertain.

During the ~~fair value hierarchy tables above are based on information available~~three months ended March 31, 2023, the Company recorded non-cash impairment charges of $102,000 and $8,500 for the ParmCrisps® and Thinsters® trademarks, respectively. Due to ~~management as~~the same factors triggering the interim impairment tests for the ParmCrisps® and Thinsters® trademarks, the Company completed an interim impairment test of the ParmCrisps® and Thinsters® asset group and recorded a non-cash impairment charges of $45,798 for the ParmCrisps® asset group (see Note 8, Goodwill and Other Intangible Assets). As of March 31, ~~2022 and June 30, 2021. These estimates are not necessarily indicative~~2023, THWR intangible assets were classified as Level 3 assets measured at fair value on a nonrecurring basis with estimated fair value of ~~the amounts we could ultimately realize.~~$32,267.

15. DERIVATIVES AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company ~~principally~~ manages its exposures to a wide variety of business and operational ~~risks through management of its core business activities.~~risks. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s receivables and borrowings.

Certain of the Company’s foreign operations expose the Company to fluctuations of foreign exchange rates. These fluctuations may impact the value of the Company’s cash receipts and payments in terms of the Company’s functional currency. The Company enters into derivative financial instruments to protect the value or fix the amount of certain assets and liabilities in terms of its functional currency, the U.S. Dollar.

Accordingly, the Company uses derivative financial instruments to manage and mitigate such risks. The Company does not use derivatives for speculative or trading purposes.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During the three and nine months ended March 31, ~~2022 and 2021,~~2023, such derivatives were used to hedge the variable cash flows associated with existing variable rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in AOCL related to derivatives will be reclassified to interest expense as interest payments are made on the ~~Company’s~~Company’s variable rate debt. During the remaining three months of fiscal ~~2022,~~2023, the Company estimates that an additional ~~$301~~$1,873 will be reclassified as ~~an increase~~a decrease to interest expense.

As of March 31, ~~2022,~~2023, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:

Interest Rate Derivative

Number of Instruments

Notional Amount

Interest Rate Derivative

Number of Instruments

Notional Amount

Interest Rate Swap

$230,000

Interest Rate Swap

$400,000

Cash Flow Hedges of Foreign Exchange Risk

The Company is exposed to fluctuations in various foreign currencies against its functional currency, the U.S. Dollar. The Company uses foreign currency derivatives including cross-currency swaps to manage its exposure to fluctuations in the USD-EUR exchange rates. Cross-currency swaps involve exchanging fixed-rate interest payments for fixed-rate interest receipts,

Table of Contents

both of which will occur at the USD-EUR forward exchange rates in effect upon entering into the instrument. The Company, at times, also uses forward contracts to manage its exposure to fluctuations in the GBP-EUR exchange rates. The Company designates these derivatives as cash flow hedges of foreign exchange ~~risk.~~risks.

For derivatives designated and that qualify as cash flow hedges of foreign exchange risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified in the period(s) during which the hedged transaction affects earnings within

~~Table of Contents~~

the same income statement line item as the earnings effect of the hedged transaction. During the remaining three months of fiscal ~~2022,~~2023, the Company ~~estimates~~estimates that ~~an additional $47~~no amount relating to cross-currency swaps will be reclassified ~~as a decrease~~ to interest expense.

As of March 31, ~~2022,~~2023, the Company had ~~the following~~no outstanding foreign currency derivatives that were used to hedge its foreign exchange ~~risk:~~

Foreign Currency Derivative Number of Instruments Notional Sold Notional Purchased
Cross-currency swap 1 €24,700 $26,775
Foreign currency forward contract 3 £2,515 €3,000
risks.

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in its European foreign entities and their exposure to the Euro. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in the foreign exchange rate on its foreign investment in Europe. Currency forward agreements involve fixing the USD-EUR exchange rate for delivery of a specified amount of foreign currency on a specified date. The currency forward agreements are typically cash settled in U.S. Dollars for their fair value at or close to their settlement date. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making ~~foreign-currency~~foreign-currency- fixed-rate payments over the life of the agreement.

For derivatives designated as net investment hedges, the gain or loss on the derivative is reported in ~~AOCL~~accumulated other comprehensive loss as part of the cumulative translation adjustment. Amounts are reclassified out of ~~AOCL~~accumulated other comprehensive loss into earnings when the hedged net investment is either sold or substantially liquidated.

As of March 31, ~~2022,~~2023, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:

Foreign Currency Derivative

Number of Instruments

Notional Sold

Notional Purchased

Foreign Currency Derivative

Number of Instruments

Notional Sold

Notional Purchased

Cross-currency swap

€76,969

$83,225

Cross-currency swap

€100,300

$105,804

~~Non-Designated~~Fair Value Hedges

~~Derivatives not designated as hedges are not speculative and are used~~The Company is exposed to manage the Company’s exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements and/or the Company has not elected to apply hedge accounting. Changeschanges in the fair value of certain of its foreign denominated intercompany loans due to changes in foreign exchange spot rates. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in foreign exchange rates affecting gains and losses on intercompany loan principal and interest. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency-fixed-rate payments over the life of the agreement.

For derivatives ~~not~~ designated and that qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in ~~hedging relationships~~interest and other financing expense, net.

Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are ~~recorded directly~~recognized over the life of the hedge on a systematic and rational basis, as documented at hedge inception in ~~earnings.~~accordance with the Company’s accounting policy election. The earnings recognition of excluded components is presented in the same income statement line item as the earnings effect of the hedged transaction. During the remaining three months of fiscal 2023, the Company estimates that an additional $121 relating to cross currency swaps will be reclassified as a decrease to interest expense.

As of March 31, ~~2022,~~2023, the Company had nothe following outstanding foreign currency derivatives that were ~~not designated as hedges~~used to hedge changes in ~~qualifying hedging relationships.~~fair value attributable to foreign exchange risk:


Foreign Currency Derivative	Number of Instruments	Notional Sold	Notional Purchased
Cross-currency swap	1	€24,700	$26,021

2625

Table of Contents

As of March 31, 2023 and June 30, 2022, the following amounts were recorded on the balance sheet related to cumulative basis adjustment for fair value hedges:


	Carrying Amount of the Hedged Asset				Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset

	March 31, 2023		June 30, 2022		March 31, 2023		June 30, 2022
Intercompany loan receivable	$	26,772	$	25,899	$	751	$	122

Designated Hedges

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of March 31, ~~2022:~~2023:

Asset Derivatives Liability Derivatives
Balance Sheet Location Fair Value Balance Sheet Location Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps Prepaid expenses and other current assets $ 2,683 Accrued expenses and other current liabilities / Other noncurrent liabilities $ —
Cross-currency swaps Prepaid expenses and other current assets — Other noncurrent liabilities 3,841
Foreign currency forward contracts Prepaid expenses and other current assets 15 Other noncurrent liabilities —
Total derivatives designated as hedging instruments $ 2,698 $ 3,841


	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	6,217	Accrued expenses and other current liabilities	$	—
Interest rate swaps	Other noncurrent assets	277		Other noncurrent liabilities	—
Cross-currency swaps	Prepaid expenses and other current assets	2,364		Accrued expenses and other current liabilities	—
Cross-currency swaps	Other noncurrent assets	—		Other noncurrent liabilities	540

Total derivatives designated as hedging instruments		$	8,858		$	540

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of June 30, ~~2021:~~2022:

Asset Derivatives

Liability Derivatives

Asset Derivatives

Liability Derivatives

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Balance Sheet Location

Fair Value

Derivatives designated as hedging instruments:

Interest rate swaps

Prepaid expenses and other current assets

Accrued expenses and other current liabilities / Other noncurrent liabilities

312

Interest rate swaps

Prepaid expenses and other current assets

4,230

Accrued expenses and other current liabilities

—

Interest rate swaps

Other noncurrent assets

—

Other noncurrent liabilities

3,184

Cross-currency swaps

Prepaid expenses and other current assets

2,400

Accrued expenses and other current liabilities

—

Cross-currency swaps

Prepaid expenses and other current assets

656

Other noncurrent liabilities

11,656

Cross-currency swaps

Other noncurrent assets

846

Other noncurrent liabilities

—

Total derivatives designated as hedging instruments

699

11,968

Total derivatives designated as hedging instruments

7,476

3,184

2726

Table of Contents

The following table presents the ~~pre-tax~~pretax effect of cash flow hedge accounting on AOCL and Consolidated Statements of Operations ~~as of~~for the three months ended March 31, ~~2022~~2023 and ~~2021:~~2022:


Derivatives in Cash Flow Hedging Relationships	Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in AOCL on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income (Expense)	Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)				Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in AOCL on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income (Expense)	Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)
		Three Months Ended March 31,					Three Months Ended March 31,					Three Months Ended March 31,					Three Months Ended March 31,
		2022		2021			2022		2021			2023		2022			2023		2022
Interest rate swaps	Interest rate swaps	$	2,023	$	217	Interest and other financing expense, net	$	(64)	$	(82)	Interest rate swaps	$	(4,285)	$	2,023	Interest and other financing expense, net	$	1,792	$	(64)
Cross-currency swaps	Cross-currency swaps	503		1,262		Interest and other financing expense, net / Other (income) expense, net	683		1,239		Cross-currency swaps	—		503		Interest and other financing expense, net / Other expense (income), net	(46)		683
Foreign currency forward contracts	Foreign currency forward contracts	15		—		Cost of sales	81		—		Foreign currency forward contracts	—		15		Cost of sales	—		81
Total	Total	$	2,541	$	1,479		$	700	$	1,157	Total	$	(4,285)	$	2,541		$	1,746	$	700

The following table presents the ~~pre-tax~~pretax effect of cash flow hedge accounting on AOCL and Consolidated Statements of Operations for the nine months ended March 31, ~~2022~~2023 and ~~2021:~~2022:


Derivatives in Cash Flow Hedging Relationships	Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in AOCL on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income (Expense)	Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)				Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in AOCL on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income (Expense)	Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)
		Nine Months Ended March 31,					Nine Months Ended March 31,					Nine Months Ended March 31,					Nine Months Ended March 31,
		2022		2021			2022		2021			2023		2022			2023		2022
Interest rate swaps	Interest rate swaps	$	2,678	$	341	Interest and other financing expense, net	$	(273)	$	(212)	Interest rate swaps	$	10,295	$	2,678	Interest and other financing expense, net	$	4,927	$	(273)
Cross-currency swaps	Cross-currency swaps	1,872		(1,124)		Interest and other financing expense, net / Other (income) expense, net	2,085		(1,120)		Cross-currency swaps	—		1,872		Interest and other financing expense, net / Other expense (income), net	(276)		2,085
Foreign currency forward contracts	Foreign currency forward contracts	(64)		(2)		Cost of sales	107		73		Foreign currency forward contracts	80		(64)		Cost of sales	—		107
Total	Total	$	4,486	$	(785)		$	1,919	$	(1,259)	Total	$	10,375	$	4,486		$	4,651	$	1,919

2827

Table of Contents

The following table presents the ~~pre-tax~~pretax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the three months ended of March 31, ~~2022~~2023 and ~~2021:~~2022:

Location and Amount of Gain (Loss) Recognized in the Consolidated Statements of Operations on Cash Flow Hedging Relationships
Three Months Ended March 31, 2022 Three Months Ended March 31, 2021
Cost of sales Interest and other financing expense, net Other expense/income, net Cost of sales Interest and other financing expense, net Other expense/income, net
The effects of cash flow hedging:
(Loss) Gain on cash flow hedging relationships
Interest rate swaps
Amount of loss reclassified from AOCL into income $ — $ (64) $ — $ — $ (82) $ —
Cross-currency swaps
Amount of gain reclassified from AOCL into income $ — $ 46 $ 637 $ — $ 39 $ 1,200
Foreign currency forward contracts
Amount of gain reclassified from AOCL into income $ 81 $ — $ — $ — $ — $ —


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
				Three Months Ended March 31, 2023						Three Months Ended March 31, 2022
				Cost of sales		Interest and other financing expense, net		Other expense/income, net		Cost of sales		Interest and other financing expense, net		Other expense/income, net
The effects of cash flow hedging:
	Gain (loss) on cash flow hedging relationships
		Interest rate swaps
			Amount of gain (loss) reclassified from AOCL into income	$	—	$	1,792	$	—	$	—	$	(64)	$	—

		Cross-currency swaps
			Amount of (loss) gain reclassified from AOCL into income	$	—	$	(46)	$	—	$	—	$	46	$	637

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	—	$	—	$	—	$	81	$	—	$	—

The following table presents the ~~pre-tax~~pretax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the nine months ended of March 31, ~~2022~~2023 and ~~2021:~~2022:

Location and Amount of Gain (Loss) Recognized in the Consolidated Statements of Operations on Cash Flow Hedging Relationships
Nine Months Ended March 31, 2022 Nine Months Ended March 31, 2021
Cost of sales Interest and other financing expense, net Other expense (income), net Cost of sales Interest and other financing expense, net Other expense (income), net
The effects of cash flow hedging:
(Loss) Gain on cash flow hedging relationships
Interest rate swaps
Amount of loss reclassified from AOCL into income $ — $ (273) $ — $ — $ (212) $ —
Cross-currency swaps
Amount of gain (loss) reclassified from AOCL into income $ — $ 131 $ 1,954 $ — $ 120 $ (1,240)
Foreign currency forward contracts
Amount of gain reclassified from AOCL into income $ 107 $ — $ — $ 73 $ — $ —


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
				Nine Months Ended March 31, 2023						Nine Months Ended March 31, 2022
				Cost of sales		Interest and other financing expense, net		Other expense (income), net		Cost of sales		Interest and other financing expense, net		Other expense (income), net
The effects of cash flow hedging:
	Gain (loss) on cash flow hedging relationships
		Interest rate swaps
			Amount of gain (loss) reclassified from AOCL into income	$	—	$	4,088	$	—	$	—	$	(273)	$	—

		Cross-currency swaps
			Amount of (loss) gain reclassified from AOCL into income	$	—	$	(276)	$	—	$	—	$	131	$	1,954

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	—	$	—	$	—	$	107	$	—	$	—

Table of Contents

The following table presents the pretax effect of fair value hedge accounting on AOCL and Consolidated Statements of Operations as of the three months ended March 31, 2023 and 2022:


Derivatives in Fair Value Hedging Relationships	Amount of Loss Recognized in AOCL on Derivatives				Location of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended March 31,					Three Months Ended March 31,
	2023		2022			2023		2022

Cross-currency swaps	$	(38)	$	—	Interest and other financing expense, net / Other expense (income), net	$	121	$	—

The following table presents the pretax effect of fair value hedge accounting on AOCL and Consolidated Statements of Operations as of the nine months ended March 31, 2023 and 2022:


Derivatives in Fair Value Hedging Relationships	Amount of Gain Recognized in AOCL on Derivatives				Location of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Nine Months Ended March 31,					Nine Months Ended March 31,
	2023		2022			2023		2022

Cross-currency swaps	$	85	$	—	Interest and other financing expense, net / Other expense (income), net	$	367	$	—

The following table presents the pretax effect of the Company’s derivative financial instruments electing fair value hedge accounting on the Consolidated Statements of Operations for the three months ended of March 31, 2023 and 2022:


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships
				Three Months Ended March 31, 2023						Three Months Ended March 31, 2022
				Cost of sales		Interest and other financing expense, net		Other expense/income, net		Cost of sales		Interest and other financing expense, net		Other expense/income, net
The effects of fair value hedging:
	Gain (loss) on fair value hedging relationships



		Cross-currency swaps
			Amount of loss reclassified from AOCL into income	$	—	$	(210)	$	—	$	—	$	—	$	—

Table of Contents

The following table presents the ~~pre-tax~~pretax effect of the Company’s derivative financial instruments electing fair value hedge accounting on the Consolidated Statements of Operations for the nine months ended of March 31, 2023 and 2022:


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships
				Nine Months Ended March 31, 2023						Nine Months Ended March 31, 2022
				Cost of sales		Interest and other financing expense, net		Other expense (income), net		Cost of sales		Interest and other financing expense, net		Other expense (income), net
The effects of fair value hedging:
	Gain (loss) on fair value hedging relationships



		Cross-currency swaps
			Amount of loss reclassified from AOCL into income	$	—	$	(506)	$	—	$	—	$	—	$	—

The following table presents the pretax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the three months ended March 31, ~~2022~~2023 and ~~2021:~~2022:


Derivatives in Net Investment Hedging Relationships	Derivatives in Net Investment Hedging Relationships	Amount of Gain (Loss) Recognized in AOCL on Derivatives				Location of Gain (Loss) Recognized in Income (Expense) on Derivatives	Amount of Gain (Loss) Recognized in Income (Expense) on Derivatives				Derivatives in Net Investment Hedging Relationships	Amount of (Loss) Gain Recognized in AOCL on Derivatives				Location of (Loss) Gain Recognized in (Expense) Income on Derivatives	Amount of Gain (Loss) Recognized in Income (Expense) on Derivatives
		Three Months Ended March 31,					Three Months Ended March 31,					Three Months Ended March 31,					Three Months Ended March 31,
		2022		2021			2022		2021			2023		2022			2023		2022
Cross-currency swaps	Cross-currency swaps	$	1,569	$	3,933	Interest and other financing expense, net	$	143	$	123	Cross-currency swaps	$	(144)	$	1,569	Interest and other financing expense, net	$	484	$	143

The following table presents the ~~pre-tax~~pretax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the nine months ended March 31, ~~2022~~2023 and ~~2021:~~2022:

Derivatives in Net Investment Hedging Relationships Amount of Gain (Loss) Recognized in AOCL on Derivatives Location of Gain (Loss) Recognized in Income (Expense) on Derivatives Amount of Gain (Loss) Recognized in Income (Expense) on Derivatives
Nine Months Ended
March 31, Nine Months Ended
March 31,
2022 2021 2022 2021
Cross-currency swaps $ 5,836 $ (3,498) Interest and other financing expense, net $ 413 $ 377

The following table presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments on the Consolidated Statements Operations for the nine months ended March 31, 2022 and 2021:

Derivatives Not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income on Derivative Amount of Gain (Loss) Recognized in Income (Expense) on Derivatives
Nine Months Ended
March 31,
2022 2021
Foreign currency forward contracts Other (income) expense, net $ — $ (399)


Derivatives in Net Investment Hedging Relationships	Amount of Gain Recognized in AOCL on Derivatives				Location of (Loss) Gain Recognized in (Expense) Income on Derivatives	Amount of (Loss) Gain Recognized in (Expense) Income on Derivatives
	Nine Months Ended March 31,					Nine Months Ended March 31,
	2023		2022			2023		2022
Cross-currency swaps	$	335	$	5,836	Interest and other financing expense, net	$	1,474	$	413

Credit-Risk-Related Contingent Features

The Company has agreements with each of its derivative counterparties that contain a cross-default provision ~~providing that~~ upon certain defaults by the Company on any of its ~~indebtedness, the Company could also be declared in default on its derivative obligations.~~indebtedness.

16. ~~TERMINATION BENEFITS RELATED TO PRODUCTIVITY AND TRANSFORMATION INITIATIVES~~

As a part of the ongoing productivity and transformation initiatives related to the Company’s strategic objective to expand profit margins and cash flow, the Company initiated a reduction in workforce at targeted locations in the United States as well as at certain locations internationally. The reduction in workforce associated with these initiatives are expected to result in charges throughout fiscal 2022.

~~The following table displays the termination benefits and personnel realignment activities and liability balances relating to the reduction in workforce for the period ended as of March 31, 2022:~~

~~Table of Contents~~

Balance at June 30, 2021 Charges (Reversals) Amounts Paid Foreign Currency Translation & Other Adjustments Balance at March 31, 2022
Termination benefits and personnel realignment $ 4,448 $ 1,912 $ (5,126) $ (18) $ 1,216

~~The liability balance as of March 31, 2022 and June 30, 2021 is included within Accrued expenses and other current liabilities on the Company’s Consolidated Balance Sheets.~~

~~17.~~ COMMITMENTS AND CONTINGENCIES

Securities Class Actions Filed in Federal Court

On August 17, 2016, 3three securities class action complaints were filed in the Eastern District of New York (the "District Court") against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The 3three complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al. (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. ~~(the~~(the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). On June 5, 2017, the District Court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the

Table of Contents~~(the “Consolidated~~

“Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August 4, 2017 and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the “Amended Complaint”). The Amended Complaint named as defendants the Company and certain of its former officers (collectively, “Defendants”) and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Amended Complaint on October 3, 2017 which the District Court granted on March 29, 2019, dismissing the case in its entirety, without prejudice to replead. Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second Amended Complaint”). The Second Amended Complaint again named as defendants the Company and certain of its former officers and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations similar to those in the Amended Complaint, including materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results, and internal controls. Defendants filed a motion to dismiss the Second Amended Complaint on June 20, 2019. On April 6, 2020, the District Court granted ~~Defendants'~~Defendants’ motion to dismiss the Second Amended Complaint in its entirety, with prejudice. Co-Lead Plaintiffs appealed the District Court’s decision dismissing the Second Amended Complaint to the United States Court of Appeals for the Second Circuit (the "Second Circuit"). By decision dated December 17, 2021, the Second Circuit vacated the District Court’s judgment and remanded the case for further proceedings. On April 6, 2022, the District Court issued an order directing the parties to submit position papers outlining their views regarding: (a) the scope of the Court's reconsideration of Defendants’ Motion to Dismiss the Second Amended Complaint; and (b) the appropriate procedure the Court should follow in light of the Second Circuit's opinion. On April 14, 2022, the District Court entered an order setting the schedule for, and determining the scope of, supplemental briefing on Defendants’ Motion to Dismiss the Second Amended ~~Complaint, which is due to be fully briefed on or before~~Complaint. The parties submitted supplemental briefing between May 12, 2022 and June 23, 2022. In June 2022, the District Court referred Defendants’ Motion to Dismiss the Second Amended Complaint to a United States Magistrate Judge (the “Magistrate Judge”) for a Report and Recommendation. On November 4, 2022, the Magistrate Judge issued a Report and Recommendation recommending that the District Court grant Defendants’ Motion to Dismiss the Second Amended Complaint with prejudice. Plaintiffs filed Objections to Magistrate Judge’s November 4, 2022 Report and Recommendation on December 7, 2022, and Defendants filed their Opposition to Plaintiffs’ Objections to Magistrate Judge’s November 4, 2022 Report and Recommendation on January 9, 2023. The Parties await a decision from the District Court on Defendants’ Motion to Dismiss the Second Amended Complaint.

Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court

On April 19, 2017 and April 26, 2017, 2two class action and stockholder derivative complaints were filed in the Eastern District of New York against the former Board of Directors and certain former officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.

~~Table of Contents~~

On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the former Board of Directors and certain former officers of the Company. The complaint alleged that the Company’s former directors and certain former officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleged that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August 9, 2017, the District Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff (the “Merenstein Complaint”).

On August 10, 2017, the District Court granted the parties' stipulation to consolidate the Barnes Complaint, the Silva Complaint and the Merenstein Complaint under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel, with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed under the caption Oliver v. Berke, et al. (the “Oliver Complaint”), and on October 6, 2017, the Oliver Complaint was consolidated with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under seal on October 26, 2017. On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through and including 30 days after a decision was rendered on the motion to dismiss the Amended Complaint in the Consolidated Securities Action, described above.

Table of Contents

On March 29, 2019, the District Court in the Consolidated Securities Action granted Defendants’ motion, dismissing the Amended Complaint in its entirety, without prejudice to replead. Co-Lead Plaintiffs in the Consolidated Securities Action filed the Second Amended Complaint on May 6, 2019. The parties to the Consolidated Stockholder Class and Derivative Action agreed to continue the stay of Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through 30 days after a decision on Defendants' motion to dismiss the Second Amended Complaint in the Consolidated Securities Action.

On April 6, 2020, the District Court granted Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action, with prejudice. Pursuant to the terms of the stay, Defendants in the Consolidated Stockholder Class and Derivative Action had until May 6, 2020 to answer, move, or otherwise respond to the complaint in this matter. This deadline was extended, and Defendants moved to dismiss the Consolidated Stockholder Class and Derivative Action Complaint on June 23, 2020, with Plaintiffs’ opposition due August 7, 2020.

On July 24, 2020, Plaintiffs made a stockholder litigation demand on the current Board containing overlapping factual allegations to those set forth in the Consolidated Stockholder Class and Derivative Action. On August 10, 2020, the District Court vacated the briefing schedule on Defendants’ pending motion to dismiss in order to give the Board of Directors time to consider the demand. On each of September 8 and October 8, 2020, the District Court extended its stay of any applicable deadlines for 30 days to give the Board of Directors additional time to complete its evaluation of the demand. On November 3, 2020, Plaintiffs were informed that the Board of Directors had finished investigating and resolved, among other things, that the demand should be rejected. On November 6, 2020, Plaintiffs and Defendants notified the District Court that Plaintiffs were evaluating the rejection of the demand, sought certain additional information and were assessing next steps, and requested that the District Court extend the stay for an additional 30 days, to on or around December 7, 2020. The Parties then filed a number of additional joint status reports, requesting that the District Court continue the stay of applicable deadlines through December 30, 2021. In light of the Second Circuit vacating the District Court’s judgment in the Consolidated Securities Action referenced above and remanding the case for further proceedings, the Parties submitted a joint status report on December 29, 2021 requesting that the District C~~ourt~~Court continue the temporary stay pending the District Court’s reconsideration of the Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action. The District Court has extended the temporary stay through ~~December 30, 2022.~~September 5, 2023.

Baby Food Litigation

Since February 2021, ~~a large number of~~the Company has been named in numerous consumer class actions ~~have been brought against the Company~~ alleging that the Company’s Earth’s Best® baby food products (the “Products”) contain unsafe and undisclosed levels of various naturally occurring heavy metals, namely lead, arsenic, cadmium and mercury. ~~There are currently 29 active lawsuits,~~Those actions have now been transferred and consolidated as a single lawsuit in the U.S. District Court for the Eastern District of New York captioned In re Hain Celestial Heavy Metals Baby Food Litigation, Case No. 2:21-cv-678 (the "Consolidated Proceeding"), which generally ~~allege~~alleges that the Company violated various state consumer protection laws and ~~make~~asserts other state and common law warranty and unjust enrichment claims related to the alleged failure to disclose the presence of these metals, ~~and~~arguing that consumers would have ~~allegedly~~ either not purchased the Products or would have paid less for them had the Company made adequate disclosures. ~~These putative class actions seek to certify a nationwide class of consumers as well as various state subclasses. One of the consumer class actions (Kathryn Gavula, et al. v. Beech-Nut Nutrition Co., et al.) filed in the U.S. District Court for the District of Oregon alleges that the Company violated the Racketeer Influenced and Corrupt Organizations Act (“RICO”) by conspiring~~

~~Table of Contents~~

with other baby food manufacturers to conceal the presence of these heavy metals in our respective products. These actions have been filed against all of the major baby food manufacturers in federal courts across the country. The U.S. Judicial Panel on Multidistrict Litigation (“JPML”) declined a request to centralize all of the consumer class action lawsuits against all of the baby food manufacturers into a single multidistrict proceeding, and all but one of these cases against the Company have now been transferred and consolidated in the U.S. District Court for the Eastern District of New York into a proceeding captioned In re Hain Celestial Heavy Metals Baby Food Litigation, Case No. 2:21-cv-678 (the "Consolidated Proceeding"). The Court appointed interim class counsel for Plaintiffs in the Consolidated Proceeding, and Plaintiffs filed a Consolidated Amended Class Action Complaint on March 18, 2022. The Company ~~intends to file~~filed a motion to dismiss the Consolidated ~~Amended~~ Class Action Complaint ~~but no briefing schedule has been set.~~on November 7, 2022. The plaintiffs filed their opposition on December 22, 2022, and the Company filed its reply brief on January 20, 2023. The Court scheduled a status conference for May 9, 2023 to address the status of the case, including the Company’s pending motion to dismiss. One consumer class action is pending in New York Supreme Court, Nassau ~~County. The Company~~County, which the court has ~~moved to stay or transfer this case~~stayed in deference to the Consolidated ~~Proceeding and that motion is pending.~~Proceeding. The Company denies the allegations in these lawsuits and contends that its baby foods are safe and properly labeled.

The claims raised in these lawsuits were brought in the wake of a highly publicized report issued by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy on Oversight and Reform, dated February 4, 2021 (the “House Report”), addressing the presence of heavy metals in baby foods made by certain manufacturers, including the Company. Since the publishing of the House Report, the Company has also received information requests with respect to the advertising and quality of its baby foods from certain governmental authorities, as such authorities investigate the claims made in the House Report. The Company is fully cooperating with these requests and is providing documents and other requested information. The Company has been named in one civil government enforcement action, State of New Mexico ex rel. Balderas v. Nurture, Inc., et al., which was filed by the New Mexico Attorney General against the Company and several other manufacturers based on the alleged presence of heavy metals in their baby food products. The Company and several other manufacturers moved to dismiss the New Mexico Attorney General’s lawsuit, which motion the Court denied. The Company filed its answer to the New Mexico Attorney General’s amended complaint on April 23, 2022. The Company denies the New

Table of Contents

Mexico Attorney General’s allegations and maintains that its baby foods are safe, properly labeled, and compliant with New Mexico law.

In addition to the consumer class actions discussed above, the Company is currently named in 5seven lawsuits in state and federal courts alleging some form of personal injury from the ingestion of the Company’s Products, purportedly due to unsafe and undisclosed levels of various naturally occurring heavy metals. ~~NaN of these lawsuits name multiple plaintiffs alleging claims of physical injuries.~~ These lawsuits generally allege injuries related to neurological development disorders such as autism and attention deficit hyperactivity disorder.

•In the matter, Palmquist et al. v. The Hain Celestial Group, Inc., a jury trial commenced on February 6, 2023 in the U.S. District Court, Southern District of Texas. The Company moved for Directed Verdict at the close of Plaintiffs’ case. The Court granted the Company’s motion, finding no liability for the Company. The Court entered Final Judgment in the Company's favor on March 3, 2023. On April 3, 2023, Plaintiffs filed their Notice of Appeal in the Fifth Circuit. Plaintiffs will have 40 days after the Fifth Circuit receives the District Court record within which to file their appellate brief, barring any extensions.

•In the matter, NC v. The Hain Celestial Group, et al., pending in Superior Court for the State of California, County of Los Angeles, discovery has closed and the Court has set a trial date of October 4, 2023.

•There are currently two Nevada state court cases pending in Clark County District Court. The cases, Benitez v. Beech-Nut Nutrition Company, Inc., et al. and Buenaventura v. Beech-Nut Nutrition Company, Inc., et al., have been consolidated for the purposes of discovery only. In Benitez, the Court issued a scheduling order in September 2022. Pursuant to this Order, discovery will close on March 7, 2024 and the case is set for trial starting on July 29, 2024. The parties have engaged in limited discovery. There has been no further activity in the Buenaventura case.

•In Watkins v. Plum, PBC, et al., currently pending in the United States District Court for the Eastern District of Louisiana, the Court has set the case for trial beginning on August 28, 2023. The parties have agreed to ask the Court to move the trial date to no earlier than March 2024 and have started to engage in discovery.

•On January 9, 2023, Plaintiffs in P.A. et al. v. Hain Celestial Group, Inc., et al. filed their First Amended Complaint in the Circuit Court of the First Circuit, State of Hawai’i. On March 8, 2023, the Company filed its Answer to Plaintiff’s First Amended Complaint. The case is set for trial starting on January 23, 2025.

•On February 3, 2023, Plaintiff in Pourdanesh v. Hain Celestial Group, Inc. et al. filed his Complaint in the Superior Court for the State of California, County of Los Angeles. Plaintiff served his Complaint on the Company on March 28, 2023. Following a meet and confer with Plaintiff’s counsel, Plaintiff has agreed to file an Amended Complaint identifying the products at issue. The case is stayed until the Initial Status Conference on May 17, 2023.

The Company denies that its Products led to any of ~~these~~the alleged injuries and will defend ~~the~~these cases vigorously. That said, additional lawsuits may be filed against the Company in the future, asserting similar or different legal theories and seeking similar or different types of damages and relief. Such lawsuits may be resolved in a manner adverse to us, and we may incur substantial costs or damages not covered by our insurance, which could have a material adverse effect on our financial condition and business.

Other

In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business.

With respect to all litigation and related matters, the Company records a liability when the Company believes it is probable that a liability has been incurred and the amount can be reasonably estimated. ~~For the matters disclosed in this note, if the Company determines that a liability is probable and the loss can be reasonably estimated, the Company discloses the liability recorded.~~ As of the end of the period covered by this report, the Company has not recorded a liability for any of the matters disclosed in this note. It is possible that some matters could require the Company to pay damages, incur other costs or establish accruals in amounts that could not be reasonably estimated as of the end of the period covered by this report.

~~18.~~17. SEGMENT INFORMATION

Our organization structure consists of two ~~geographic based~~geographic-based reportable segments: North America and International. Our North America reportable segment consists of the United States and Canada as operating segments. Our International reportable segment is comprised of 3three operating segments: United Kingdom, Ella’s Kitchen UK, and Europe. This structure is in line with how our Chief Operating Decision Maker, ~~(“CODM”)~~the Company's Chief Executive Officer, assesses our performance and allocates resources.

~~We use~~

Table of Contents

The Company uses segment net sales and operating income to evaluate performance and to allocate resources. ~~We believe~~The Company believes these measures are most relevant in order to analyze segment results and trends. Segment operating income excludes certain general corporate expenses (which are a component of selling, general and administrative expenses)~~, impairment~~ and acquisition related expenses, restructuring, integration, and other charges.

~~Table of Contents~~

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.


		Three Months Ended March 31,				Nine Months Ended March 31,					Three Months Ended March 31,				Nine Months Ended March 31,
		2022		2021		2022		2021			2023		2022		2023		2022
Net Sales:	Net Sales:									Net Sales:
North America	North America	$	325,742	$	287,500	$	866,281	$	850,780	North America	$	286,649	$	325,742	$	857,406	$	866,281
International	International	177,197		205,104		568,502		668,869		International	168,594		177,197		491,396		568,502

		$	502,939	$	492,604	$	1,434,783	$	1,519,649		$	455,243	$	502,939	$	1,348,802	$	1,434,783

Operating Income (Loss):
Operating (Loss) Income:										Operating (Loss) Income:
North America(a)	North America(a)	$	28,526	$	39,492	$	72,530	$	105,188	North America(a)	$	(136,127)	$	28,526	$	(79,420)	$	72,530
International	International	18,303		26,774		69,740		8,144		International	13,604		18,303		33,219		69,740
		46,829		66,266		142,270		113,332			(122,523)		46,829		(46,201)		142,270
Corporate and Other ~~(a)~~(b)	Corporate and Other ~~(a)~~(b)	(11,665)		(16,689)		(49,538)		(47,518)		Corporate and Other ~~(a)~~(b)	(18,403)		(11,665)		(51,513)		(49,538)
		$	35,164	$	49,577	$	92,732	$	65,814		$	(140,926)	$	35,164	$	(97,714)	$	92,732

(a) North America operating loss includes non-cash impairment charges of $156,298 related to ParmCrisps® and Thinsters® trademarks and ParmCrisps® customer relationships for the three and nine months ended March 31, 2023 (see Note 8, Goodwill and Other Intangible Assets).

(b) In addition to general Corporate and Other expenses as described above, for the three and nine months ended March 31, ~~2022,~~2023, Corporate and Other included ~~$218~~$2,603 and ~~$3,228~~$3,133 of Productivity and transformation costs, respectively. For the three and nine months ended March 31, ~~2021,~~2022, Corporate and Other included ~~$2,804~~$218 and ~~$6,343~~$3,228 of Productivity and transformation costs, respectively.

~~The Company's net sales by product category(1)~~ ~~are as follows:~~

Three Months Ended March 31, Nine Months Ended March 31,
2022 2021 2022 2021
Turbocharge $ 194,526 $ 183,877 $ 544,084 $ 535,455
Targeted Investment 182,050 173,380 508,615 507,809
Fuel 99,322 100,467 303,898 311,013
Simplify 27,041 34,880 78,186 165,372
Total $ 502,939 $ 492,604 $ 1,434,783 $ 1,519,649

~~(1)~~The Turbocharge brands are made up of plant-based meat and non-dairy beverages as well as snacks. The Targeted Investment brands are made up of tea, baby, yogurt, and personal care. The Fuel brands are made up of pantry brands in categories such as soup, cooking oils and nut butters.~~The Simplify brands include all other brands.~~

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiaries, were as follows:


		Three Months Ended March 31,				Nine Months Ended March 31,					Three Months Ended March 31,				Nine Months Ended March 31,
		2022		2021		2022		2021			2023		2022		2023		2022
United States	United States	$	295,152	$	251,887	$	772,548	$	735,948	United States	$	259,468	$	295,152	$	774,032	$	772,548
United Kingdom	United Kingdom	124,029		139,094		387,129		475,738		United Kingdom	122,069		124,029		354,808		387,129
All Other	All Other	83,758		101,623		275,106		307,963		All Other	73,706		83,758		219,962		275,106
Total	Total	$	502,939	$	492,604	$	1,434,783	$	1,519,649	Total	$	455,243	$	502,939	$	1,348,802	$	1,434,783

~~Table of Contents~~

The Company’s long-lived assets, which represent net property, plant and equipment and operating lease right-of-use assets, were as follows by geographic area:

March 31,
2022 June 30,
2021
United States $ 153,569 $ 148,950
United Kingdom 144,279 142,973
All Other 103,607 112,864
Total $ 401,455 $ 404,787

~~19. RELATED PARTY TRANSACTIONS~~

~~On April 15, 2021, the Company completed the divestiture of its North America non-dairy beverages brands, Dream~~® ~~and WestSoy~~®~~, for $31,320. The purchaser in this transaction was SunOpta Inc. (“SunOpta”). The non-employee chair of the Company's Board of Directors is also the chair of the board of SunOpta.~~

~~SunOpta is also one of the Company’s suppliers, for which the Company incurred expenses in the ordinary course of business. The Company incurred expenses of $247 and~~ ~~$3,649~~ ~~in the three months ended March 31, 2022 and 2021, respectively, to SunOpta and affiliated entities. For the~~ ~~nine months ended~~ ~~March 31, 2022 and 2021, the Company incurred expenses of $467 and $12,806, respectively, to SunOpta and affiliated entities.~~

On November 9, 2021, the Company entered into a share repurchase agreement with Engaged Capital Co-Invest VI, LP, Engaged Capital Co-Invest VI-B, LP, Engaged Capital Co-Invest VI-C, LP, Engaged Capital Co-Invest VI-D, LP and Engaged Capital Co-Invest VI-E, LP (collectively, the “Selling Stockholders”), which are affiliates of Engaged Capital, LLC, pursuant to which the Company agreed to repurchase, directly from the Selling Stockholders, ~~1,700~~ ~~shares of the Company’s common stock for~~ ~~$45.00 per share (the "Share Repurchase"), which equals the price at which the~~ ~~Underwriter (as defined below)~~ purchased shares from the Selling Stockholders, net of underwriting commissions and discounts, in an underwritten public offering that launched on November 10, 2021, whereby the Selling Stockholders sold certain other shares of common stock (the “Offering”). In connection with the Offering, on November 10, 2021, the Company entered into an underwriting agreement with Morgan Stanley & Co. LLC, as underwriter (the “Underwriter”), and the Selling Stockholders. The Share Repurchase and the Offering were completed on November 15, 2021. The aggregate price paid by the Company for the Share Repurchase was $76,500 (see Note 3, ~~Earnings per Share~~), which the Company funded with borrowings under the Credit Agreement. The Company did not receive any proceeds from the Offering. The Founder and Chief Investment Officer of Engaged Capital, LLC is a member of the Company's Board of Directors.


	March 31, 2023		June 30, 2022
United States	$	165,470	$	182,038
United Kingdom	132,831		133,213
All Other	96,438		96,845
Total	$	394,739	$	412,096

3534

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Consolidated Financial Statements and the related Notes thereto for the period ended March 31, ~~2022~~2023 contained in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021. Forward-looking~~2022. Forward- looking statements in this Form 10-Q are qualified by the cautionary statement included in this Form 10-Q under the sub-heading “Forward-Looking Statements” in the introduction of this Form 10-Q.

Overview

The Hain Celestial Group, Inc., a Delaware corporation (collectively, along with its subsidiaries, the “Company,” and herein referred to as “Hain Celestial,” “we,” “us” and “our”), was founded in 1993 and is headquartered in ~~Lake Success, New York.~~Boulder, Colorado. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet. The Company continues to be a leading marketer, manufacturer and seller of organic and natural, ~~"better-for-you"~~“better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores ~~in over 80 countries~~ worldwide. ~~The Company operates under two reportable segments: North America and International.~~

The Company manufactures, markets, distributes, and sells organic and natural products, ~~under brand names~~ providing consumers with the opportunity to lead A Healthier Way of Life®. ~~Hain Celestial's~~The Company’s food and beverage brands include Celestial Seasonings®, Clarks™, Cully & Sully®, Earth’s Best®, Ella’s Kitchen®, Frank Cooper’s®, Garden of Eatin’®, ~~Hain Pure Foods~~®, Hartley’s®, Health Valley®, Imagine®, Joya®, Lima®, Linda ~~McCartney's~~McCartney’s® (under license), MaraNatha®, Natumi®, New Covent Garden Soup Co.®, ParmCrisps®,Robertson’s®, ~~Rose's~~Rose’s® (under license), Sensible Portions®, Spectrum®, Sun-Pat®, Terra®, The Greek Gods®, Thinsters®, Yorkshire Provender® and Yves Veggie Cuisine®. ~~Hain Celestial’s~~The Company’s personal care brands include Alba Botanica®, Avalon Organics®, JASON®, Live Clean®, and Queen Helene®.

Global Economic Environment

~~Our previous strategy, which we refer to as Hain 2.0, was executed under~~
~~four key pillars—(1) simplify our portfolio; (2) strengthen our capabilities; (3) expand profit margins~~

Economic conditions during fiscal year 2022 and ~~cash flow;~~the first nine months of fiscal year 2023 have been marked by inflationary pressures, rising interest rates and (4) reinvigorate profitable topline growth. This strategy has laid the foundation for Hain 3.0, our vision and strategy for the next several years, which is about building a global healthy food and beverage company with industry-leading top line growth. We believe Hain 3.0 positions us as an advantaged and differentiated company, as compared to othersshifts in ~~the food industry for several reasons:~~consumer demand.

•Inflation – The inflationary environment has led to higher costs for ingredients, packaging, energy, transportation and other supply chain components. We expect this higher cost environment to continue, although we ~~are singularly focused on health~~expect these higher costs to be partially mitigated by pricing actions we have implemented to date and ~~wellness,~~further pricing actions that we may implement.

•Interest Rates – Loans under our credit agreement bear interest at a variable rate, and the interest rate on our outstanding indebtedness has increased as market interest rates have risen significantly starting in the second half of fiscal year 2022. These higher interest rates, together with a higher outstanding debt balance, has led to an increase in our interest expense and we ~~are a global company in high-growth categories with opportunities for expansion in existing and new channels and geographies,~~expect this high rate environment to continue.

•weConsumer Demand – Recent economic conditions have ~~unique and advantaged brands with strong points of difference, and~~

•~~given~~resulted in changes in consumer spending patterns, which has had an impact on our ~~size, small wins can drive material incremental growth.~~

We have re-segmented the brand portfolio with a more global view to where we have the most growth potential. As a result, we have migrated from a strategy focused on rejuvenating North America behind a construct of “Get Bigger" and "Get Better” brand categories to one that focuses on growing global brands in categories where we think we have the most potential. The categories we have identified are called Turbocharge, Targeted Investment, and Fuel:

•~~The~~ ~~Turbocharge~~ brands are leading-share brands in very high-growth categories. The Turbocharge brands are made up of plant-based meat and non-dairy beverages as well as snacks. Our meat and dairy alternatives are concentrated outside the United States, while the snacks businesses include brands both within the United States and in International.

•~~The~~ ~~Targeted Investment~~ brands are made up of leading-share brands in lower-growth categories. To date, we have demonstrated our ability to drive market share and reinvigorate these categories, and we expect that we can continue to do this in the future. The Targeted Investment brands are made up of tea, baby, yogurt, and personal care. In contrast with Hain 2.0, baby is now one of our growth focus areas, due to its strong brands, scale, profitability, and growth prospects.

•~~The~~ ~~Fuel~~ ~~brands are stable brands that will be leveraged to fuel investment in the Turbocharge and Targeted Investment categories. Fuel brands are made up of premium pantry brands with scale, in categories~~sales. During an economic downturn, factors such as ~~soup, cooking oils~~increased unemployment, decreases in disposable income and ~~nut butters.~~

~~Table of Contents~~

~~Additionally, as part of Hain 3.0, we will continue~~declines in consumer confidence can cause changes in consumer spending behavior. Economic conditions have prompted some consumers, particularly in Europe, to ~~simplify our brand portfolio as we continue~~shift to identify brands that are declining and have low margins. The Simplify brands are subscale declining businesses that have limited long-term potential for the Company, and therefore will be managed for profit until they are potentially divested, likely over the course of the next several years. Acquisitions are expected to play a role in Hain 3.0 and part of our capital allocation strategy is focused on actively looking for targets in the market. As we continue to simplify and stabilize the organization and consolidate sales into fewer priority categories, we are well-positioned and expect to make targeted acquisitions supported by our borrowing capacity to help us further strengthen our position in those categories.

~~COVID-19~~

~~The COVID-19 pandemic has resulted in a net increase in overall demand for our~~lower-priced products. The impact was particularly pronounced during the early stages of the pandemic as consumers reacted to stay-at-home measures and the uncertainty of the pandemic. In particular, our net sales during the third quarter of fiscal 2020 through the second quarter of fiscal 2021 benefited from pandemic-driven demand. The pandemic-driven demand for our products has subsided as effective vaccines have become available, governments have eased safety measures and consumer purchasing behaviors have started to return to pre-pandemic norms.

The pandemic and the measures being taken by governments, businesses and consumers to limit the spread of COVID-19 have led to operational challenges in our business and may result in broader and longer-term challenges and uncertainty that we will need to manage successfully. Such challenges include but are not limited to:

•manufacturing, supply chain and logistics challenges resulting from health and safety precautions among our employees and the general population as well as macroeconomic factors resulting from the pandemic, including labor market shortages;

•~~an uncertain future demand environment as a result of changing consumer behaviors amid uncertain economic conditions; and~~

•~~increased costs of operating our business and managing our supply chain during a global pandemic, driven by well-publicized industry-wide inflation, supply chain and labor challenges.~~

Russia-Ukraine War

Although we have no material assets in Russia, Belarus or Ukraine, our supply chain was adversely impacted by the Russia-Ukraine war during the ~~three~~second half of fiscal year 2022 and the first nine months ~~ended March 31, 2022,~~of fiscal year 2023 and we continue to face other challenges and risks arising from the war. In particular, the war has added significant costs to existing inflationary pressures through increased ~~fuel~~energy and raw material ~~prices and labor costs.~~prices. Further, beyond increased costs, labor challenges and other factors have led to supply chain disruptions. While, to date, we have been able to identify replacement raw materials where necessary, we have incurred increased costs in doing so. ~~For example, the supply of sunflower oil has become constrained, compelling us to identify and procure alternative oils.~~ The war has also negatively impacted consumer sentiment, particularly in Europe, with some consumers shifting to lower-priced products, which has somewhat affected demand for our products. Additionally, we face increased cybersecurity risks, as companies based in the United States and its allied countries have become targets of malicious cyber activity. While we are continuing to monitor and manage the impacts of the war on our business, the extent to which the Russia-Ukraine war and the related economic impact may affect our financial condition or results of operations in the future remains uncertain.

~~Acquisition~~

On December 28, 2021, the Company acquired all outstanding stock of Proven Brands, Inc. (and its subsidiary That's How We Roll LLC) and KTB Foods Inc., collectively doing business as "That's How We Roll" ("THWR"), the producer and marketer of ParmCrisps® and Thinsters®. The acquisition of these two fast-growing, better-for-you brands deepens the Company's position in the snacking category and represents a significant step in establishing the Company as a high-growth, global healthy food company. See Note 4, ~~Acquisitions and Dispositions,~~ ~~in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Qfor additional details.~~

~~Discontinued Operations~~

On August 27, 2019, the Company and Ebro Foods S.A. (the “Purchaser”) entered into, and consummated the transactions contemplated by, an agreement relating to the sale and purchase of the entities comprising the Company’s Tilda operating segment and certain other assets.

~~The Company's dispositions are described in more detail in Note 5,~~ ~~Dispositions, in the Notes to the Consolidated Financial Statements in the Form 10-K.~~

3735

Table of Contents

CEO Succession

On November 22, 2022, the Board of Directors (the "Board") of the Company approved a succession plan pursuant to which the Board appointed Wendy P. Davidson to the role of President and Chief Executive Officer and as a director on the Board, in each case effective as of January 1, 2023. As part of the succession plan, Mark L. Schiller transitioned from his position as President and Chief Executive Officer of the Company effective as of December 31, 2022 (the “Transition Date”). Mr. Schiller remains as a director on the Board following the Transition Date.

Comparison of Three Months Ended March 31, ~~2022~~2023 to Three Months Ended March 31, ~~2021~~2022

Consolidated Results

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the three months ended March 31, ~~2022~~2023 and ~~2021~~2022 (amounts in thousands, other than per share data and percentages, which may not add due to rounding):


		Three Months Ended						Change in				Three Months Ended						Change in
		March 31, 2022			March 31, 2021			Dollars		Percentage		March 31, 2023			March 31, 2022			Dollars		Percentage
Net sales	Net sales	$	502,939	100.0%	$	492,604	100.0%	$	10,335	2.1%	Net sales	$	455,243	100.0%	$	502,939	100.0%	$	(47,696)	(9.5)%
Cost of sales	Cost of sales	387,236		77.0%	362,698		73.6%	24,538		6.8%	Cost of sales	357,764		78.6%	387,236		77.0%	(29,472)		(7.6)%
Gross profit	Gross profit	115,703		23.0%	129,906		26.4%	(14,203)		(10.9)%	Gross profit	97,479		21.4%	115,703		23.0%	(18,224)		(15.8)%
Selling, general and administrative expenses	Selling, general and administrative expenses	75,750		15.1%	74,325		15.1%	1,425		1.9%	Selling, general and administrative expenses	75,047		16.5%	75,750		15.1%	(703)		(0.9)%
Intangibles and long-lived asset impairment											Intangibles and long-lived asset impairment	156,583		34.4%	—		—%	156,583		*

Amortization of acquired intangible assets	Amortization of acquired intangible assets	3,110		0.6%	2,145		0.4%	965		45.0%	Amortization of acquired intangible assets	2,842		0.6%	3,110		0.6%	(268)		(8.6)%
Productivity and transformation costs	Productivity and transformation costs	1,679		0.3%	4,451		0.9%	(2,772)		(62.3)%	Productivity and transformation costs	3,933		0.9%	1,679		0.3%	2,254		134.2%
Proceeds from insurance claim		—		—%	(592)		(0.1)%	592		*
Operating income		35,164		7.0%	49,577		10.1%	(14,413)		(29.1)%
Interest and other financing expense, net		3,224		0.6%	2,030		0.4%	1,194		58.8%
Other (income) expense, net		(712)		(0.1)%	1,566		0.3%	(2,278)		*
Income from continuing operations before income taxes and equity in net loss (income) of equity-method investees		32,652		6.5%	45,981		9.3%	(13,329)		(29.0)%
Provision for income taxes		7,738		1.5%	11,797		2.4%	(4,059)		(34.4)%
Equity in net loss (income) of equity-method investees		383		0.1%	(70)		—%	453		*

Net income		$	24,531	4.9%	$	34,254	7.0%	$	(9,723)	(28.4)%

Operating (loss) income											Operating (loss) income	(140,926)		(31.0)%	35,164		7.0%	(176,090)		(500.8)%
Interest and other financing expense, net											Interest and other financing expense, net	13,421		2.9%	3,224		0.6%	10,197		316.3%
Other expense (income), net											Other expense (income), net	439		0.1%	(712)		(0.1)%	1,151		(161.7)%
(Loss) income before income taxes and equity in net loss of equity-method investees											(Loss) income before income taxes and equity in net loss of equity-method investees	(154,786)		(34.0)%	32,652		6.5%	(187,438)		(574.0)%
(Benefit) provision for income taxes											(Benefit) provision for income taxes	(39,587)		(8.7)%	7,738		1.5%	(47,325)		(611.6)%
Equity in net loss of equity-method investees											Equity in net loss of equity-method investees	528		0.1%	383		0.1%	145		37.9%

Net (loss) income											Net (loss) income	$	(115,727)	(25.4)%	$	24,531	4.9%	$	(140,258)	(571.8)%

Adjusted EBITDA	Adjusted EBITDA	$	58,669	11.7%	$	73,752	15.0%	$	(15,083)	(20.5)%	Adjusted EBITDA	$	37,260	8.2%	$	58,669	11.7%	$	(21,409)	(36.5)%

Diluted net income per common share		$	0.27		$	0.34		$	(0.07)	(20.6)%
Diluted net (loss) income per common share											Diluted net (loss) income per common share	$	(1.29)		$	0.27		$	(1.56)	*

* Percentage is not meaningful due to one or more numbers being negative.

Net Sales

Net sales for the three months ended March 31, ~~2022~~2023 were ~~$502.9~~$455.2 million, ~~an increase~~a decrease of ~~$10.3~~$47.7 million, or ~~2.1%~~9.5%, as compared to ~~$492.6~~$502.9 million in the three months ended March 31, ~~2021.~~2022. On a constant currency basis, adjusted for the impact of acquisitions, divestitures and discontinued brands, net sales ~~increased~~decreased approximately ~~$7.2~~$28.9 million, or ~~1.5%~~5.8%, from the prior year quarter driven by ~~growth in~~ both the North America ~~reportable segment offset by a decline in the~~and International reportable ~~segment.~~segments. Further details of changes in net sales by segment are provided below in the Segment Results section.

Table of Contents

Gross Profit

Gross profit for the three months ended March 31, ~~2022~~2023 was ~~$115.7~~$97.5 million, a decrease of ~~$14.2~~$18.2 million, or ~~10.9%~~15.8%, as compared to the prior year quarter. Additionally, gross profit margin of ~~23.0%~~21.4% was lower when compared with 23.0% in the prior year quarter. The decrease in gross profit was driven primarily by the North America reportable segment as a result of lower net sales, changes in sales mix of high margin products and inflation. The International reportable segment also had a decrease in gross profit mainly ~~due to~~resulting from lower net sales in the ~~United Kingdom and~~ Europe operating ~~segments, as well as~~segment, change in sales mix of high margin products and higher energy and supply chain costs when compared to the prior year period, partially offset by higher net sales in the Ella's Kitchen UK operating segment. The North America reportable segment also had a decrease in gross profit mainly due to inflationary and supply chain challenges, such as continued industry-wide distribution and warehousing cost pressures driven by labor shortages, freight carrier availability and other freight cost issues, as well as lower net sales in the Canada operating segment when compared with the prior year period.

~~Table of Contents~~

Selling, General and Administrative Expenses

Selling, general and administrative expenses were ~~$75.8~~$75.0 million for the three months ended March 31, ~~2022, an increase~~2023, a decrease of ~~$1.4~~$0.7 million, or ~~1.9%~~0.9%, from ~~$74.3~~$75.8 million for thethe prior year quarter. The ~~increase~~decrease was ~~primarily~~ driven by the North America reportable segment offset in part by the International reportable segment and Corporate and Other. The United States operating segment accounted for the increase in the North America reportable segment due to the acquisition of THWR. The increase was partially offset by a decrease in people-related expenseslower marketing costs as well as efficiencies gained from the Company's productivity and transformation ~~initiatives.~~initiatives, partially offset by higher labor-related expenses primarily in Corporate.

Intangibles and long-lived asset impairment

During the three months ended March 31, 2023, the Company recognized an aggregate impairment charge of $156.6 million, primarily related to the ParmCrisps® and Thinsters® indefinite-lived trademarks and ParmCrisps® definite-lived customer relationships, which reduced the carrying value of such assets to their estimated fair value. The fair value of indefinite-lived trademarks and definite-lived customer relationships were determined using the relief from royalty method and multi-period excess earnings method, respectively. See Note 8, Goodwill and Other Intangible Assets and Note 14, Fair Value Measurements, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Amortization of Acquired Intangible Assets

Amortization of acquired intangibles was ~~$3.1~~$2.8 million for the three months ended March 31, ~~2022, an increase~~2023, a decrease of ~~$1.0~~$0.3 million from ~~$2.1~~$3.1 million in the prior year quarter due to ~~the~~ ~~acquisition~~complete amortization of ~~THWR~~certain acquired intangible assets primarily in the ~~current fiscal year, partially offset by lower amortization expense in~~Europe and the ~~current year period as a result of~~United Kingdom operating segments when compared with the prior year ~~dispositions that occurred in the later part of fiscal 2021.~~quarter.

Productivity and Transformation Costs

Productivity and transformation costs were ~~$1.7~~$3.9 million for the three months ended March 31, ~~2022, a decrease~~2023, an increase of ~~$2.8~~$2.3 million from ~~$4.5~~$1.7 million in the prior year quarter. The ~~decrease~~increase was primarily duedue to ~~reduced~~increased spending related to productivity and transformation ~~initiatives~~strategy consulting costs as a part of the ~~current transformation effort approaches its conclusion.~~Company’s strategic plan update.

Operating ~~Income~~Loss (Income)

Operating ~~income~~loss for the three months ended March 31, ~~2022~~2023 was ~~$35.2~~$140.9 million compared to ~~$49.6~~income of $35.2 million in the prior year quarter as a result of the items described above.

Interest and Other Financing Expense, Net

Interest and other financing expense, net totaled ~~$3.2~~$13.4 million for the three months ended March 31, ~~2022,~~2023, an increase of ~~$1.2~~$10.2 million, or ~~58.8%~~316.3%, from ~~$2.0~~$3.2 million in the prior year quarter. TheThe increase resulted primarily from rising interest rates and a higher outstanding debt balance driven primarily by the acquisition of THWR ~~in the prior quarter as well as~~and share repurchase ~~activity.~~activity during fiscal 2022. See Note 9, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Other Expense (Income) ~~Expense,~~, Net

Other ~~income,~~expense, net totaled ~~$0.7~~$0.4 million for the three months ended March 31, ~~2022,~~2023, compared to ~~other expense, net totaling $1.6~~income of $0.7 million in the prior year quarter. The ~~change to~~decrease in income ~~from expense~~ was primarily attributable to ~~a loss on~~ the ~~sale~~recognition of ~~the Fruit business, which occurred~~foreign exchange gain in the prior year quarter ~~with no comparable~~compared to foreign exchange loss in the current ~~year~~ quarter.

Table of Contents

(Loss) Income ~~from Continuing Operations~~ Before Income Taxes and Equity in Net Loss ~~(Income)~~ of Equity-Method Investees

~~Income from continuing operations~~Loss before income taxes and equity in net loss ~~(income)~~ of our equity-method investees for the three months ended March 31, ~~2022~~2023 was ~~$32.7~~$154.8 million compared to ~~$46.0~~income of $32.7 million in the prior year quarter. The decrease was due to the items discussed above.

(Benefit) Provision for Income Taxes

The provision for income taxes includes federal, foreign, state and local income taxes. Our income tax ~~expense from continuing operations~~benefit was ~~$7.7~~$39.6 million for the three months ended March 31, ~~2022~~2023 compared to an income tax expense of ~~$11.8~~$7.7 million in the prior year quarter.

The effective income tax rate ~~from continuing operations~~ was a benefit of 25.6% and an expense of 23.7% ~~and 25.7%~~ for the three months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively. The effective income ttax rate for the three months ended March 31, 2023 was impacted by ParmCrispsax® and Thinsters® trademarks and ParmCrisps® asset group impairment charges, stock-based compensation and changes in uncertain tax positions. The effective income tax rate ~~from continuing operations~~ for the three months ended March 31, 2022 was impacted by deductions related to stock-based compensation and the finalization of fiscal year 2021 income tax returns. The effective income tax ~~rate from continuing operations for the three months ended March 31, 2021 was~~rates in each period were also impacted by ~~various discrete items including~~ the ~~finalization~~geographical mix of ~~fiscal year 2020 U.S.~~earnings and state income ~~tax returns.~~taxes.

~~Table of Contents~~

Equity in Net Loss ~~(Income)~~ of Equity-Method Investees

Our equity in net loss ~~(income)~~ from our equity-method investments for the three months ended March 31, ~~2022~~2023 was ~~a loss of $0.4~~$0.5 million and ~~income of $0.1~~$0.4 million in the prior year quarter. See Note 13, Investments, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Net (Loss) Income

Net ~~income~~loss for the three months ended March 31, ~~2022~~2023 was ~~$24.5~~$115.7 million, or ~~$0.27~~$1.29 per diluted share, compared to ~~$34.3~~net income of $24.5 million, or ~~$0.34~~$0.27 per diluted share, in the prior year quarter. The ~~decrease~~change was attributable to the factors noted above.

Adjusted EBITDA

Our Adjusted EBITDA was ~~$58.7~~$37.3 million and ~~$73.8~~$58.7 million for the three months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, as a result of the factors ~~discussed~~discussed above, and the adjustments described in the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures presented following the discussion of our results of operations. On a constant currency basis, Adjusted EBITDA decreased by $19.3 million, or 33.0%, from $58.7 million for the three months ended March 31, 2022 to $39.3 million for the three months ended March 31, 2023.

Table of Contents

Segment Results

The following table provides a summary of net sales and operating income (loss) by reportable segment for the three months ended March 31, ~~2022~~2023 and ~~2021:~~2022:


(dollars in thousands)	(dollars in thousands)	North America			International			Corporate and Other			Consolidated			(dollars in thousands)	North America			International			Corporate and Other			Consolidated
Net sales	Net sales													Net sales
Three months ended 3/31/23														Three months ended 3/31/23	$	286,649		$	168,594		$	—		$	455,243
Three months ended 3/31/22	Three months ended 3/31/22	$	325,742		$	177,197		$	—		$	502,939		Three months ended 3/31/22	325,742			177,197			—			502,939
Three months ended 3/31/21		287,500			205,104			—			492,604
$ change	$ change	$	38,242		$	(27,907)		n/a			$	10,335		$ change	$	(39,093)		$	(8,603)		n/a			$	(47,696)
% change	% change	13.3		%	(13.6)		%	n/a			2.1		%	% change	(12.0)		%	(4.9)		%	n/a			(9.5)		%

Operating income (loss)
Operating (loss) income														Operating (loss) income
Three months ended 3/31/23(a)														Three months ended 3/31/23(a)	$	(136,127)		$	13,604		$	(18,403)		$	(140,926)
Three months ended 3/31/22	Three months ended 3/31/22	$	28,526		$	18,303		$	(11,665)		$	35,164		Three months ended 3/31/22	28,526			18,303			(11,665)			35,164
Three months ended 3/31/21		39,492			26,774			(16,689)			49,577
$ change	$ change	$	(10,966)		$	(8,471)		$	5,024		$	(14,413)		$ change	$	(164,653)		$	(4,699)		$	(6,738)		$	(176,090)
% change	% change	(27.8)		%	(31.6)		%	(30.1)		%	(29.1)		%	% change	(577.2)		%	(25.7)		%	57.8		%	(500.8)		%

Operating income margin
Operating (loss) income margin														Operating (loss) income margin
Three months ended 3/31/23														Three months ended 3/31/23	(47.5)		%	8.1		%	n/a			(31.0)		%
Three months ended 3/31/22	Three months ended 3/31/22	8.8		%	10.3		%	n/a			7.0		%	Three months ended 3/31/22	8.8		%	10.3		%	n/a			7.0		%
Three months ended 3/31/21		13.7		%	13.1		%	n/a			10.1		%

(a) North America operating loss includes non-cash impairment charges of $156,298 related to ParmCrisps® and Thinsters® trademarks and ParmCrisps® customer relationships (see Note 8, Goodwill and Other Intangible Assets).

North America

Our net sales in the North America reportable segment for the three months ended March 31, ~~2022~~2023 were ~~$325.7~~$286.6 million, ~~an increase~~a decrease of ~~$38.2~~$39.1 million, or ~~13.3%~~12.0%, from net sales of ~~$287.5~~$325.7 million in the prior year quarter. On a constant currency basis, adjusted for the impact of ~~an acquisition,~~acquisitions, divestitures and discontinued brands, net sales ~~increased~~decreased by ~~8.5%~~10.8%. In the United States operating segment, adjusted sales were ~~higher~~lower compared to the prior year quarter mainly due to ~~stronger~~lower sales in snacks, ~~baby,~~ personal care and ~~other product categories. In~~tea, partially offset by higher sales in yogurt. The net sales decrease within snacks was substantially driven by reduced distribution and customer promotions associated with the ParmCrisps® brand. Similar trends were noted in the Canada operating ~~segment, adjusted sales decreased compared to the prior year quarter primarily due to lower sales in personal care product categories.~~segment. Operating ~~income~~loss in North America for the three months ended March 31, ~~2022~~2023 was ~~$28.5~~$136.1 million, a decrease of ~~$11.0~~$164.7 million ~~from $39.5~~compared to operating income of $28.5 million in the prior year quarter. The decrease ~~in operating income~~ was mainly driven by ~~inflationary~~aggregate non-cash impairment charges of $156.3 million related to the ParmCrisps® and ~~supply chain challenges, such as continued industry-wide distribution~~Thinsters® intangible assets and ~~warehousing cost pressures driven by labor shortages, freight carrier availability and other freight cost issues, as well as~~ lower net sales in the ~~Canada~~United States operating segment, ~~when compared with the prior year quarter.~~partially offset by cost improvements due to higher productivity.

~~Table of Contents~~

I~~nternational~~International

Our net sales in the International reportable segment for the three months ended March 31, ~~2022~~2023 were ~~$177.2~~$168.6 million, a decrease of ~~$27.9~~$8.6 million, or ~~13.6%~~4.9%, from net sales of ~~$205.1~~$177.2 million in the prior year quarter. ~~Foreign exchange and divestitures reduced net sales for the three months ended March 31, 2022.~~ On a constant currency basis, ~~adjusted for the impact of divestitures,~~ net ~~sales decreased 8.2%~~sales increased 3.5% from the prior year quarter primarily due to ~~a decline in sales in the Europe and United Kingdom operating segments, partially offset by~~ an increase in sales in the ~~Ella's Kitchen UK~~United Kingdom operating ~~segment.~~ ~~The net sales decrease~~segment, partially offset by softness in plant-based categories in the ~~Europe operating segment was primarily due to the loss~~rest of a large non-dairy co-manufacturing customer. The net sales decrease in the United Kingdom was due to lower sales in plant-based, soup and puddings resulting from lower total store sales and the impact of shipment halts during the price increase negotiations with certain customers. The net sales increase in the Ella's Kitchen UK operating segment was due to higher sales coming out of the COVID-19 pandemic, since Ella's Kitchen UK sales were negatively impacted in the prior year quarter due to a slow-down in consumer demand for baby food as a result of the COVID-19 pandemic stay-at-home requirements and sales pull back in the second quarter of the prior year due to Brexit (e.g. the sales were made the second quarter of the prior year rather than the third quarter of the prior year).Europe. Operating income in our International ~~reportable~~reportable segment for the three months ended March 31, ~~2022~~2023 was ~~$18.3~~$13.6 million, a decrease of ~~$8.5~~$4.7 million from ~~operating income of $26.8~~$18.3 million for the three months ended March 31, ~~2021.~~2022. Operating income was lower in the current quarter when compared to the prior year quarter mainly due to ~~lower gross profit resulting from a decline in sales, as well as higher~~increased energy and ~~supply chain costs.~~input costs and volume mix, partially offset by improved pricing and productivity.

Table of Contents

Corporate and Other

Our Corporate and Other category consists of expenses related to the Company’s centralized administrative functions, which do not specifically relate to an operating segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our entire enterprise as well as expenses for certain professional fees, acquisition and divestiture transaction costs, facilities, and other items which benefit the Company as a whole. Our operating loss in Corporate and Other for the three months ended March 31, ~~2022~~2023 was ~~$11.7~~$18.4 million,~~, a decrease~~ an increase of ~~$5.0~~$6.7 million, from ~~operating loss of $16.7~~$11.7 million for the three months ended March 31, ~~2021.~~2022. This change was primarily due to ~~lower employee-related expenses, partially offset by~~ higher ~~baby food litigation~~strategic consulting charges and employee related expenses.

Refer to Note ~~18,~~17, Segment Information, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

~~Table of Contents~~

Comparison of Nine Months Ended March 31, ~~2022~~2023 to Nine Months Ended March 31, ~~2021~~2022

Consolidated Results

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the nine months ended March 31, ~~2022~~2023 and ~~2021~~2022 (amounts in thousands, other than per share data and percentages, which may not add due to rounding):

Nine Months Ended Change in
March 31, 2022 March 31, 2021 Dollars Percentage
Net sales $ 1,434,783 100.0% $ 1,519,649 100.0% $ (84,866) (5.6)%
Cost of sales 1,096,367 76.4% 1,140,614 75.1% (44,247) (3.9)%
Gross profit 338,416 23.6% 379,035 24.9% (40,619) (10.7)%
Selling, general and administrative expenses 229,875 16.0% 238,471 15.7% (8,596) (3.6)%
Amortization of acquired intangible assets 7,254 0.5% 6,771 0.4% 483 7.1%
Productivity and transformation costs 8,448 0.6% 10,895 0.7% (2,447) (22.5)%
Proceeds from insurance claim (196) —% (592) —% (396) *
Long-lived asset and intangibles impairment 303 —% 57,676 3.8% (57,373) (99.5)%
Operating income 92,732 6.5% 65,814 4.3% 27,710 42.1%
Interest and other financing expense, net 7,672 0.5% 6,820 0.4% 852 12.5%
Other income, net (10,570) (0.7)% (852) (0.1)% (9,718) *
Income from continuing operations before income taxes and equity in net loss of equity-method investees 95,630 6.7% 59,846 3.9% 35,784 59.8%
Provision for income taxes 19,425 1.4% 33,197 2.2% (13,772) (41.5)%
Equity in net loss of equity-method investments 1,374 0.1% 1,025 0.1% 349 34.0%
Net income from continuing operations $ 74,831 5.2% $ 25,624 1.7% $ 49,207 192.0%
Net income from discontinued operations, net of tax — —% 11,255 0.7% (11,255) (100.0)%
Net income $ 74,831 5.2% $ 36,879 2.4% $ 37,952 102.9%
Adjusted EBITDA 165,249 11.5% 190,838 12.6% $ (25,589) (13.4)%
Diluted net income per common share from continuing operations $ 0.79 $ 0.25 $ 0.54 216.0%
Diluted net income per common share from discontinued operations $ — 0.11 (0.11) (100.0)%
Diluted net income per common share $ 0.79 $ 0.36 $ 0.43 119.4%


	Nine Months Ended						Change in
	March 31, 2023			March 31, 2022			Dollars		Percentage
Net sales	$	1,348,802	100.0%	$	1,434,783	100.0%	$	(85,981)	(6.0)%
Cost of sales	1,053,131		78.1%	1,096,367		76.4%	(43,236)		(3.9)%
Gross profit	295,671		21.9%	338,416		23.6%	(42,745)		(12.6)%
Selling, general and administrative expenses	222,355		16.5%	229,679		16.0%	(7,324)		(3.2)%
Intangibles and long-lived asset impairment	156,923		11.6%	303		—%	156,620		**
Amortization of acquired intangible assets	8,415		0.6%	7,254		0.5%	1,161		16.0%
Productivity and transformation costs	5,692		0.4%	8,448		0.6%	(2,756)		(32.6)%





Operating (loss) income	(97,714)		(7.2)%	92,732		6.5%	(190,446)		*
Interest and other financing expense, net	31,910		2.4%	7,672		0.5%	24,238		315.9%
Other income, net	(2,413)		(0.2)%	(10,570)		(0.7)%	8,157		(77.2)%
(Loss) income before income taxes and equity in net loss of equity-method investees	(127,211)		(9.4)%	95,630		6.7%	(222,841)		*
(Benefit) provision for income taxes	(30,599)		(2.3)%	19,425		1.4%	(50,024)		*
Equity in net loss of equity-method investees	1,226		0.1%	1,374		0.1%	(148)		(10.8)%


Net (loss) income	$	(97,838)	(7.3)%	$	74,831	5.2%	$	(172,669)	*

Adjusted EBITDA	$	123,106	9.1%	$	165,249	11.5%	$	(42,143)	(25.5)%


Diluted net (loss) income per common share	$	(1.09)		$	0.79		$	(1.88)	*

* Percentage is not meaningful due to one or more numbers being negative.

** Percentage is not meaningful due to significantly lower number in the comparative period

Table of Contents

Net Sales

Net sales for the nine months ended March 31, ~~2022~~2023 were ~~$1,434.8~~$1,348.8 million, a decrease of ~~$84.9~~$86.0 million, or ~~5.6%~~6.0%, as compared to ~~$1,519.6~~$1,434.8 million in the nine months ended March 31, ~~2021.~~2022. On a constant currency basis, adjusted for the impact of acquisitions, divestitures and discontinued brands, net sales decreased approximately ~~$4.3~~$44.2 million, or ~~0.3%~~3.1%, from the prior comparable period primarily driven by ~~the~~ International ~~reportable segment, partially offset by the North America~~ reportable segment. Further details of changes in net sales by segment are provided below in the Segment Results section.

~~Table of Contents~~

Gross Profit

Gross profit for the nine months ended March 31, ~~2022~~2023 was ~~$338.4~~$295.7 million, a decrease of ~~$40.6~~$42.7 million, or ~~10.7%~~12.6%, as compared to the prior year comparable period. Gross profit margin was ~~23.6%~~21.9% of net sales, compared to ~~24.9%~~23.6% in the prior year comparable period. The decrease in gross profit was driven primarily by the International reportable segment mainly due to lower net sales in the Europe and United Kingdom operating segments and higher energy and supply chain costs when compared to the prior year period. The North America reportable segment ~~as a result of both the United States~~gross profit remained relatively flat due to pricing increases and ~~Canada operating segments which were impacted~~cost improvements driven by higher ~~costs associated with inflationary~~productivity, partially offset by inflation and supply chain challenges, such as continued industry-wide distribution and warehousing cost pressures driven by labor shortages, freight carrier availability and other freight cost issues. Additionally, the decrease in gross profit was due to lower net sales in the Canada operating segment when compared with the prior year comparable period. The International reportable segment gross profit also decreased due to both the United Kingdom and Europe operating segments partially offset by increased gross profit in the Ella's Kitchen UK operating segment. The decrease in gross profit in the Europe and United Kingdom operating segments was due to lower net sales and higher delivery and warehousing costs while the increased gross profit in the Ella's Kitchen UK operating segment was due to higher net sales than the prior year period due to a slow-down in consumer demand for baby food in the prior year period as a result of the COVID-19 pandemic stay-at-home requirements which negatively impacted prior year net sales.

Selling, General and Administrative Expenses

Selling, general and administrative ~~expense~~sexpenses were ~~$229.9~~$222.4 million for the nine months ended March 31, ~~2022,~~2023, a decrease of ~~$8.6~~$7.3 million, or ~~3.6%~~3.2%, from ~~$238.5~~$229.7 million for the prior year comparable period. The decrease was primarily driven by ~~a decrease~~reductions in the ~~International~~United States and ~~North America reportable segments, partially offset by an increase~~the United Kingdom operating segments. The decrease reflected reduced broker fees and sales related expenses primarily in ~~Corporate~~the United States operating segment and ~~Other as a result of higher transaction~~lower marketing costs, incurred in fiscal year 2022 including costs related to the acquisition of THWR, advisory costs related to the divestiture by affiliates of Engaged Capital, LLC of their shares of the Company's common stock, as well as ~~higher litigation expenses related to~~efficiencies gained from the ~~baby food litigation described in Note 17,~~ ~~Commitments~~Company's productivity and ~~Contingencies~~. The decrease in the International reportable segment was primarily due to (1) the sale of the Fruit business in the third quarter of the prior year with no comparable selling, general and administrative expenses in the current year, (2) lower broker commissions in the Europe operating segment, and (3) lower people-related expenses. The decrease in the North America reportable segment was primarily due to lower people-related expenses.

~~Amortization of Acquired Intangible Assets~~transformation initiatives.

~~Amortization of acquired intangibles was $7.3 million for the nine months ended March 31, 2022, an increase of $0.5 million from $6.8 million in the prior year comparable period due to the~~ ~~acquisition of THWR in the current fiscal year, partially offset by lower amortization in the current year period as a result of prior year dispositions that occurred in the later part of fiscal 2021.~~

~~Productivity~~Intangibles and ~~Transformation Costs~~

Productivity and transformation costs were $8.4 million for the nine months ended March 31, 2022, a decrease of $2.4 million from $10.9 million in the prior year comparable period. The decrease was primarily d~~ue to reduced spending related to productivity and transformation initiatives as the current transformation effort approaches its conclusion.~~

~~Long-lived Asset and Intangibles Impairment~~long-lived asset impairment

During the nine months ended March 31, ~~2022~~,2023, the Company recognized ~~a pre-tax~~aggregate impairment charge of $156.9 million , an increase of $156.6 million from $0.3 million in the prior year comparable period, related to ~~a facility in~~ the ~~United Kingdom. Duri~~ParmCrisps~~ng the nine months ended March 31, 2021, the Company recognized a pre-tax impairment charge of $57.7 million primarily related to a reduction in~~® and Thinsters® indefinite-lived trademarks and ParmCrisps® definite-lived customer relationships, which reduced the carrying value of such assets to ~~the~~their estimated fair value. The fair value ~~less costs to sell, for~~of indefinite-lived trademarks and definite-lived customer relationships were determined using the ~~United Kingdom fruit business (see~~relief from royalty method and multi-period excess earnings method, respectively. See Note 4,8, ~~Acquisitions~~Goodwill and ~~Dispositions~~Other Intangible Assets and Note 14, Fair Value Measurements, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form ~~10-Q).~~10-Q.

~~Operating Income~~Amortization of Acquired Intangible Assets

~~Operating income~~Amortization of acquired intangibles was $8.4 million for the nine months ended March 31, ~~2022~~2023, an increase of $1.2 million from $7.3 million in the prior year comparable period due to the acquisition of THWR in the second quarter of the prior fiscal year.

Productivity and Transformation Costs

Productivity and transformation costs were $5.7 million for the nine months ended March 31, 2023, a decrease of $2.8 million from $8.4 million in the prior year comparable period. The decrease was ~~$92.7~~primarily due to wind down of prior year restructuring costs partially offset by new spending on our strategic plan update.

Operating (Loss) Income

Operating loss for the nine months ended March 31, 2023 was $97.7 million compared to ~~$65.8~~income of $92.7 million in the prior year comparable period as a result of the items described above.

4341

Table of Contents

Interest and Other Financing Expense, Net

Interest and other financing expense, net totaled ~~$7.7~~$31.9 million for the nine months ended March 31, ~~2022,~~2023, an increase of ~~$0.9~~$24.2 million, or ~~12.5%~~315.9%, from ~~$6.8~~$7.7 million in the prior year comparable period. The increase resulted primarily ~~due to~~from a higher outstanding debt ~~balances~~balance driven primarily by the acquisition of THWR ~~acquisition and~~in the second quarter of the prior fiscal year as well as share repurchase activity ~~partially offset~~during fiscal 2022. Interest and other financing expense was also impacted by ~~lower variable~~higher interest rates ~~applied~~compared to ~~borrowings outstanding under~~ the ~~Company's revolving credit facility.~~prior comparable period. See Note 9, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Other Income, Net

Other i~~ncome,~~income, net totaled ~~$10.6~~$2.4 million for the nine months ended March 31, ~~2022,~~2023, compared to ~~$0.9~~$10.6 million in the prior year comparable period. The ~~increase~~decrease in income was primarily attributable to the recognition of an $8.7 million gain on sale of assets in the prior year period related to the sale of undeveloped land plots in Boulder, ~~Colorado resulting in a gain of $8.7 million with no comparable gain in the prior year period.~~Colorado.

(Loss) Income ~~from Continuing Operations~~ Before Income Taxes and Equity in Net Loss of Equity-Method Investees

~~Income from continuing operations~~Loss before income taxes and equity in net loss of our equity-method investees for the nine months ended March 31, ~~2022~~2023 was $127.2 million compared to income of $95.6 ~~million compared to $59.8~~ million in the prior year comparable period. The ~~increase~~decrease was due to the items discussed above.

(Benefit) Provision for Income Taxes

The provision for income taxes includes federal, foreign, state and local income taxes. Our income tax ~~expense from continuing operations~~benefit was ~~$19.4~~$30.6 million for the nine months ended March 31, ~~2022~~2023 compared to ~~$33.2~~expense of $19.4 million in the prior year comparable period. The effective income tax rate was a benefit of 24.1% and expense of 20.3% for the nine months ended March 31, 2023 and 2022, respectively.

The effective income tax rate ~~from continuing operations was an expense of 20.3% and 55.5%~~ for the nine months ended March 31, ~~2022~~2023 was impacted by ParmCrisps® and ~~2021, respectively.~~ Thinsters® trademarks and ParmCrisps® asset group impairment charges, gain on the sale of Westbrae (See Note 4, Acquisition and Disposition, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q), an operating lease modification during the second quarter, severance with respect to our former CEO (as part of the limitation on the deductibility of executive compensation), stock-based compensation and changes in uncertain tax positions. The effective income tax rate ~~from continuing operations~~ for the nine months ended March 31, 2022 was impacted by the reversal of uncertain tax position accruals based on filing and approval of certain elections by taxing authorities, deductions related to stock-based compensation, non-deductible transaction costs related to acquisition of THWR, the reversal of a valuation allowance due to the utilization of a capital loss carryover, and the finalization of fiscal year 2021 U.S. income tax returns. The effective income tax ~~rate from continuing operations for the nine months ended March 31, 2021 was negatively~~rates in each period were also impacted by ~~various discrete items including~~ the ~~tax impact~~geographical mix of ~~the United Kingdom fruit business reserve, the legal entity reorganization~~earnings and ~~the U.K. rate change.~~state income taxes.

Equity in Net Loss of Equity-Method Investees

Our equity in net loss from our equity-method investments for the nine months ended March 31, ~~2022~~2023 was ~~$1.4~~$1.2 million compared to ~~$1.0~~$1.4 million in the prior year comparable period. See Note 13, Investments, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Net (Loss) Income ~~from Continuing Operations~~

Net ~~income from continuing operations~~loss for the nine months ended March 31, ~~2022~~2023 was ~~$74.8~~$97.8 million, or ~~$0.79~~$(1.09) per diluted share, compared to ~~net~~ income of ~~$25.6 million, or $0.25 per diluted share, for the nine months ended March 31, 2021. The change was attributable to the factors noted above.~~

~~Net Income from Discontinued Operations, Net of Tax~~

Net income from discontinued operations, net of tax, for the nine months ended March 31, 2021 was $11.3 million, or $0.11 per diluted share. During the nine months ended March 31, 2021, the Company recognized an $11.3 million adjustment to the Tilda business primarily related to the recognition of a deferred tax benefit. There was no comparable line item for the nine months ended March 31, 2022.

~~See Note 4,~~ ~~Acquisitions and Dispositions, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q for further discussion.~~

~~Table of Contents~~

~~Net Income~~

~~Net income for the nine months ended March 31, 2022 was~~ $74.8 million, or $0.79 ~~per diluted share, compared to $36.9 million, or $0.36~~ per diluted share, in the prior year comparable period. The change was attributable to the factors noted above.

Adjusted EBITDA

Our Adjusted EBITDA was ~~$165.2~~$123.1 million and ~~$190.8~~$165.2 million for the nine months ended March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, as a result of the factors discussed above, and the adjustments described in the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures presented following the discussion of our results of operations. On a constant currency basis, Adjusted EBITDA decreased by $34.5 million, or 20.9%, from $165.2 million for the nine months ended March 31, 2022 to $130.7 million for the nine months ended March 31, 2023.

Table of Contents

Segment Results

The following table provides a summary of net sales and operating income by reportable segment for the nine months ended March 31, ~~2022~~2023 and ~~2021:~~2022:


(dollars in thousands)	(dollars in thousands)	North America			International			Corporate and Other			Consolidated			(dollars in thousands)	North America			International			Corporate and Other			Consolidated
Net sales	Net sales													Net sales
Nine months ended 3/31/23														Nine months ended 3/31/23	$	857,406		$	491,396		$	—		$	1,348,802
Nine months ended 3/31/22	Nine months ended 3/31/22	$	866,281		$	568,502		$	—		$	1,434,783		Nine months ended 3/31/22	866,281			568,502			—			1,434,783
Nine months ended 3/31/21		850,780			668,869			—			1,519,649
$ change	$ change	$	15,501		$	(100,367)		n/a			$	(84,866)		$ change	$	(8,875)		$	(77,106)		n/a			$	(85,981)
% change	% change	1.8		%	(15.0)		%	n/a			(5.6)		%	% change	(1.0)		%	(13.6)		%	n/a			(6.0)		%

Operating income (loss)
Operating (loss) income														Operating (loss) income
Nine months ended 3/31/23(a)														Nine months ended 3/31/23(a)	$	(79,420)		$	33,219		$	(51,513)		$	(97,714)
Nine months ended 3/31/22	Nine months ended 3/31/22	$	72,530		$	69,740		$	(49,538)		$	92,732		Nine months ended 3/31/22	72,530			69,740			(49,538)			92,732
Nine months ended 3/31/21		105,188			8,144			(47,518)			65,814
$ change	$ change	$	(32,658)		$	61,596		$	(2,020)		$	26,918		$ change	$	(151,950)		$	(36,521)		$	(1,975)		$	(190,446)
% change	% change	(31.0)		%	756.3		%	4.3		%	40.9		%	% change	(209.5)		%	(52.4)		%	4.0		%	(205.4)		%

Operating income margin
Operating (loss) income margin														Operating (loss) income margin
Nine months ended 3/31/23														Nine months ended 3/31/23	(9.3)		%	6.8		%	n/a			(7.2)		%
Nine months ended 3/31/22	Nine months ended 3/31/22	8.4		%	12.3		%	n/a			6.5		%	Nine months ended 3/31/22	8.4		%	12.3		%	n/a			6.5		%
Nine months ended 3/31/21		12.4		%	1.2		%	n/a			4.3		%

North America

Our net sales in the North America reportable segment for the nine months ended March 31, ~~2022~~2023 were ~~$866.3~~$857.4 million, ~~an increase~~a decrease of ~~$15.5~~$8.9 million, or ~~1.8%~~1.0%, from net sales of ~~$850.8~~$866.3 million in the prior year comparable period. On a constant currency basis, adjusted for the impact of acquisitions, divestitures and discontinued b~~rands,~~brands, net sales ~~increased~~decreased by ~~2.6%~~3.7% due to decreased sales in the Canada operating segment due to lower sales in personal care product categories and reduced club distribution and programming for certain brands, partially offset by increased sales in the United States operating segment ~~as a result of~~due to stronger sales in ~~certain snack products and baby food in the current year period partially offset by decreased sales in the Canada operating segment.~~snacks. Operating ~~income~~loss in North America for the nine months ended March 31, ~~2022~~2023 was ~~$72.5~~$79.4 million, ~~a decrease~~compared to operating income of ~~$32.7 million from $105.2~~$72.5 million in the prior year comparable period. The decrease was mainly driven by ~~higher cost of goods sold in the United States operating segment largely because of inflationary~~ ParmCrisps® and ~~supply chain challenges, such as continued industry-wide distribution~~Thinsters® indefinite-lived trademarks and ~~warehousing cost pressures driven by labor shortages, freight carrier availability and other freight cost issues;~~ParmCrisps® definite-lived customer relationships impairment charges and lower net sales in the Canada operating segment, partially offset by ~~lower selling, general and administrative expenses in both the United States and Canada operating segments. Lower selling, general and administrative expenses were mainly~~cost improvements due to ~~lower marketing and people-related expense.~~higher productivity.

~~Table of Contents~~

I~~nternational~~International

Our net sales in the International reportable segment for the nine months ended March 31, ~~2022~~2023 were ~~$568.5~~$491.4 million, a decrease of ~~$100.4~~$77.1 million, or ~~15.0%~~13.6%, from net sales of ~~$668.9~~$568.5 million in the prior year comparable period. On a constant currency basis, ~~adjusted for the impact of divestitures and discontinued brands,~~ net sales decreased ~~4.4%~~2.3% from the prior year comparable period mainly due to lower sales in the Europe and United Kingdom operating segments, ~~partially offset by higher sales~~particularly in relation to plant-based categories and snacks, and the impact of the loss of a large non-dairy co-manufacturing customer in the ~~Ella's Kitchen UK operating segment.~~ ~~Ella's Kitchen UK net sales improved during the nine months ended March 31, 2022 compared to~~second half of the prior ~~year period due to a slow-down in consumer demand for baby food in the prior year period as a result of the COVID-19 pandemic stay-at-home requirements which negatively impacted prior year net sales.~~fiscal year. Operating income in our International reportable segment for the nine months ended March 31, ~~2022~~2023 was ~~$69.7~~$33.2 million, ~~an increase~~a decrease of ~~$61.6~~$36.5 million from ~~operating income of $8.1~~$69.7 million for the nine months ended March 31, ~~2021. The increase mainly reflected non-recurring charges associated with~~2022. Operating income was lower in the ~~fruit business impairment that was recognized in~~current period when compared to the prior year ~~period. In addition, the International reportable segment incurred~~comparable period mainly due to lower ~~selling, general~~gross profit resulting from a decline in sales and ~~administrative expenses for the reasons noted above.~~

higher energy and supply chain costs, partially offset by lower delivery and warehouse costs due to improved utilization of warehouse space and efficiencies.

Corporate and Other

Our Corporate and Other category consists of expenses related to the Company’s centralized administrative functions, which do not specifically relate to an operating segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our entire enterpris~~e as well as expenses for certain professional fees, acquisition and divestiture transaction costs, facilities, and other items which benefit the Company as a whole.~~ Our operating ~~expenses~~loss in Corporate and Other for the nine months ended March 31, ~~2022 were $49.5~~2023 was $51.5 million, an increase of $2.0 million, from ~~$47.5~~$49.5 million in the prior year period. This change was primarily due to higher general and administrative expenses mainly related to ~~higher transaction costs incurred in fiscal year 2022 including costs related to the acquisition~~increased salaries, wages, and benefits.

Table of THWR and advisory costs related to the divestiture by affiliates of Engaged Capital, LLC of their shares of the Company's common stock, as well as higher litigation expenses related to the baby food litigation described in Note 17, Contents~~Commitments and Contingencies, partially offset by lower employee-related expenses.~~

Refer to Note ~~18,~~17, Segment Information, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Liquidity and Capital Resources

We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our Credit Agreement (as defined below). We believe that our cash flows from operations and borrowing capacity under our Credit Agreement (as defined below) will be adequate to meet anticipated operating and other expenditures for the foreseeable future.

Amended and Restated Credit Agreement

On December 22, 2021, the Company refinanced its revolving credit facility by entering into a Fourth Amended and Restated Credit Agreement ~~(the~~(as amended by a First Amendment dated December 16, 2022, the “Credit Agreement”). The Credit Agreement provides for senior secured financing of $1,100.0 million in the aggregate, consisting of (1) $300.0 million in aggregate principal amount of term loans (the ~~"Term Loans"~~“Term Loans”) and (2) an $800.0 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and is comprised of a $440.0 million U.S. revolving credit facility and $360.0 million global revolving credit facility) (the ~~"Revolver"~~“Revolver”). Both the Revolver and the Term Loans mature on December 22, 2026.

The Credit Agreement includes financial covenants that require compliance with a consolidated interest coverage ratio, a consolidated leverage ratio and a consolidated secured leverage ratio. The minimum consolidated interest coverage ratio is 2.75:1.00. The maximum consolidated leverage ratio is 6.00:1.00. Through December 31, 2023 or such earlier date as elected by the Company (the “Amendment Period”), the maximum consolidated secured leverage ratio is 5.00:1.00. Following the Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions.

During the Amendment Period, loans under the Credit Agreement will bear interest at (a) the Secured Overnight Financing Rate, plus a credit spread adjustment of 0.10% (as adjusted, “Term SOFR”) plus 2.0% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 1.0% per annum. Following the Amendment Period, loans will bear interest at rates based on (a) Term SOFR plus a rate ranging from 0.875% to 1.750% per annum or (b) the Base Rate plus a rate ranging from 0.00% to 0.750% per annum, the relevant rate in each case being the Applicable Rate. The Applicable Rate following the Amendment Period will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. The weighted average interest rate on outstanding borrowings under the Credit Agreement at March 31, 2023 was 5.90%. Additionally, the Credit Agreement contains a Commitment Fee (as defined in the Credit Agreement) on the amount unused under the Credit Agreement ranging from 0.15% to 0.25% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

As of March 31, 2023, there were$567.0 million of loans under the Revolver, $290.6 million of Term Loans, and $4.1 million letters of credit outstanding under the Credit Agreement. As of March 31, 2023, $228.9 million was available under the Credit Agreement, subject to compliance with the financial covenants, as compared to $204.0 million as of June 30, 2022. As of March 31, 2023, the Company was in compliance with all associated covenants.

In addition to obligations under the Credit Agreement, we are party to other contractual obligations involving commitments to make payments to third parties, including purchase commitments and lease obligations, which impact our short-term and long-term liquidity and capital resource needs. See Note 7, Leases, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Our cash and cash equivalents balance decreased ~~$18.1~~$21.8 million at March 31, ~~2022~~2023 to ~~$57.8~~$43.7 million as compared to ~~$75.9~~$65.5 million at June 30, ~~2021.~~2022. Our working capital ~~from continuing operations~~ was ~~$273.6~~$348.1 million at March 31, ~~2022, a decrease~~2023, an increase of ~~$11.1~~$19.1 million from ~~$284.7~~$329.0 million at the end of fiscal ~~2021.~~2022. Additionally, our total de~~bt increased~~debt decreased by ~~$604.5~~$32.1 million at March 31, ~~2022~~2023 to ~~$835.5~~$856.6 million as compared to ~~$231.0~~$888.6 million at June 30, ~~2021~~2022 as a result of ~~increased~~$31.6 million of net ~~borrowings to support the THWR acquisition and~~ ~~the share repurchases~~repayments carried out during the period. ~~As of March 31, 2022, $253.1 million was available under the Credit Agreement as compared to $763.6 million available as of June 30, 2021~~ ~~under the predecessor agreement to the Credit Agreement. The Company was in compliance with all covenants at March 31, 2022.~~

Liquidity is affected by many factors, some of which are based on normal ongoing operations of the Company’s business and some of which arise from fluctuations related to global economics and markets. Our cash balances are held in the United States, United Kingdom, Canada, Europe, the Middle East and India. As of March 31, ~~2022,~~2023, substantially all ~~of the total~~ cash ~~balance from continuing operations~~ was held outside of the United States. ~~It is our current intent to indefinitely reinvest our remaining foreign earnings outside the United States.~~

4644

Table of Contents

We maintain our cash and cash equivalents primarily in money market funds or their equivalent. ~~As of March 31, 2022, all of our investments were expected to mature in less than three months.~~ Accordingly, we do not believe that our investments have significant exposure to interest rate risk. Cash (used in) provided by ~~(used in)~~ operating, investing and financing activities is summarized below.

Nine Months Ended March 31, Change in
(amounts in thousands) 2022 2021 Dollars
Cash flows provided by (used in):
Operating activities from continuing operations $ 99,186 $ 146,517 $ (47,331)
Investing activities from continuing operations (284,271) (25,968) (258,303)
Financing activities from continuing operations 172,858 (110,956) 283,814
Effect of exchange rate changes on cash from continuing operations (5,836) 5,650 (11,486)
Net (decrease) increase in cash and cash equivalents $ (18,063) $ 15,243 $ (33,306)


	Nine Months Ended March 31,				Change in
(amounts in thousands)	2023		2022		Dollars
Cash flows provided by (used in):
Operating activities	$	26,309	$	99,186	$	(72,877)
Investing activities	(13,243)		(284,271)		271,028
Financing activities	(34,792)		172,858		(207,650)
Effect of exchange rate changes on cash	(104)		(5,836)		5,732


Net decrease in cash and cash equivalents	$	(21,830)	$	(18,063)	$	(3,767)

Cash provided by operating activities ~~from continuing operations~~ was ~~$99.2~~$26.3 million for the nine months ended March 31, ~~2022,~~2023, a decrease of ~~$47.3~~$72.9 million from cash provided by operating activities ~~from continuing operations~~ of ~~$146.5~~$99.2 million in the prior year period. This decrease versus the prior period resulted primarily from a reduction of ~~$18.1~~$60.5 million in net income adjusted for non-cash charges in the current period and ~~lower~~higher cash ~~generation~~utilization of ~~$29.2~~$12.3 million from our working capital accounts ~~which was mainly~~primarily due to a ~~refund~~higher account receivable balance due to timing of ~~$53.8 million received~~cash receipts, partially offset by ~~the Company~~a reduction in the ~~prior year from Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act").~~change in other current assets.

Cash used in investing activities ~~from continuing operations~~ was ~~$284.3~~$13.2 million for the nine months ended March 31, ~~2022, an increase~~2023, a decrease of ~~$258.3~~$271.0 million from ~~$26.0~~$284.3 million in the prior year period primarily due to the acquisition of THWR in the ~~current year, partially offset by $10.8 million in proceeds from~~same period of the ~~sale of assets in the current year, which was primarily related to~~ ~~the sale of undeveloped land plots in Boulder, Colorado~~.prior year.

Cash ~~provided by~~used in financing activities ~~from continuing operations~~ was ~~$172.9~~$34.8 million for the nine months ended March 31, ~~2022, an increase~~ ~~in cash provided~~2023, a decrease of ~~$283.8~~$207.7 million compared to ~~$111.0~~$172.9 million of cash ~~used~~provided in the prior year period. The ~~increase~~decrease in c~~ash~~cash provided by f~~inancing~~financing activities ~~was~~is primarily due to higher borrowings under the Credit Agreement to finance the THWR acquisition, ~~partially offset by higher repayments under the revolver,~~ higher share repurchases, and payment of shares withheld for employee payroll taxes during the ~~nine months ended March 31, 2022.~~same period in the prior year.

Operating Free Cash ~~Flow from Continuing Operations~~Flows

~~Our operating~~Operating free cash ~~flow from~~ ~~continuing operations was $65.2~~flows were $4.9 million for the nine months ended March 31, ~~2022,~~2023, a decrease of ~~$28.2~~$60.4 million from ~~$93.5~~$65.2 million provided by operating free cash flows in the nine months ended March 31, ~~2021.~~2022. This decrease versus the prior year period resulted primarily from a decrease in cash flow from operations of ~~$47.3~~$72.9 million driven by the reasons explained ~~above. Additionally, the decrease was due to a $19.1 million~~above, partially offset by reduction in ~~property, plant and equipment purchases in the current period.~~capital expenditures. See the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation from our net cash provided by operating activities ~~from continuing operations~~ to operating free cash ~~flow from continuing operations.~~flows.

Share Repurchase Program

In ~~June 2017, August 2021 and~~ January 2022, the Company’s Board of Directors authorized the repurchase of up to ~~$250.0 million, $300.0 million and~~ $200.0 million of the Company’s issued and outstanding common ~~stock, respectively.~~stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. ~~The 2017 and 2021 authorizations have been fully utilized.~~ The current 2022 authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. In November 2021, the Company entered into a share repurchase agreement with affiliates of Engaged Capital, LLC (collectively, the “Selling Stockholders”), pursuant to which the Company repurchased 1.7 million shares directly from the Selling Stockholders at a price of $45.00 per share. During the nine months ended March 31, ~~2022,~~2023, the Company ~~repurchased 10.1 million~~did not repurchase any shares under the repurchase ~~program, inclusive of the shares repurchased from the Selling Stockholders, for a total of $395.8 million, excluding commissions, at an average price of $39.09 per share.~~program. As of March 31, ~~2022,~~2023, the Company had ~~$186.6~~$173.5 million of remaining authorization under the share repurchase program. ~~During the nine months~~

~~Table of Contents~~

~~ended March 31, 2021, the Company repurchased~~ ~~2.4 million~~ ~~shares under the repurchase program for a total of $80.3 million, excluding commissions, at an average price of $33.33 per share.~~

Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures

We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these measures provide useful information to investors and include these measures in other communications to investors.

For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-U.S. GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board of Directors believe the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors use the non-U.S. GAAP measures. These non-U.S. GAAP measures should be viewed in addition to, and not in lieu of, the comparable U.S. GAAP measures.

Table of Contents

Net Sales - Constant Currency Presentation

We believe that ~~this measure~~net sales adjusted for the impact of foreign currency provides useful information to investors because it provides transparency to underlying performance in our consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on year-to-year comparability given the volatility in foreign currency exchange markets. To present ~~this information~~net sales adjusted for ~~historical periods,~~the impact of foreign currency, current period net sales for entities reporting in currencies other than the U.S. Dollar are translated into U.S. Dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal period and the corresponding period of the prior fiscal year.

Net Sales - Adjusted for the Impact of Acquisitions, Divestitures and Discontinued Brands

We also exclude the impact of acquisitions, divestitures and discontinued brands when comparing net sales to prior periods, which results in the presentation of certain non-U.S. GAAP financial measures. The Company's management believes that excluding the impact of acquisitions, divestitures and discontinued brands when presenting period-over-period results of net sales aids in comparability.

To present net sales adjusted for the impact of acquisitions, the net sales of an acquired business are excluded from fiscal quarters constituting or falling within the current period and prior period where the applicable fiscal quarter in the prior period did not include the acquired business for the entire quarter. To present net sales adjusted for the impact of divestitures and discontinued brands, the net sales of a divested business or discontinued brand are excluded from all periods.

A reconciliation between reported net sales and net sales adjusted for the impact of foreign currency, acquisitions, divestitures and discontinued brands is as follows:

Table of Contents

~~A reconciliation between reported and constant currency net sales increase (decrease) is as follows:~~

(amounts in thousands) North America International Hain Consolidated
Net sales - Three months ended March 31, 2022 $ 325,742 $ 177,197 $ 502,939
Acquisitions, divestitures and discontinued brands (25,232) — (25,232)
Impact of foreign currency exchange 30 7,301 7,331
Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands - Three months ended March 31, 2022 $ 300,540 $ 184,498 $ 485,038
Net sales - Three months ended March 31, 2021 $ 287,500 $ 205,104 $ 492,604
Divestitures and discontinued brands (10,562) (4,224) (14,786)
Net sales adjusted for divestitures and discontinued brands - Three months ended March 31, 2021 $ 276,938 $ 200,880 $ 477,818
Net sales growth (decline) 13.3 % (13.6) % 2.1 %
Impact of acquisitions, divestitures and discontinued brands (4.8) % 1.8 % (2.1) %
Impact of foreign currency exchange — % 3.6 1.5 %
Net sales growth (decline) on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands 8.5 % (8.2) % 1.5 %
Net sales - Nine months ended March 31, 2022 $ 866,281 $ 568,502 $ 1,434,783
Acquisitions, divestitures and discontinued brands (25,759) — (25,759)
Impact of foreign currency exchange (2,697) (1,067) (3,764)
Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands - Nine months ended March 31, 2022 $ 837,825 $ 567,435 $ 1,405,260
Net sales - Nine months ended March 31, 2021 $ 850,780 $ 668,869 $ 1,519,649
Divestitures and discontinued brands (34,536) (75,511) (110,047)
Net sales adjusted for divestitures and discontinued brands - Nine months ended March 31, 2021 $ 816,244 $ 593,358 $ 1,409,602
Net sales growth (decline) 1.8 % (15.0) % (5.6) %
Impact of acquisitions, divestitures and discontinued brands 1.1 % 10.8 % 5.5 %
Impact of foreign currency exchange (0.3) % (0.2) % (0.2) %
Net sales growth (decline) on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands 2.6 % (4.4) % (0.3) %


(amounts in thousands)	North America			International			Hain Consolidated
Net sales - Three months ended March 31, 2023	$	286,649		$	168,594		$	455,243
Acquisitions, divestitures and discontinued brands	(163)			—			(163)
Impact of foreign currency exchange	1,881			14,760			16,641
Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands - Three months ended March 31, 2023	$	288,367		$	183,354		$	471,721

Net sales - Three months ended March 31, 2022	$	325,742		$	177,197		$	502,939
Acquisitions, divestitures and discontinued brands	(2,311)			—			(2,311)
Net sales adjusted for acquisitions, divestitures and discontinued brands - Three months ended March 31, 2022	$	323,431		$	177,197		$	500,628

Net sales decline	(12.0)		%	(4.9)		%	(9.5)		%
Impact of acquisitions, divestitures and discontinued brands	0.6		%	—		%	0.4		%
Impact of foreign currency exchange	0.6		%	8.4			3.3		%
Net sales (decline) growth on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands	(10.8)		%	3.5		%	(5.8)		%

Net sales - Nine months ended March 31, 2023	$	857,406		$	491,396		$	1,348,802
Acquisitions, divestitures and discontinued brands	(34,663)			—			(34,663)
Impact of foreign currency exchange	5,024			64,266			69,290
Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands - Nine months ended March 31, 2023	$	827,767		$	555,662		$	1,383,429

Net sales - Nine months ended March 31, 2022	$	866,281		$	568,502		$	1,434,783
Acquisitions, divestitures and discontinued brands	(7,142)			—			(7,142)
Net sales adjusted for acquisitions, divestitures and discontinued brands - Nine months ended March 31, 2022	$	859,139		$	568,502		$	1,427,641

Net sales decline	(1.0)		%	(13.6)		%	(6.0)		%
Impact of acquisitions, divestitures and discontinued brands	(3.3)		%	—		%	(1.9)		%
Impact of foreign currency exchange	0.6		%	11.3		%	4.8		%
Net sales decline on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands	(3.7)		%	(2.3)		%	(3.1)		%

Adjusted EBITDA

The Company defines Adjusted EBITDA ~~is defined~~ as net income before net interest expense, income taxes, depreciation and amortization, equity in net loss ~~(income)~~ of equity-method investees, stock-based compensation, net, unrealized currency ~~gains and~~ losses (gains), certain litigation and related costs, CEO succession costs, plant closure related ~~costs, net,~~costs-net, productivity and transformation costs, warehouse and manufacturing consolidation and other costs, costs associated with acquisitions, divestitures and other transactions, gains ~~or losses~~ on sales of assets, ~~and businesses,~~certain inventory write-downs, ~~impairment of~~intangibles and long-lived ~~assets and intangibles~~asset impairment and other adjustments. The Company’s management believes that this presentation provides useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses this measure for reviewing the financial results of the Company and as a component of performance-based

~~Table of Contents~~

executive compensation. Adjusted EBITDA is a non-U.S. GAAP measure and may not be comparable to similarly titled measures reported by other companies.

Table of Contents

We do not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP. The principal limitation of Adjusted EBITDA is that it excludes certain expenses and income that are required by U.S. GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S. GAAP results.

A reconciliation of net (loss) income to Adjusted EBITDA is as follows:

Three Months Ended March 31, Nine Months Ended March 31,
(amounts in thousands) 2022 2021 2022 2021
Net income $ 24,531 $ 34,254 $ 74,831 $ 36,879
Net income from discontinued operations, net of tax — — — 11,255
Net income from continuing operations $ 24,531 $ 34,254 $ 74,831 $ 25,624
Depreciation and amortization 12,638 12,814 34,396 37,768
Equity in net loss (income) of equity-method investees 383 (70) 1,374 1,025
Interest expense, net 2,846 1,327 5,677 4,781
Provision for income taxes 7,738 11,797 19,425 33,197
Stock-based compensation, net 3,846 3,698 12,289 11,888
Unrealized currency (gains) losses (594) 442 (2,097) (535)
Litigation and related costs
Litigation expenses 2,005 644 5,585 644
Proceeds from insurance claim — (592) (196) (592)
Restructuring activities
Plant closure related costs, net 82 21 895 17
Productivity and transformation costs 1,626 3,813 7,077 8,952
Warehouse/manufacturing consolidation and other costs 94 3,598 2,632 7,313
Acquisitions, divestitures and other
Transaction and integration costs, net 3,419 102 12,151 1,476
Loss (gain) on sale of assets 55 — (9,047) —
Loss on sale of businesses — 1,904 1,293
Impairment charges
Inventory write-down — — (46) 311
Long-lived asset and intangibles impairment — — 303 57,676
Adjusted EBITDA $ 58,669 $ 73,752 $ 165,249 $ 190,838

Table of Contents


	Three Months Ended March 31,				Nine Months Ended March 31,
(amounts in thousands)	2023		2022		2023		2022
Net (loss) income	$	(115,727)	$	24,531	$	(97,838)	$	74,831



Depreciation and amortization	13,784		12,638		37,909		34,396
Equity in net loss of equity-method investees	528		383		1,226		1,374
Interest expense, net	12,924		2,846		30,582		5,677
(Benefit) provision for income taxes	(39,587)		7,738		(30,599)		19,425
Stock-based compensation, net	3,228		3,846		10,657		12,289
Unrealized currency losses (gains)	202		(594)		651		(2,097)
Litigation and related costs
Certain litigation expenses, net(a)	(1,582)		2,005		3,363		5,389


Restructuring activities
CEO succession	—		—		5,113		—
Plant closure related costs, net	22		82		73		895
Productivity and transformation costs	3,933		1,626		5,692		7,077
Warehouse/manufacturing consolidation and other costs, net	2,871		94		899		2,632
Acquisitions, divestitures and other
Transaction and integration costs, net	215		3,419		1,984		12,151
(Gain) loss on sale of assets	(134)		55		(3,529)		(9,047)

Impairment charges
Inventory write-down	—		—		—		(46)
Intangibles and long-lived asset impairment	156,583		—		156,923		303
Adjusted EBITDA	$	37,260	$	58,669	$	123,106	$	165,249

(a) Expenses and items relating to securities class action and baby food litigation.

Adjusted EBITDA - Constant Currency Presentation

The Company provides Adjusted EBITDA and Adjusted EBITDA on a constant currency basis because the Company’s management believes that these presentations provide useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses these measures for reviewing the financial results of the Company as well as a component of performance-based executive compensation. The Company believes presenting Adjusted EBITDA on a constant currency basis provides useful information to investors because it provides transparency to underlying performance in the Company’s Adjusted EBITDA by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets.

Table of Contents

A reconciliation between Adjusted EBITDA and constant currency Adjusted EBITDA for the three months ended March 31, 2023 and 2022 is as follows:


(amounts in thousands)	Hain Consolidated
Adjusted EBITDA - Three months ended March 31, 2023	$	37,260
Impact of foreign currency exchange	2,067
Adjusted EBITDA on a constant currency basis - Three months ended March 31, 2023	$	39,327

Adjusted EBITDA - Three months ended March 31, 2022	$	58,669

A reconciliation between Adjusted EBITDA and constant currency Adjusted EBITDA for the nine months ended March 31, 2023 and 2022 is as follows:


(amounts in thousands)	Hain Consolidated
Adjusted EBITDA - Nine months ended March 31, 2023	$	123,106
Impact of foreign currency exchange	7,594
Adjusted EBITDA on a constant currency basis - Nine months ended March 31, 2023	$	130,700

Adjusted EBITDA - Nine months ended March 31, 2022	$	165,249

Operating Free Cash ~~Flow from Continuing Operations~~Flows

In our internal evaluations, we use the non-U.S. GAAP financial measure “Operating Free Cash ~~Flow from continuing operations.”~~Flows” The difference between Operating Free Cash ~~Flow from continuing operations~~Flows and cash flow provided by or used in operating activities, ~~from continuing operations,~~ which is the most comparable U.S. GAAP financial measure, is that Operating Free Cash ~~Flow from continuing operations~~Flows reflects the impact of purchases of property, plant and equipment (capital spending). Since capital spending is essential to maintaining our operational capabilities, we believe that it is a recurring and

~~Table of Contents~~

necessary use of cash. As such, we believe investors should also consider capital spending when evaluating our cash provided by or used in operating activities. We view Operating Free Cash ~~Flow from continuing operations~~Flows as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments. We do not consider Operating Free Cash ~~Flow from continuing operations~~Flows in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP.

A reconciliation from cash ~~flow~~flows provided by operating activities ~~from continuing operations~~ to Operating Free Cash ~~flow from continuing operations~~Flows is as follows:


		Nine Months Ended March 31,					Nine Months Ended March 31,
(amounts in thousands)	(amounts in thousands)	2022		2021		(amounts in thousands)	2023		2022
Net cash provided by operating activities from continuing operations		$	99,186	$	146,517
Net cash provided by operating activities						Net cash provided by operating activities	$	26,309	$	99,186
Purchases of property, plant and equipment	Purchases of property, plant and equipment	(33,939)		(53,062)		Purchases of property, plant and equipment	(21,434)		(33,939)
Operating free cash flow from continuing operations		$	65,247	$	93,455
Operating free cash flows						Operating free cash flows	$	4,875	$	65,247

~~Off-Balance Sheet Arrangements~~

~~At March 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303~~

Table of ~~Regulation S-K that have had, or are likely to have, a material current or future effect on our consolidated financial statements.~~

Contents

Critical Accounting Estimates

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. We believe in the quality and reasonableness of our critical accounting policies; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have applied. The accounting policies that have been identified as critical to our business operations and to understanding the results of our operations pertain to ~~revenue recognition, trade promotions and sales incentives,~~variable consideration, valuation of accounts and chargeback receivable, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation and valuation allowances for deferred tax assets. The application of each of these critical accounting policies and estimates is discussed in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021,~~2022 from which there have been no material changes.

Recent Accounting Pronouncements

Refer to Note 2, Basis of Presentation, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Seasonality

Certain of our product lines have seasonal fluctuations. Hot tea, hot-eating desserts and soup sales are stronger in colder months, while sales of snack foods, sunscreen and certain of our personal care products are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations. In recent years, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in market risk from those addressed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021~~2022 during the nine months ended March 31, ~~2022.~~2023. See the information set forth in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk, of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021.~~2022.

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), with the assistance of other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Our disclosure controls and procedures are intended to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Consistent with guidance issued by the Securities and Exchange Commission that an assessment of internal controls over financial reporting of a recently acquired business may be omitted from management's evaluation of disclosure controls and procedures, management is excluding an assessment of such internal controls of Proven Brands, Inc. (and its subsidiary That's How We Roll LLC) and KTB Foods Inc. (collectively doing business as "That's How We Roll" ("THWR")) from its evaluation of the effectiveness of the Company's disclosure controls and procedures. The Company acquired all outstanding stock of THWR on December 28, 2021. THWR represented approximately 13.2% of the Company's consolidated total assets at March 31, 2022. THWR's net sales included in our consolidated results were 5.0% and 1.8% for the three and nine months ended March 31, 2022. Based on this review, our CEO and CFO have concluded that the disclosure controls and procedures for the Company were effective as of March 31, ~~2022.~~2023.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect every misstatement. An evaluation of effectiveness is subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may decrease over time.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting that occurred during the ~~three months~~quarter ended March 31, ~~2022~~2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting except that, as reported above, on December 28, 2021, the Company acquired all outstanding stock of THWR. As a result, the Company is currently integrating THWR’s operations into its overall system of internal control over financial reporting and, if necessary, will make appropriate changes as it integrates THWR into the Company's overall internal control over financial reporting process.reporting.

Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

The information called for by this item is incorporated herein by reference to Note ~~17,~~16, Commitments and Contingencies, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Item 1A. Risk Factors

There have been no material changes from the discussion of the material factors that make an investment in the Company speculative or risky contained in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021,~~2022, filed with the SEC on August ~~26, 2021.~~25, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The table below sets forth information regarding repurchases by the Company of its common stock during the periods indicated.

Period (a)
Total number
of shares
purchased (1)
(b)
Average
price paid
per share
(c)
Total number of
shares purchased
as part of
publicly
announced plans
(d)
Maximum
number of shares
that may yet be
purchased under
the plans (in millions of dollars) (2)
January 1, 2022 - January 31, 2022 2,332,093 $ 37.80 2,295,033 $ 230.3
February 1, 2022 - February 28, 2022 425,086 36.46 421,762 $ 214.9
March 1, 2022 - March 31, 2022 857,340 33.07 857,340 $ 186.6
Total 3,614,519 $ 36.52 3,574,135


Period	(a) Total number of shares purchased (1)	(b) Average price paid per share		(c) Total number of shares purchased as part of publicly announced plans	(d) Maximum number of shares that may yet be purchased under the plans (in millions of dollars) (2)
January 1, 2023 - January 31, 2023	—	$	—	—	$	173.5
February 1, 2023 - February 28, 2023	(3,260)	(20.48)		—	$	173.5
March 1, 2023 - March 31, 2023	—	—		—	$	173.5
Total	(3,260)	$	(20.48)	—

(1) ~~Includes~~Consists of shares surrendered for payment of employee payroll taxes due on shares issued under stock-based compensation ~~plans and shares repurchased under share repurchase programs approved by the Board of Directors. See (2) below for further details.~~plans.

(2) In ~~June 2017, August 2021, and~~ January 2022, the ~~Company’s~~Company's Board of Directors authorized the repurchase of up to ~~$250 million, $300 million, and~~ $200 million ~~respectively,~~ of the Company’s issued and outstanding common stock. ~~Share repurchases under the 2021 and 2022 authorizations commenced after the previous authorizations were fully utilized.~~ Repurchases may be made from time to time in the open market, pursuant to ~~preset~~pre-set trading plans, in private transactions or otherwise. The ~~current 2022~~ authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions, and other corporate considerations. During the ~~three months~~quarter ended March 31, ~~2022,~~2023, the Company ~~repurchased 3.6 million~~did not repurchase any shares under the repurchase ~~program for a total of $130.4 million, excluding commissions, at an average price of $36.48 per share.~~program. As of March 31, ~~2022,~~2023, the Company had ~~$186.6~~$173.5 million of remaining authorization under the share repurchase program.

Table of Contents

Item 5. Other Information

Amended and Restated By-Laws

On May ~~3, 2022,~~8, 2023, the ~~Company’s~~ Board of Directors ~~eliminated the position of Executive Vice President and Chief Commercial Officer as part of a restructuring~~(the “Board”) of the ~~leadership~~Company approved an amendment and restatement of the Company’s ~~Commercial organization. Accordingly, Christopher J. Boever,~~By-Laws (as amended and restated, the ~~Company’s current Executive Vice President and Chief Commercial Officer, is leaving the Company~~“By-Laws”), effective May ~~6, 2022. Mr. Boever’s responsibilities will be assumed by other executives within the Company’s Commercial organization.~~8, 2023, as set forth below.

~~Mr. Boever is entitled~~Advance Notice Amendment

The By-Laws were primarily amended to ~~receive the cash severance that is payable under the terms~~establish informational, timing and procedural requirements for stockholders intending to submit a proposal or director nomination at either an annual or special meeting of ~~his existing offer letter upon a termination of his employment by the Company without cause, subject to his execution of a separation agreement and release of claims.~~stockholders, including:

•for a stockholder to properly bring a nomination or other business before an annual meeting of stockholders, the stockholder must generally provide notice to the Company’s Secretary not less than ninety (90) days nor more than one hundred twenty (120) days prior to the first anniversary of the preceding year’s annual meeting of stockholders;

•the stockholder’s notice must provide certain information or other documentation about the stockholder and, if applicable, specified information related to the stockholder’s director nominee or to the other business brought by the stockholder; and

•in light of the adoption of Rule 14a-19 of the Securities Exchange Act of 1934, as amended, to provide for universal proxies, the By-Laws require stockholders relying on the universal proxy rule to make certain representations to the Company, certify compliance with the universal proxy rule and submit director nominee questionnaires to the Company’s Secretary.

Administrative Amendments

The By-Laws were also amended to incorporate certain administrative amendments, including to (i) conform the Company’s meeting notice provision with the applicable Delaware statute, (ii) incorporate a new Delaware law provision related to notices of adjournments, including with respect to remote meetings of stockholders, and (iii) remove the requirement that the Company provide a list of stockholders at stockholder meetings in line with Delaware law updates. Moreover, the By-Laws provide that any stockholder soliciting proxies from other stockholders must use a proxy card color other than white, which color is reserved for the exclusive use by the Board.

The foregoing description is qualified in its entirety by reference to the By-Laws, which are attached hereto as Exhibit 3.2 and incorporated herein by reference.

Table of Contents

Item 6. Exhibits


Exhibit Number						Description

3.1						Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021, filed with the SEC on August 26, 2021).

3.2						3.Amended and Restated By-Laws.

23.3						Amended and Restated By-Laws, ~~(incorporated by reference~~marked to ~~Exhibit 3.1~~show amendments effective as of ~~the Company’s Current Report on Form 8-K filed with the SEC on December 7, 2018).~~May 8, 2023.

4.1						Specimen of common stock certificate (incorporated by reference to Exhibit 4.1 of Amendment No. 1 to the Company’s Registration Statement on Form S-4 filed with the SEC on April 24, 2000).

10.1*						~~Offer Letter, dated January 18, 2022, between the Company and Christopher J. Bellairs.~~

10.2*						Restricted Share Unit Agreement under The Hain Celestial Group, Inc. ~~Amended and Restated 2002~~2022 Long Term Incentive and Stock Award Plan – ~~Christopher J. Bellairs (2022-2024~~Wendy P. Davidson (2023-2025 LTIP).

10.2*						~~31.1~~Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Wendy P. Davidson (2023-2025 LTIP; Relative Total Shareholder Return).

10.3*						Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Wendy P. Davidson (2023-2025 LTIP; Absolute Total Shareholder Return).

10.4*						Restricted Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Wendy P. Davidson (Make-Whole RSU Award).

10.5*						Separation Agreement, dated as of February 6, 2023, between the Company and David J. Karch.











31.1						Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.

31.2						Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.

32.1						Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2						Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH						Inline XBRL Taxonomy Extension Schema Document.

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*Indicates management contract or compensatory plan or arrangement.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

5455

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		THE HAIN CELESTIAL GROUP, INC.
		(Registrant)

Date:	May ~~5, 2022~~9, 2023	/s/ ~~Mark L. Schiller~~Wendy P. Davidson
		~~Mark L. Schiller,~~Wendy P. Davidson, President and Chief Executive Officer


Date:	May ~~5, 2022~~9, 2023	/s/ Christopher J. Bellairs
		Christopher J. Bellairs, Executive Vice President and Chief Financial Officer (Principal Financial ~~and Accounting~~ Officer)


Date:	May 9, 2023	/s/ Michael J. Ragusa
		Michael J. Ragusa, Senior Vice President and Chief Accounting Officer (Principal Accounting Officer)

5556


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statements of Operations on Cash Flow Hedging Relationships
				Three Months Ended March 31, 2022						Three Months Ended March 31, 2021
				Cost of sales		Interest and other financing expense, net		Other expense/income, net		Cost of sales		Interest and other financing expense, net		Other expense/income, net
The effects of cash flow hedging:
	(Loss) Gain on cash flow hedging relationships
		Interest rate swaps
			Amount of loss reclassified from AOCL into income	$	—	$	(64)	$	—	$	—	$	(82)	$	—

		Cross-currency swaps
			Amount of gain reclassified from AOCL into income	$	—	$	46	$	637	$	—	$	39	$	1,200

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	81	$	—	$	—	$	—	$	—	$	—


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statements of Operations on Cash Flow Hedging Relationships
				Nine Months Ended March 31, 2022						Nine Months Ended March 31, 2021
				Cost of sales		Interest and other financing expense, net		Other expense (income), net		Cost of sales		Interest and other financing expense, net		Other expense (income), net
The effects of cash flow hedging:
	(Loss) Gain on cash flow hedging relationships
		Interest rate swaps
			Amount of loss reclassified from AOCL into income	$	—	$	(273)	$	—	$	—	$	(212)	$	—

		Cross-currency swaps
			Amount of gain (loss) reclassified from AOCL into income	$	—	$	131	$	1,954	$	—	$	120	$	(1,240)

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	107	$	—	$	—	$	73	$	—	$	—


	Balance at June 30, 2021		Charges (Reversals)		Amounts Paid		Foreign Currency Translation & Other Adjustments		Balance at March 31, 2022
Termination benefits and personnel realignment	$	4,448	$	1,912	$	(5,126)	$	(18)	$	1,216